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ABSTRACT
Cvetkov, T.L. Ph.D., Biomedical Sciences Ph.D. Program, Wright State University,
2010. Cytochrome c Oxidase from Rhodobacter sphaeroides: Oligomeric Structure in the
Phospholipid Bilayer and the Structural and Functional Effects of a C-Terminal
Truncation in Subunit III.
Cytochrome c oxidase (COX) of the mitochondrial electron transport chain
catalyzes the reduction of oxygen to water while concomitantly translocating protons
across the inner mitochondrial membrane. This two part dissertation is a structural and
functional investigation of COX using the bacterial model system from Rhodobacter
sphaeroides (R.sph.).
First, the oligomeric structure of R.sph. COX within the lipid bilayer was
investigated using discontinuous sucrose gradient ultracentrifugation. Utilizing this
technique, liposomes containing R.sph. COX (pCOV) were separated from liposomes
lacking enzyme (COV). The net buffering capacity and degree of light scattering per
COX molecule were reduced in pCOVs, making them well suited for low buffer
spectroscopic studies. Also, pCOVs maintained high oxygen reduction and proton
pumping activities relative to COVs, indicating minimal damage induced by the
centrifugation process. Quantitative lipid and protein concentrations were used to
estimate the number of COX molecules per vesicle in the pCOVs. There was only one
R.sph. COX molecule per vesicle, indicating that within the lipid bilayer, R.sph. COX
exists in the monomeric state in contrast to the bovine enzyme which is dimeric. As a
monomer, therefore, R.sph. COX is capable of maximal electron transfer and proton
pumping efficiency.
iii

Second, the structural and functional effects of a c-terminal subunit III truncation
were characterized in R.sph. in order to gain insight into the critical role played by this
subunit in proper COX functioning. The mutation was modeled after a human
mitochondrial disease mutation which genetically truncates subunit III after the third of
its seven helices (114 COX). In R.sph. cells,114 COX had lower expression levels
and impeded rates of COX assembly. Altered levels of native in vivo processing of
subunits II and IV were observed in 114 COX and in COX which had subunit III
genetically removed (I-II COX). The truncated subunit III was incorporated into the COX
complex with at least 70% stoichiometry and was subject to proteolytic processing at a
specific cleavage site. Prior to enzymatic turnover induced inactivation, the proton
pumping and oxygen reduction activities of 114 COX were half that of wildtype and
equivalent to I-II COX at physiological pH. 114 and I-II COX had similar catalytic
lifetimes in detergent micelle, but when supplemented with phospholipids from soybean,
the catalytic lifetime of 114 COX was increased compared to I-II COX. Taken together,
these results indicate that the c-terminal bundle of subunit III plays a role in the assembly
of COX in R.sph. and in the native processing of subunits II and IV. They also highlight
the role of the structural lipids within the v-shaped cleft of subunit III as being important
for providing protection against turnover induced inactivation.

iv

TABLE OF CONTENTS
Page
I.

INTRODUCTION
The Mitochondrial Electron Transport Chain
The Mitochondrion………………………………………………………..1
The Electron Transport Chain and Chemiosmotic Theory………………..6
The Structure and Function of Cytochrome c Oxidase
Three Dimensional Structure…………………………………………….11
Proton and Electron Transfer…………………………………………….23
The Functional Role of Subunit III……………………………………....31
Specific Aims………………………………………………………………...36

II.

MATERIALS AND METHODS
Mutagenesis of R.sph. COX Subunit III……………………………………..38
Expression and Purification of R.sph. COX…………………………………45
Biochemical Depletion of Subunit III………………………………………..47
Two Dimensional PAGE…………………………………………………….48
Silver Staining Polyacrylamide Protein Gels………………………………...49
Estimating Subunit III Content in 114 COX……………………………….49
Protein Immunoblotting of COX Subunit III………………………………...50
MALDI-TOF Mass Spectrometry of COX…………………………………..51
Catalytic Activity and Catalytic Lifetime Measurement…………………….52
v

TABLE OF CONTENTS (Continued)
Page
Measuring the pH Dependence of Activity and Catalytic Lifetime…………53
Calculating Turnover Induced Inactivation of Mutant COX………………...53
Reconstitution of COX into Phospholipid Vesicles………………………….56
Measuring the Respiratory Control Ratio of COVs………………………….59
Stopped-Flow Measurement of Proton Pumping Activity…………………...60
Discontinuous Sucrose Gradient Ultracentrifugation………………………..62
Estimation of the Number of COX Molecules per Vesicle………………….62
III.

RESULTS
Part 1: Biophysical and Biochemical Characterization of pCOV
Purification of COVs via Discontinuous Sucrose Gradient
Ultracentrifugation……………………………………………………….66
Functional and Biophysical Properties of COV and pCOV……………..67
Estimation of the Number of COX Molecules per pCOV……………….73
Part 2: Structural and Functional Characterization of R.sph. 114 COX
Expression and Purification……………………………………………...75
Optical Absorbance Analysis…………………………………………….80
SDS-PAGE and Immunoblot Analysis…………………………………..85
MALDI-TOF Mass Spectral Analysis…………………………………...89
Two Dimensional PAGE Analysis……………………………………..101
Steady State Catalytic Activity…………………………………………110
Turnover Induced Inactivation.................................................................117
Proton Pumping Activity.........................................................................121
vi

TABLE OF CONTENTS (Continued)
Page
IV.

DISCUSSION
Characterization of R.sph. pCOV: Insight into the Oligomeric
Structure of R.sph. COX................................................................................127
Discontinuous Sucrose Gradient Ultracentrifugation…………………..128
The Oligomeric Structure of R.sph. COX in the Phospholipid
Bilayer………..........................................................................................133
Characterization of R.sph. 114 COX: Insight into the Role of
Subunit III in the Assembly and Function of COX.......................................136
The Role of Subunit III in R.sph. COX Assembly..................................137
The Role of Subunit III in the Native Processing of Subunit II………...139
The Role of Subunit III in D-pathway Proton Uptake………………….141
The Role of Subunit III and Its Cleft Lipids in Stabilizing the
D-pathway and the Active Site................................................................146
R.sph. 114 COX and Human Mitochondrial Disease............................152

V.

CONCLUSIONS…………………………………………………………...157
APPENDIX
Probing the Dynamic Conformation of R.sph. COX Subunit III with
Thiol-Reactive Fluorophores……………………………………………….159
LIST OF ABBREVIATIONS…………………………………………........184
LIST OF REFERENCES…………………………………………………...188

vii

LIST OF FIGURES
Figure

Page

1. Structural Compartmentalization of the Mitochondrion…………………………..3
2. The Mitochondrial Electron Transport Chain……………………………………..7
3. Three Dimensional Crystal Structure of Bovine COX…………………………..12
4. Multiple Protein Structure Alignment of the Functional Core of COX………….15
5. Three Dimensional Crystal Structure of R.sph. COX……………………………18
6. Crystal Structure of the Resolved Lipids in R.sph. COX Subunit III Cleft……...21
7. Electron and Proton Pathways in COX…………………………………………..24
8. The Oxygen Reduction Catalytic Cycle of COX………………………………...28
9. Subunit III DNA and Protein Sequences and PCR Primers……………………..39
10. Schematic of Site-Directed Mutagensis Protocol………………………………..41
11. Diagram of CC50 Calculation…………………………………………………….54
12. Cholate Dialysis Technique for Reconstitution of COX………………………...57
13. Purification of COVs by Discontinuous Sucrose Gradient
Ultracentrifugation……………………………………………………………….63
14. Proton Pumping Traces of COV and pCOV……………………………………..70
15. Crystal Structure of R.sph. COX Showing 114 Truncation of Subunit III..........76
16. Reduced minus Oxidized -Peak of Wildtype, 114, I-IIGD and I-IIBD COX…...83
17. SDS-PAGE and Immunoblot Analysis of Wildtype and 114 COX…………....87
18. MALDI-TOF Mass Spectral Analysis of COX SIII-114 Content……………...90

viii

LIST OF FIGURES (Continued)
Figure

Page

19. MALDI-TOF Mass Spectral Analysis of Subunit II and III Content
in Wildtype, I-IIGD and 114 COX………………………………………………95
20. SDS-PAGE Analysis of Subunit IIA and IIC Content in
Wildtype and 114 COX………………………………………………………...97
21. MALDI-TOF Mass Spectral Analysis of Subunit IV Content
in Wildtype, I-IIGD and 114 COX……………………………………………....99
22. Two-Dimensional PAGE Analysis of Wildtype, I-IIGD and 114 COX………103
23. SDS-PAGE Analysis of Impurities Contained in 114 COX Preparations……107
24. Steady-State Activity of Wildtype, I-IIGD, I-IIBD and 114 COX……………...112
25. pH Dependence of Steady State Activity in Wildtype, I-IIBD and 114 COX…115
26. Catalytic Lifetimes of I-IIGD, I-IIBD and 114 COX……………………………119
27. pH Dependence of the Catalytic Lifetimes of I-IIGD, I-IIBD and 114 COX…...122
28. Proton Pumping Activity of Wildtype, I-IIGD and 114 COX…………………124

ix

LIST OF TABLES
Table

Page

I.

Functional and Biophysical Properties of R.sph. COV and pCOV.......................68

II.

Estimation of the Number of COX Molecules per Vesicle...................................74

III.

Relative Expression Levels of Wildtype, 114 and I-IIGD COX in
Purified R.sph. Membranes....................................................................................79

IV.

Optical Absorbance Parameters of Wildtype, 114 and I-IIGD and
I-IIBD COX.............................................................................................................81

V.

Summary of MALDI-TOF Mass Peaks Observed in Wildtype, 114
and I-IIGD COX......................................................................................................92

VI.

Summary of Two-Dimensional PAGE Analysis of 114 COX..........................106

VII.

Summary of Impurities Observed in 114 Preparations.....................................109

VIII.

Summary of the Functional Properties of Wildtype, and I-IIGD and
I-IIBD COX...........................................................................................................114

x

ACKNOWLEDGEMENTS

I would like to acknowledge my dissertation director, Larry Prochaska, for
providing a supportive training environment. Your mentorship has been an important
component in my development as a scientist. I also thank you for your friendship and
encouragement throughout the years.
The members of my dissertation committee were an inspiration and
encouragement to me, and I am grateful for the time they spent reading my work and
providing constructive and supportive feedback.
I have had the privilege of working with a number of great people during my time
in the Prochaska laboratory. Many thanks to all, and special thanks to Rachel, Alagu and
Khadijeh who were present and supportive during the writing process. Your humor and
friendship helped me immeasurably.
I would also like to thank my parents for encouraging an interest in learning and a
drive for excellence, and I thank my entire family and my friends for the love and support
they have provided.
Graduate school is notorious for its many stressors and difficulties. Learning to
believe in myself and to face the uncertainty and obstacles with increasing confidence
and resilience has been an invaluable life experience. I extend my deepest and enduring
gratitude to those who have patiently and persistently helped me in that process.

xi

I. Introduction

The Mitochondrial Electron Transport Chain
The Mitochondrion
The processes of life utilize a myriad of biochemical reactions and interactions in
order to maintain a state distinct from environmental equilibrium. These processes
require a constant input of energy in a form readily useable by the enzymes which
catalyze the constitutive reactions of life. The high energy phosphate bonds of adenosine
tri-phosphate (ATP) have been harnessed as an anciently conserved mechanism for
providing this requisite energy. As such, central to the sustenance of life is the ability of a
cell to convert food energy into ATP, which in turn provides energy for the vast majority
of that cell’s reactions and processes. The cellular organelle responsible for this vital
energy conversion process is the mitochondrion.
The mitochondrion is the remnant of an ancient -proteobacterium which entered
into a symbiotic relationship with a proto-eukaryotic host cell some two billion years ago
(Gray et al., 1999; Wallace, 2005; Wallace and Fan, 2010). The proto-mitochondrion
provided energy via its oxidative reactions to the host cell, which became the
environment for the increasingly specialized organelle. Much of the genome original to
the -protobacterium was co-opted by the host cell, which eventually became dependent
on the mitochondrion for its energy needs (Wallace, 2007). The signatures of this ancient
rendezvous are evident in the structure and genetics of the mitochondrion.
1

The mitochondrion retains a small, double-stranded circular chromosome
approximately 16 kb in size, for which the entire sequence is now known and confirms
the evolutionary relatedness of mitochondria and -proteobacteria (Andrews et al., 1999;
Gray et al., 1999; Tuppen et al., 2010). The genome contains 37 genes, 13 encoding for
polypeptides which form many of the core subunits of the complexes in the
mitochondrial electron transport chain (Tuppen et al., 2010). There are multiple copies of
the genome per mitochondrion, and up to thousands of copies per cell (Holt et al., 2007).
The mitochondrion replicates its DNA and undergoes division within the cell largely
independent of the cell cycle (Owusu-Ansah et al., 2008; Tuppen et al., 2010).
Mitochondrial function requires the concerted expression of both mitochondrial and
nuclear-encoded proteins, the details of which are still being elucidated and are becoming
an increasing interest area in biomedical research (Wallace and Fan, 2010).
The mitochondrion is a double membranous structure, which is often ellipsoid in
shape and around one micron in length (Figure 1A)(Frey and Mannella, 2000). The outer
membrane bounds the organelle as a semi-permeable membrane studded with porin
proteins, allowing for the exchange of substrates and molecules used in the various
mitochondrial functions (Bay and Court, 2002; Neupert and Herrmann, 2007). The highly
impermeable inner membrane, depicted in Figure 1A as an extensively baffled structure,
is actually composed of two distinct regions (Figure 1B), an inner membrane boundary
(light blue) and the cristae membrane (yellow) which is joined to the inner membrane
boundary by small, tubular openings called cristae junctions (Zick et al., 2009). These
two regions of the inner membrane are enriched in different types of proteins. The inner
membrane boundary is enriched primarily with proteins involved in protein translocation
2

Figure 1
Structural compartmentalization of the mitochondrion. A) Schematic structure of the
mitochondrion, indicating key structural components. The mitochondrion is a double
membrane organelle, consisting of an outer and inner membrane. The outer membrane
bounds the organelle. The inner membrane contains the aqueous matrix. The aqueous
inner membrane space is enclosed between the two membranes. B) Three-dimensional
electron tomographic reconstruction of the mitochondrion. The inner membrane is
composed of two regions, the inner membrane boundary and the cristae membrane,
which is joined to the inner membrane boundary by cristae junctions. Adapted from (Frey
and Mannella, 2000).
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and mitochondrial fusion. The cristae membrane houses the machinery of oxidative
phosphorylation as well as proteins for protein translation, metabolite exchange and
mitochondrial morphology (Vogel et al., 2006; Wurm and Jakobs, 2006; Zick et al.,
2009). The inner membrane encloses the matrix, leaving an inner membrane space
between the inner and outer membranes. The morphology of the cristae membrane can be
highly variable in a manner that is likely reciprocally linked to the respiratory state of the
mitochondrion, however the exact relationships between mitochondrial function and the
structure of the cristae membrane are still under investigation (Mannella, 2006; Zick et
al., 2009).
Historically, the major thrust of mitochondrial research has focused on its role in
metabolism, although the organelle now has proven involvement in a diverse array of
functions (Zick et al., 2009; Tuppen et al., 2010). A critical mitochondrial process is
oxidative phosphorylation, wherein an electrochemical gradient is created by the electron
transport chain across the inner membrane and is harnessed to synthesize ATP (Saraste,
1999). Other mitochondrial functions central to metabolism include the Krebs cycle, oxidation of fatty acids and the metabolism of various amino acids (Tuppen et al., 2010).
The chemiosmotic potential of mitochondria has implications for additional
mitochondrial functions, including calcium signaling and apoptosis (Tsujimoto and
Shimizu, 2007; Walsh et al., 2009). The mitochondrion is also the site for heme
biosynthesis and iron-sulfur cluster biogenesis (Zick et al., 2009; Tuppen et al., 2010).

5

The Mitochondrial Electron Transport Chain and Chemiosmotic Theory
Nearly fifty years ago, Peter Mitchell proposed an innovative hypothesis that has
forever changed the way scientists view metabolism. In his 1961 Nature paper, he writes,
“In the exact sciences, cause and effect are no more than events linked in sequence…The
underlying thesis of the hypothesis put forward here is that…not only can metabolism be
the cause of transport, but transport can be the cause of metabolism” (Mitchell, 1961). He
hypothesized that the transport of protons across a charge-impermeable membrane in the
mitochondrion resulted in an electrochemical gradient which drove the phosphorylation
of ADP. Although initially controversial, the research that followed for the next several
years lead to the establishment of his theory, resulting in his reception of the 1978 Nobel
Prize in chemistry.
The molecular machinery of mitochondrial oxidative phosphorylation consists of
a series of inner membrane-bound proteins, localized primarily to the cristae membrane
and collectively referred to as the electron transport chain (Figure 2). Upstream metabolic
reactions result in the production of NADH and FADH2 from food sources (Wallace,
2007; Ordys et al., 2010). Complexes I and II respectively oxidize these substrates and
transfer the electrons to the membrane bound electron carrier ubiquinone (Q) (Cecchini,
2003). Complex I conserves the energy of the oxidation reaction by pumping a proton
across the inner membrane (Hirst, 2009). The complex Q-cycle catalyzed by Complex III
results in ubiquinol oxidation, cytochrome c reduction, and proton translocation into the
inner membrane space (Crofts et al., 2008). Complex IV uses the electrons from
cytochrome c molecules and protons from the matrix to reduce oxygen to water, coupling
the reaction to proton pumping (Hosler et al., 2006). The electrochemical gradient

6

Figure 2
The mitochondrial electron transport chain. Schematic of the components of the
+
electron transport chain. NADH and FADH2 are oxidized to NAD and FAD by
complexes I and II, respectively. The electrons from this reaction are transferred to
coenzyme Q, which reduces complex III. Complex III reduces the soluble electron carrier
cytochrome c which is oxidized by Complex IV. Ultimately the electrons are used to
reduce O2 to H2O. The reactions of Complex I, III and IV result in net translocation of
protons from the matrix (or bacterial cytoplasm) to the innermembrane space (or bacterial
periplasm). Complex IV, ATP synthase, harnesses the resulting electrochemical gradient
to drive the synthesis of ATP from ADP and inorganic phosphate.
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resulting from the proton pumping activities of Complexes I, III and IV is harnessed by
Complex V to drive the synthesis of ATP from ADP and inorganic phosphate (von
Ballmoos et al., 2009).
Complex I, or NADH:quinone oxidoreductase, consists of 14 core subunits and
up to 31 accessory subunits arranged into an L-shape, with an soluble domain extending
into the mitochondrial matrix (Radermacher et al., 2006; Sazanov, 2007; Zickermann et
al., 2009). The soluble domain contains a catalytic site for NADH oxidation, as well as a
bound flavin nucleotide and a series of iron-sulfur centers for transferring the electrons
from NADH to the integral membrane domain where ubiquinone (coenzyme Q)
reduction and proton translocation occur (Hirst, 2009). A high resolution structure for the
hydrophobic domain is still unavailable, which limits the understanding of the reactions it
catalyzes. The net result is that for every two electrons extracted from NADH and
donated to ubiquinone, four protons are translocated from the matrix to the inner
membrane space (Zickermann et al., 2009). Given the low redox potentials of its metal
cofactors, Complex I is also a major site of reactive oxygen species generation (Hirst,
2009).
Succinate:ubiquinone oxidoreductase, or Complex II, is involved in both the
electron transport chain and in the Krebs cycle (Maklashina and Cecchini, 2010). As a
part of the Kreb’s cycle, it catalyzes the oxidation of succinate to fumarate, which
involves abstracting two electrons and two protons and transferring them to an internally
bound FAD, forming FADH2. The electrons are then transferred to ubiquinone via the
enzyme’s iron-sulfur clusters, and the protons are released back into the matrix (Sun et
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al., 2005; Horsefield et al., 2006). Complex II thus increases the pool of ubiquinol within
the membrane.
Complex III, also called cytochrome bc1, catalyzes the oxidation of ubiquinol and
the reduction of cytochrome c, coupling the reaction to proton translocation across the
inner membrane (Crofts, 2004). The complete structure of the mitochondrial form of
Complex III consists of 13 subunits, three of which form the catalytic core. The protein
catalyzes many metal prosthetic groups for electron transfer, including two heme b
molecules, a heme c molecule, and an iron-sulfer cluster (Iwata et al., 1998). The
mechanism by which the oxidoreductive reactions are accomplished involves many
catalytic sites and proton and electron transfer pathways (Crofts et al., 2008). The
reaction results in two single-electron transfers to two cytochrome c molecules, the
uptake of two protons from the matrix, and the release of four protons into the inner
membrane space (Crofts, 2004). Reduced cytochrome c is oxidized by Complex IV,
cytochrome c oxidase (COX) in a reaction driven by reduction of oxygen and coupled to
proton pumping (Hosler et al., 2006). The structure and mechanism of COX is discussed
in detail below. The net result of the electron transport activity is that for every two
electrons transferred from NADH to ½ O2 there are ten protons pumped across the inner
mitochondrial membrane.
The fifth complex of the electron transport chain is ATP synthase. ATP synthase
utilizes the electrochemical proton gradient generated by Complexes I, III and IV to drive
the phosphorylation of ADP. ATP synthase is composed of a water soluble F1 protein
complex and a membrane bound F0 protein complex, joined together by a central and
peripheral stalk (von Ballmoos et al., 2009). The F0 complex facilitates proton transfer
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from the inner membrane into the matrix, coupling the process to a physical rotation in a
portion of the F0 complex. The F0 rotation forces a rotary motion of the F1 complex,
which drives the synthesis of ATP at its nucleotide binding/catalytic sites (NakanishiMatsui et al., 2010). The majority of a cell’s ATP is synthesized by this mechanism.
Thus, the mitochondrial electron transport chain is of central importance to virtually
every biochemical pathway and process of life.

The Structure and Function of Cytochrome c Oxidase
Cytochrome c oxidase (COX) is the terminal oxidase of the mitochondrial
electron transport chain and catalyzes the reduction of molecular oxygen to water while
concomitantly translocating protons across the inner mitochondrial membrane. The
resulting electrochemical proton gradient is used to drive the synthesis of ATP and
various other mitochondrial functions. COX is thus indispensible for proper cellular
function.

Three Dimensional Structure of Cytochrome c Oxidase
Early structural studies of cytochrome c oxidase were complicated by difficulties
in crystallization of membrane proteins and in an inability to conduct site-directed
mutagenesis studies on the mitochondrially-encoded subunits which constitute the
enzyme’s functional core. In more recent years, however, three-dimensional crystal
structures of COX have been solved for a number of species (Tsukihara et al., 1996;
Iwata et al., 2002; Svensson-Ek et al., 2002; Tsukihara et al., 2003). Shown in Figure 3 is
the crystal structure of mitochondrial COX from bovine heart (PDB 1V54), which shares
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Figure 3
The three dimensional crystal structure of bovine heart COX. Mitochondrial COX is
composed of 13 subunits. The functional core of the enzyme consists of the
mitochondrial-DNA encoded subunits, SI (cyan), SII (orange) and SIII (pink). In addition
there are ten nuclear-DNA encoded subunits (gray). The enzyme crystallizes and
functions as dimer. Each monomer contains a CuA-CuA center (green spheres), a heme a
center (yellow), and a heme a3-CuB active site (yellow heme, green sphere CuB). A)
Bovine COX dimer viewed within the plane of the membrane. B) Bovine COX dimer
viewed from the inner membrane space, perpendicular to the plane of the membrane.
Prepared using Accelrys DS Viewer Pro. PDB 1V54 (Tsukihara et al., 2003).
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98% sequence identity to human COX. The protein consists of 13 subunits with a
combined molecular weight of 205 kDa. Subunits I, II and III are encoded by
mitochondrial DNA and are considered the functional core of the enzyme, sharing
structural and functional homology across a wide range of species (cyan, subunit I;
orange, subunit II; pink, subunit III)(Tsukihara et al., 2003; Hosler, 2004). The functions
of the ten remaining nuclear DNA-encoded subunits (shown in gray) are still under
investigation with putative roles ranging from complex assembly and stability to
regulation of enzymatic activity (Galati et al., 2009; Fornuskova et al., 2010). The bovine
form of the enzyme crystallizes as a dimer, and cross-linking and gel filtration studies
indicate that this is also its functional oligomeric structure (Estey and Prochaska, 1993;
Lee et al., 2001; Sadoski et al., 2001; Musatov and Robinson, 2002).
The “functional core” of COX consists of the mitochondrially encoded subunits,
which are experimentally difficult to mutate due to the thousands of mitochondria per cell
which each contain their own genome (Brega et al., 2001; Wallace and Fan, 2010). It is
therefore necessary to conduct site-directed mutagenesis studies in prokaryotic forms of
the enzyme. The two model systems most widely used for such studies are the 124 kD
COX from Parachocus denitrificans (P.dent.) and the 128 kD COX from Rhodobacter
sphaeroides (R.sph.) (Cao et al., 1992; Hosler et al., 1992; Iwata et al., 2002; SvenssonEk et al., 2002). The three largest subunits of these four subunit bacterial enzymes are
structurally and functionally homologous to their mitochondrial counterparts, the
functional core of COX. The fourth prokaryotic subunit is not homologous to any
mitochondrial subunit and its function is not known. The structural homology of the
functional core is shown in Figure 4, a multiple structure alignment of subunits I, II and
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Figure 4
Multiple structure alignment of the functional core of cytochrome c oxidase. The
aligned x-ray crystal structures of subunits I, II and III are shown for bovine (PDB
1OCC, blue)(Tsukihara et al., 1996), P.dent. (PDB 1QLE, green)(Harrenga and Michel,
1999) and R.sph. COX (PDB 1M56, red)(Svensson-Ek et al., 2002). Figure from (Geyer,
2007).
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III for bovine (blue, PDB 1OCC), P.dent. (green, PDB 1QLE), and R sph. COX (red,
PDB 1M56). R.sph. COX is the form of the enzyme used in the studies described herein,
as the validity of this model has been well established (Cao et al., 1992; Hosler et al.,
1992).
Figure 5 shows the x-ray crystal structure of R.sph. COX. The prokaryotic forms
of COX crystallize as either a monomer (P.dent.) or as a head to tail dimer which would
not be structurally possible in the membrane (R.sph.). Research suggests that they also
function as monomers, although this has not been definitively demonstrated (ShinzawaItoh et al., 2007). Subunit I (cyan) is a ~60 kD peptide with 12 transmembrane helices. It
contains heme a (yellow) and the binuclear active site consisting of heme a3 (yellow) and
CuB (green sphere). In addition, there are two conserved proton pathways coordinating a
series of conserved water molecules which serve to shuttle protons to the active site and
across the membrane. They are designated as the D-pathway (blue, D-pathway residues;
red spheres, water molecules) and the K-pathway (magenta, K-pathway residues; pink
spheres, waters molecules), named for the conserved residues D132 and K362 in the
respective pathways (Brzezinski and Johansson, 2010; Ganesan and Gennis, 2010).
Subunit II (Figure 5, orange) is about 30 kD and contains two transmembrane
helices and a large globular beta structure which sits within the mitochondrial
innermembrane space or the bacterial periplasm. The subunit II globular domain contains
a binding pocket with a number of conserved acidic residues, which facilitate an
electrostatic interaction with the conserved lysine residues of cytochrome c (FergusonMiller et al., 1978). Ferrocytochrome c binds at this location and donates its electron to
the CuA-CuA (green spheres) metal center also contained in subunit II. In contrast to the
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Figure 5
The x-ray crystal structure of R.sph. COX. Subunit I (cyan) consists of 12
transmembrane helices and contains two heme centers (yellow), a CuB (green sphere),
and the D-pathway and K-pathway for proton transfer. Subunit II (orange) has two
transmembrane helices and a globular periplasmic domain which binds and oxidizes
cytochrome c, receiving the electron onto its CuA-CuA center (green double sphere).
Subunit III (pink) consists of seven transmembrane helices which are separated by a vshaped cleft into two domains. Subunit IV is a single spanning transmembrane helix
(blue). A) Side view in the plane of the membrane with the orientation of the metal
centers and proton pathways shown to the right. The blue stick structures and small red
spheres are the residues and water molecules of the D-pathway. The magenta stick
structures and magenta spheres are the residues and water molecules of the K-pathway.
Heme iron is shown as a red sphere with the associated porphyrin ring in yellow. Green
spheres are copper atoms. B) Side view showing the v-shaped cleft of subunit III. C) Top
view as shown from the periplasmic space, perpendicular to the membrane. Prepared
using Accelrys DS Viewer Pro (PDB 1M56)(Svensson-Ek et al., 2002).
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other subunits of the bacterial COX enzyme, subunit IV (blue) is a single spanning
transmembrane helix about 5.2 kD in molecular weight and has no homology to any of
the mitochondrial subunits.
Subunit III (Figure 5, pink), a 30 kD peptide, shares an extensive interface with
subunit I and is composed of seven transmembrane helices which are separated by a vshaped cleft into two -helical bundles ((Iwata et al., 2002; Svensson-Ek et al., 2002;
Shinzawa-Itoh et al., 2007)). At the n-terminus, two -helices of subunit III sit along an
interface with subunit I in close proximity to the mouth of the D-pathway. There are a
number of conserved histidine, acidic and hydrophobic residues on the n-terminus of
subunit III that have been proposed to play a functional role (Gilderson et al., 2003;
Hosler, 2004). The c-terminal bundle of subunit III, consists of 5 -helices also
containing many conserved residues which seem to be of structural and functional
importance (Mather and Rottenberg, 1998; Tiranti et al., 2000; DiMauro and Schon,
2003; DiMauro et al., 2006).
The v-shaped cleft between the two -helical bundles of subunit III contains two
lipids which are resolved in a conserved orientation in the protein x-ray crystal structures
of R.sph. and bovine COX (Figure 6A)(PDB 1V54 (Tsukihara et al., 2003), PDB 1M56
(Svensson-Ek et al., 2002)). In the bovine structure, these lipids are phosphotidyl
glycerols, and in the R.sph. structure they are phosphotidyl ethanolamines; the fatty acid
tails are 18 carbons long and are singly unsaturated (Varanasi et al., 2006; Shinzawa-Itoh
et al., 2007). These lipids are held tightly into place through a variety of ionic
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Figure 6
The x-ray crystal structure of R.sph. COX showing the resolved lipids contained
within the v-shaped cleft of subunit III. Subunits I-IV are shown in the same color
scheme as Figure 5. A) Within the v-shaped cleft of subunit III there are two phophotidyl
ethanolamines (PL1, dark green; PL2, light green) resolved in the crystal structure. B)
The conserved residues in subunits I and III which interact with the phospholipids. The
headgroup of PL1 (dark green) is coordinated by R137 of subunit I, and its fatty acid tails
interact with a variety of hydrophobic residues conserved in subunits I and III. The
headgroup of PL2 (light green) is coordinated by R226 on helix 6 of subunit III, and its
fatty acid tails interact with conserved residues on helices 2 and 3 of subunit III.
Prepared using Accelrys DS Viewer Pro (PDB 1M56)(Svensson-Ek et al., 2002).
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interactions, hydrogen bonds and van der Waals contact with highly conserved residues
in subunits I and III. One of the lipids, PL1, sits at the interface with subunit I with its
phosphate headgroup being coordinated by R137 in subunit I (Figure 6B, dark green
lipid). Its fatty acid tails come into van der Waals contact with several conserved residues
on helix 2 and 3 of subunit III, as well as with some conserved residues in subunit I. The
headgroup of the second lipid, PL2, forms a strong ionic and hydrogen bond interaction
with R226, a highly conserved residue on helix 6 in the c-terminal bundle of subunit III
(light green lipid). The fatty acid tail of PL2 forms hydrophobic interactions with several
of the conserved residues in helix 2 and 3 of subunit III which also coordinate PL1
(Tsukihara et al., 1996; Svensson-Ek et al., 2002; Shinzawa-Itoh et al., 2007; Varanasi
2006). It has been noted that there is a chain of interactions involving three residues
which extends about 16Å from the fatty acid tail of PL1 to H284 of subunit I which is a
CuB ligand, providing a lipid-mediated structural link between the active site and both
domains of subunit III (Varanasi et al., 2006).

Proton and Electron Transfer in Cytochrome c Oxidase
The two enzymatic activities of cytochrome c oxidase are to transfer electrons
from ferrocytochrome c to oxygen and to pump protons across the mitochondrial inner
membrane (Hosler et al., 2006; Brzezinski et al., 2008). The reaction stoichiometry is
indicated in the following scheme:
4 cytochrome c2+ + O2 + 8H+ → 2H2O + 4H+pumped + 4 cytochrome c3+.
Subunits I and II contain the metal centers which are responsible for transferring
the electrons necessary for oxygen reduction (Figure 7, blue arrows). Subunit II
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Figure 7
Electron and proton pathways in COX. The electron transfer pathway in COX is
shown (blue arrows) as well as the D-pathway (red arrow), K-pathway (green arrow) and
proton exit pathway (purple hash arrow). Subunit II contains the CuA-CuA center, which
is the initial acceptor of the electron from cytochrome c. From here, the electron is
transferred to subunit I, first to heme a and finally to the heme a3-CuB active site where
molecular oxygen binds and is reduced to water. The D-pathway consists of a number of
conserved subunit I residues (blue stick structures) which coordinate a series of water
molecules (red spheres). The pathway starts at D132 and extends 27Å to E286 where
protons are shuttle either to the active site or to a pump site and across the membrane
through an unknown exit pathway (purple hash arrow). The K-pathway starts at subunit
II residue E101 and extend through conserved residues (magenta stick structure) and
coordinated water molecules (magenta spheres) to the active site. Prepared using
Accelrys DS Viewer Pro (PDB 1M56)(Svensson-Ek et al., 2002).
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electrostatically binds and oxidizes cytochrome c2+, receiving the electron onto its
bicupric center (CuA-CuA). From here, the electron is transferred to subunit I, first to
heme a and finally to the heme a3-CuB active site where molecular oxygen binds and is
reduced to water (Yoshikawa et al., 1998; Jancura et al., 2006).
In addition to its two metal centers, subunit I contains pathways which shuttle
protons to the active site and across the membrane (Hosler et al., 2006). The K-pathway
provides the protons necessary for the initial reduction of the enzyme prior to oxygen
binding (Figure 7, green arrow) (Lepp et al., 2008a; Ganesan and Gennis, 2010). The
electrostatic alteration of the active site caused by its reduction drives the uptake of 1-2
protons from the matrix through the K-pathway to the active site. The pathway starts at
residue E101 of subunit II which is situated at the interface between subunits I and II.
The pathway proceeds to the active site through a series of water molecules, which are
coordinated by the conserved residues K362, S299 and Y288 of subunit I (magenta
residues). These water molecules (magenta spheres) are resolved in conserved locations
in the crystal structures across a range of species and are used to transfer the protons via a
Grotthuss mechanism (Brzezinski and Johansson, 2010).
The D-pathway provides from the matrix all protons used for pumping, as well 23 of the protons needed to reduce oxygen to water (Figure 7, red arrows) (Lepp et al.,
2008b; Brzezinski and Johansson, 2010). The conserved aspartate residue in subunit I
(D132) for which the D-pathway is named is putatively the initial proton acceptor of the
pathway. An internal water chain extends from D132 approximately 27Å to E286, which
is the branch point for protons to be shuttled to the active site or to be pumped to the
opposite side of the membrane (Han et al., 2005; Lepp et al., 2008b). The residues which
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coordinate this water chain are broadly conserved and are all within subunit I (blue
residues). From E286, the protons are either transferred to the active site, or to a proton
acceptor in the proton pumping exit pathway (purple hashed arrow). The initial acceptor
for the pumped protons has not been identified, but it is thought to involve the heme a3
propionates and/or H334 (Branden et al., 2005; Pisliakov et al., 2008; Egawa et al., 2009;
Lee et al., 2009; Brzezinski and Johansson, 2010).
The mechanism by which COX reduces dioxygen is complex and consists of
multiple intermediates, each having characteristic spectroscopic absorbances
corresponding to the various oxidation states of the metal centers (Figure 8). The R state
is reduced at heme a3 and CuB, and binds O2 to form the A state with a time constant of 
= 10 s. Next, two electrons from heme a3, one electron from CuB and an electron and a
proton from Y288 are transferred to oxygen, which undergoes molecular scission to form
the P state ( = 200-300 s) (Gorbikova et al., 2008b). Then, an electron is transferred
from heme a to the tyrosyl radical and the CuB the oxygen ligand is protonated from the
D-pathway, resulting in the formation of the F state ( = 100 s) (Gorbikova et al.,
2008a). The P to F transition is also coupled to a proton pumping event, which involves a
second proton uptake through the D-pathway. The decay from F to O is accomplished by
a one electron reduction of heme a3 by heme a followed by a protonation of the heme a3
oxygen ligand via the D-pathway and is coupled to a proton pumping event ( = 1.5 ms).
Another proton is pumped during the subsequent O to E transition, which also involves a
displacement of the water molecule at CuB, a protonation of Y288 by a K-pathway and a
reduction of CuB (Adelroth et al., 1997; Jasaitis et al., 1999). The E to R transition is
coupled to a proton pumping event and proton uptake through the K-pathway, which
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Figure 8
The oxygen reduction catalytic cycle of COX. The oxygen reduction cycle of COX is
complex, consisting of multiple intermediates. The redox and ligand states of the heme
a3-CuB active site are displayed within the boxes designated with one letter codes for the
intermediates. Substrates indicated in blue are utilized or produced in oxygen chemistry.
The red protons are those pumped across the membrane. Adapted from (Brzezinski and
Johansson, 2010).
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provides the proton to the remaining oxygen ligand on heme a3, allowing it to leave as
water (Verkhovsky et al., 2006). The COX molecule has now cycled back to the reduced
state and is capable of binding another oxygen molecule (Brzezinski and Gennis, 2008;
Brzezinski and Johansson, 2010).
It has been over thirty years since COX was empirically established as a proton
pump (Wikstrom, 1977; Krab and Wikstrom, 1978). Since then, much progress has been
made toward elucidating the molecular mechanism of the pumping function, although
there are still many questions to resolve (Brzezinski and Gennis, 2008). In theory, there
are four general components of the current model of the COX proton pump. Firstly, the
active site supplies the driving force for proton translocation by the reduction of O2 to
water via the reactions described above. Second, there is a proton loading site for pumped
protons which is in some manner coupled to the driving force provided at the active site.
Third are the proton pathways necessary to provide protons to the active site and to
shuttle protons across the membrane. Finally, there must be a gating mechanism to
prevent short circuiting or proton leaks (Brzezinski and Gennis, 2008). Current theories
for the mechanism by which the O2 chemistry at the active site is coupled to the
protonation of the proton pump site primarily involve the principle of electroneutrality
(see Mitchell and Rich, 1994). In short, it is highly thermodynamically favorable for the
negative charge of an electron introduced into the low dielectric environment of the
protein interior to be compensated with a positively charged proton. According to this
principle, when the electron from cytochrome c is transferred from CuA to heme a, it
drives the transfer of a proton from the D-pathway to a pump site, which is in the vicinity
of the active site. The subsequent transfer of the electron from heme a to heme a3-CuB

30

drives the transfer of a chemical proton to the active site which in turn expels the proton
from the pump site to the exterior of the protein (Salomonsson et al., 2005; Wikstrom and
Verkhovsky, 2007; Brzezinski and Gennis, 2008; Sharpe and Ferguson-Miller, 2008).
The identity of the pump site is not known, but the most likely current candidates are His
334 or the A-propionate group of heme a3 (Sharpe and Ferguson-Miller, 2008; Lee et al.,
2009; Brzezinski and Johansson, 2010). The gating or valve mechanism must establish
unidirectional proton movement from the matrix to the inner membrane space and
prevent leaks or short circuits. Multiple mechanisms have been proposed, and the
mechanism may include many amino acid residues (Sharpe and Ferguson-Miller, 2008).
Given current evidence, E286 which sits at the top of the D-pathway seems to play a
predominate role. The mechanism seems to depend upon the proper orientation of water
molecules in the vicinity of E286 and may involve a conformation change in the residue
side chain (Xu et al., 2007; Sharpe and Ferguson-Miller, 2008; Brzezinski and Johansson,
2010).

The Functional Role of Cytochrome c Oxidase Subunit III
Cytochrome c oxidase subunit III is a member of the 3 subunit functional core of
the enzyme, although all of the protein’s metal centers and proton pathways are contained
in subunits I and II. The explicit function of subunit III is not fully understood, but it is
highly conserved across all species, sharing 45% sequence identity between the R.sph.
and human homologs (Saraste, 1990; Varanasi et al., 2006). The severity of in vivo
mutations in subunit III is further evidence for its importance (Saraste, 1990; Mather and
Rottenberg, 1998; Horvath et al., 2002; DiMauro and Schon, 2003; Horvath et al., 2005;
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DiMauro et al., 2006), and it has been postulated to play roles in maintaining adequate
proton transfer rates in subunit I, in the stabilization of the active site during catalytic
turnover, in regulation of oxygen reduction activity, and in the assembly of the COX
complex (Bratton et al., 2000; Lincoln et al., 2003; Mills et al., 2003; Mills and Hosler,
2005).
The importance of subunit III in proper COX functioning was demonstrated early
on by removing the subunit from the bovine form of the enzyme (Puettner et al., 1985;
Prochaska and Reynolds, 1986). The subunit III deficient enzyme had decreased electron
transfer activity and its proton pumping efficiency was reduced to an even greater extent
(Prochaska and Reynolds, 1986). A similar effect was also observed when the conserved
subunit III residue E90 was labeled with DCCD (Prochaska et al., 1981). The deleterious
effects caused by DCCD labeling were shown to be accompanied by a conformational
change in subunit III which was likely caused by a disruption in hydrogen bonds within
the subunit (Ogunjimi et al., 2000).
In more recent years, the functional role of subunit III has been examined by
studies that remove the subunit from the bacterial forms of the enzyme, R.sph. or P.dent.
COX, leaving only subunits I and II of the functional core (I-II OX). The removal of
subunit III results in a reduction of the enzyme’s catalytic lifetime to only about 0.5% of
that of four subunit COX (Bratton et al., 1999; Gilderson et al., 2003; Hosler, 2004; Mills
and Hosler, 2005; Varanasi et al., 2006). This shortened catalytic lifetime is the result of
the phenomenon termed turnover-induced inactivation, which is a spontaneous and
irreversible inactivation of the enzyme which takes place only during catalytic turnover
and is accompanied by structural alteration of the heme a3-CuB active site. Specifically,
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the heme a3 center of the inactivated enzyme is in a more flexible structural environment
and CuB is depleted from the active site which displays decreased binding to oxygenintermediate analogs (Bratton et al., 1999). At low pH (6.5), the initial rate of O2
reduction activity of I-II OX is unimpeded, however the pH dependence of its activity is
altered such that at physiological pH it is only about half that of normal COX,
corresponding to a decrease in the rate of proton uptake in the D-pathway from bulk
solution through D132 to E286 (Gilderson et al., 2003). I-II OX also shows a decrease in
proton pumping efficiency to about half that of normal COX, which could be due to
impeded proton flow through the D-pathway and through the proton exit pathway and/or
due to a structural alteration in the environment of subunit I E286, which could hinder its
ability to protonate the pump site (Gilderson et al., 2003; Mills et al., 2003). The
mechanism of turnover-induced inactivation is not known, but the impedance of Dpathway proton uptake increases the lifetimes of the reactive oxoferryl intermediates P
and F (see Figure 8), allowing for the possibility of a hydroxylation reaction in the
vicinity of the active site (Mills et al., 2003; Mills and Hosler, 2005).
The preceding results suggest a role for subunit III in maintaining adequate proton
uptake through the D-pathway. Indeed, direct measurement of D-pathway proton uptake
in the absence of subunit III shows a rate that is only about 3-4% of four subunit COX
(Gilderson et al., 2003). One mechanism by which subunit III might facilitate D-pathway
proton uptake is by the function of a putative proton antenna on its n-terminus. D132 is
surrounded by a number of conserved protonatable residues in subunit III which are
thought to collect protons and transfer them to D132 at a rate faster than simple diffusion
from bulk solution allows, thus serving as a putative “proton collection antennae” (Mills
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et al., 2003; Hosler, 2004; Adelroth and Hosler, 2006). In addition, the shift in pH profile
of proton uptake through the D-pathway seen in the absence of subunit III suggests an
alteration in a protonateable residue within the pathway, perhaps D132 itself. The nterminus of subunit III also contains a stretch of conserved hydrophobic residues which
may play a role in fine tuning an optimal pKa of D132 for maximal D-pathway uptake
(Gilderson et al., 2003; Hosler, 2004).
Subunit III may also serve to stabilize the structure of the subunit I active site
during catalytic turnover. Even when proton uptake through the D-pathway is completely
abolished by the mutation of D132 to an alanine, the removal of subunit III from D132A
still results in a 10 fold decrease in its catalytic lifetime (Mills and Hosler, 2005; Adelroth
and Hosler, 2006). This suggests that there is an additional protective mechanism against
turnover-induced inactivation provided by subunit III, such as structural stabilization,
which does not depend upon the rate of proton uptake through the D-pathway. The
presence of subunit III could decrease the degree of structural oscillations in the active
site thereby lowering the probability of a hydroxylation reaction. Stabilization would be
mediated via long range protein-protein interactions, and may be enhanced by the
presence of the structural lipids within the v-shaped cleft of subunit III (Hosler, 2004;
Varanasi et al., 2006). Mutagenesis of the conserved residues which bind the cleft lipids
increases the propensity of the enzyme to undergo turnover-induced inactivation without
slowing proton uptake through the D-pathway (Varanasi et al., 2006). It has been
proposed that the structural lipids act as a “flexible buttress,” allowing small catalysisassociated motions within the active site while preventing larger scale motions which
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could increase the probability of turnover-induced inactivation (Hosler, 2004; Varanasi et
al., 2006).
Finally, subunit III might be involved in facilitating proper assembly of COX
(Bratton et al., 2000; Tiranti et al., 2000). One of the early assembly intermediates of
COX is a form of subunit I which contains a heme a center but not the heme a3-CuB
active site. This form of subunit I, denoted subunit Ia, appears to accumulate in the
membrane in the initial stages of assembly (Bratton et al., 2000; Fontanesi et al., 2008;
Fernandez-Vizarra et al., 2009). The next step in assembly of R.sph. COX involves the
insertion of the heme a3-CuB active site and requires the presence of subunit II and some
additional assembly factors (Bratton et al., 2000; Smith et al., 2005). When subunit III
has been genetically deleted from the R.sph. genome, COX subunits I and II are capable
of folding correctly with proper insertion of all their metal centers. However, there is a
significant enrichment of subunit Ia in these cells, suggesting that although subunit III is
not required for proper assembly of subunits I and II, it does participate in the process,
perhaps by increasing the rate of assembly by stabilizing an assembly intermediate
(Bratton et al., 2000). Proper assembly of COX is also aided by various proteases which
degrade improperly folded subunits (Stiburek and Zeman, 2010). These proteases are
located in both the matrix and inner-membrane space and are conserved from prokaryotes
to mammalian mitochondria (Tatsuta and Langer, 2009).
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Specific Aims
The research designs of this dissertation are aimed at elucidating the structural
and functional properties of Rhodobacter sphaeroides cytochrome c oxidase (R.sph.
COX). The dissertation is divided into two parts, each with different aims:

Specific Aim 1: To examine the functional oligomeric structure of R.sph. COX via
discontinuous sucrose gradient ultracentrifugation.
Mitochondrial COX crystalizes as a dimer and has been shown to exist in the
dimeric state under mild detergent concentration and within a phopholipid bilayer (Estey
and Prochaska, 1993; Tsukihara et al., 1996; Nguyen et al., 2002). R.sph. COX does not
crystallize in a functional dimeric state, and its oligomeric structure within a phospholipid
bilayer is unknown (Svensson-Ek et al., 2002). In this aim, discontinuous sucrose
gradient ultracentrifugation was used to purify phospholipid vesicles containing COX
from those lacking protein. The biophysical and biochemical characterization of these
purified vesicles containing R.sph. sheds insight into its oligomeric structure in a
membrane environment.

Specific Aim 2: To examine the structural and functional significance of a c-terminal
truncation in subunit III of R.sph. COX.
A human mitochondrial disease resulting in severe lactic acidosis episodes has
been shown to result from a mutation in which the four c-terminal helices of subunit III
have been genetically deleted by a stop codon introduced into the mitochondrial DNA
(Tiranti et al., 2000). In order to assess the structural and functional importance of the c-
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terminal domain of COX subunit III, the corresponding mutation was made in R.sph
COX (114). This mutation removes the bulk of the c-terminal helical bundle while
retaining the v-shaped lipid-binding cleft, the subunit I-subunit III interface, and the
residues conserved in the putative D-pathway proton antenna of subunit III. The
structural and functional properties of this mutant were compared to wildtype COX and
to two forms of COX in which subunit III has been genetically or biochemically
removed. Characterization of this mutant can shed insight into the functional importance
of n-terminal and c-terminal domains of subunit III as well as into the importance of its
lipid-binding cleft.
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II. Materials and Methods

Mutagenesis of R.sph. COX Subunit III
A c-terminal truncation of R.sph. COX subunit III was created to model a human
mitochondrial disease mutation (Tiranti et al., 2000). Figure 9A shows the protein
sequence alignment of R.sph. and human COX subunit III. The stop codon introduced in
the human sequence at Q111 corresponds to I115 in R.sph. COX. Site-directed
mutagenesis of subunit III was conducted using a Stratagene QuickChange kit. Figure
9B shows the DNA and protein sequences of R. sphaeroides COX subunit III,
highlighting the location of I115 which was mutated to a stop codon to form 114 COX.
The primers used to mutagenesis are shown in Figure 9C. The template DNA of subunit
III used for mutagenesis was incorporated into a plasmid termed pMB301, shown in
Figure 10A (Bratton et al., 2003). For mutagenesis, 20 ng of pMB301 was mixed with
125 g of the forward and reverse primers in addition to reaction buffer, dNTP mix, and
Pfu DNA polymerase provided with the Stratagene kit (50 L final volume). Following
an initial 30 second melting phase at 95˚C, sixteen thermocycles were conducted in a
PCR thermocycler, each consisting of a 30 second melting phase (95˚C), a 1 minute
annealing phase (55˚C) and 5 minutes of polymerase extension (68˚C). Parental DNA
was selectively degraded by adding the restriction enzyme DpnI and digesting at 37˚C for
1 hour. This reaction was used to transform Stratagene XLI-Blue Supercompetent cells
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Figure 9
DNA, protein and primer sequences used for site-directed mutagenesis of R.sph.
COX subunit III. A) Protein sequence alignment of the n-terminus of subunit III in
R.sph. and human COX showing the location of the truncation in red. Human Q111
aligns with I115 in the R.sph. sequence. B) The DNA and protein sequence of R.sph.
COX subunit III. Pink shading indicates the binding region of the PCR primers used for
site-directed mutagenesis. The residue mutated to a stop codon (I115) in the 114
truncation mutation is shaded blue. B) The sequence of the forward and reverse primers
used for site-directed mutagenesis. The underlined residues are mismatched from the
original sequence.
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A)
R.sph.MAHAKNHDYHILPPSIWPFMASVGAFVMLFGAVLWMHGSGPWMGLIGLVVVLYTMFGWWS 60
Human MTHQS-HAYHMVKPSPWPLTGALSALLMTSGLAMWFHFHSMTLLMLGLLTNTLTMYQWWR 59
R.sph.DVVTES-LEGDHTPVVRLGLRWGFILFIMSEVMFFSAWFWSFFKHALYPMGPESPIIDGI 119
Human DVTRESTYQGHHTPPVQKGLRYGMILFITSEVFFFAGFFWAFYHSSLAPT----PQLGGH 115
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Forward 5’-GGGCCCGAGAGCCCGTAAATCGACGGGATCTTTC-3’
Reverse 3’-CCCGGGCTCTCGGGCATTTAGCTGCCCTAGAAAG-5’
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Figure 10
Schematic of site-directed mutagenesis protocol for constructing R.sph. COX
subunit III mutants. Site directed mutagenesis was conducted on COX subunit III using
pMB301 as the template DNA. A) Mutated pMB301 and pMB307 were digested with
XmaI, and the 0.9 kb fragment from pMB301 containing mutant subunit III was ligated
into the linearized pMB301 vector. B) pMB307+III and pRK415 were digested with
HindIII and EcoRI, and the 5.2 kb fragment from pMB307+III was ligated into the
linearized pRK415 vector. C) The pRK415+COX plasmid contains genes for COX
Subunit II, cox10, cox11, mutant subunit III, and COX subunit I with a poly histidine tag.
Arrows indicate the direction of transcription.
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which were subsequently spread onto LB plates containing 10 g/mL chloroamphenicol
and incubated overnight at 37˚C. Resulting colonies were used to inoculate 3 mL LB
cultures (10 g/mL chloro), which were grown with shaking for 12-16 hours at 37˚C. A
Qiagen QIAprep Spin Miniprep kit was used to isolate the pMB301 plasmid, which was
sequenced by Davis Sequencing (Davis, CA) for verification of the desired mutation.
Mutated pMB301 (pMB301-114) and the plasmid pMB307 (see Figure 10A)
were digested with XmaI for 45 minutes at 37˚C, and the digestion fragments were
separated by 1% agarose gel electrophoresis (Tris-Acetate-EDTA buffer, 60 volts for 1
hour). The 0.9 kb subunit III insert from pMB301-114 and the 7.9 kb linearized vector
from pMB307 were purified by gel extraction using a Qiagen QIAquick Gel Extraction
kit. Ligation was performed using a New England BioLabs Quick Ligation kit, using
approximately 50 ng of vector and 500 ng of insert in a total volume of 20 L. The entire
ligation reaction was used to transform Stratagene XL-10 Gold Ultracompetent cells,
which were incubated overnight on LB plates at 37˚C (40 g/mL ampicillin). Colonies
were used to inoculate 3 mL cultures (LB, 40 g/mL amp, 12-16 hours, 37˚C, shaking),
and the pMB307-114 plasmids were isolated via miniprep. In order to screen for proper
insertion orientation, pMB307-114 plasmid DNA was digested with XhoI for 1 hour at
37˚C, and the fragments were separated by 1% agarose gel electrophoresis. Plasmids with
the correct insertion orientation resulted in fragment sizes of 6.2 kb and 2.6 kb.
pMB307-114 and the broad-host range vector pRK-415 (see Figure 10B) were
digested with EcoRI and HindIII for 40 minutes at 37˚C. The 6.2 kb fragment from
pMB307-114 which contained COX subunits I, II and III-114 and two requisite
accessory genes was purified via gel extraction. This insert was ligated into the gel
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extracted 10.5 kb EcoRI/HindIII vector from pRK415. The ligation was conducted as
above utilizing approximately 50 ng of vector and 250 ng of insert (20 L final volume).
This ligation reaction was used to transform Stratagene JM109 cells, which were
incubated overnight at 37˚C on LB plates containing 2.5 g/mL tetracycline. Resultant
colonies were used to inoculate 3mL cultures grown as above, and the plasmids were
isolated by miniprep and checked for proper ligation via an EcoRI/HindIII double digest
and gel electrophoresis which yields fragments of 6.2 kb and 10.5 kb if correct.
Triparental conjugation was used to create a strain of R. sphaeroides that
expressed the subunit III-114 mutant form of COX (Figurski and Helinski, 1979).
JM109 cells containing pRK415-114 and HB101 cells containing the helper plasmid
pRK2013 were grown for 16 hours at 37˚C in 3 mL LB cultures containing 2.5 g/mL
tetracycline and 30 g/mL kanamycin, respectively. Concurrently, R. sphaeroides YZ200 cells – a strain in which the genes for subunits II and III have been deleted from the
genome – were grown to an OD660 of 1.0-1.2 in 3 mL Sistrom’s media containing both 50
g/mL spectinomycin and 50 g/mL streptinomycin (Sistrom, 1962; Zhen et al., 1998).
Two milliliters of the YZ-200 culture, 1 mL of the JM109 culture, and 1 mL of the
HB101 culture were separately spun down in sterile eppendorf tubes using a lab bench
microcentrifuge. The pellets were each washed 3 times in 1 mL of sterile 1x Phos Buffer
(30 mM potassium phosphate, pH 7.0) and then combined in 100 L of the same buffer.
The mixture was pipetted onto a Peptone-Yeast Extract agar plate which contained no
antibiotics and was incubated upside down 12-16 hours at 30-32˚C. The cells were
collected, suspended in 100 L of sterile 1x Phos Buffer and spread onto a Sistrom’s agar
plate containing 50 g/mL spectinomycin, 50 g/mL streptinomycin and 1 g/mL
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tetracycline. Colonies began to develop after 3-4 days of incubation at 30-32˚C and were
restreaked on fresh Sistrom’s plates containing the three antibiotics. Colonies that formed
were used to overexpress COX-114 as described below.

Expression and Purification of COX from R. sphaeroides
R. sphaeroides cytochrome c oxidase was expressed in a strain of the bacterium in
which genomic subunit II and subunit III have been deleted (termed YZ-200). The strain
also contains resistance genes to spectinomycin and streptomycin (Zhen et al., 1998).
These cells are conjugated with a plasmid (pRK415, see Figure 10C) containing genes for
subunit II, for the assembly accessory genes cox10 and cox11, for tetracycline resistance,
for wildtype or mutant subunit III, and for subunit I, which has been genetically
engineered to contain a 6 histidine tag at the c-terminus. A form of oxidase in which
subunit III is genetically deleted (I-IIGD) can also be expressed by using the pRK415
plasmid without the subunit III insertion.
Three milliliters of Sistrom’s media was inoculated with 100 L of the
appropriate YZ-200 glycerol stock, and the cells were grown in a shaking incubator at
30-32ºC (300 rpm) to an OD660 of 0.8-1.0 in the presence of 50 g/mL spectinomycin, 50
g/mL streptomycin and 1 g/mL tetracycline. Entire 3 mL cultures were used to
inoculate 100 mL cultures, which were grown in baffled flasks under the same
conditions. When the cultures reached an OD660 of 0.8-1.0, 12-15 mL were used to
inoculate 250 mL cultures grown in 1 L baffled flasks. Cultures typically reached an
OD660 of 1.0-1.2 within 20-24 hours at which point they were harvested by centrifugation
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at 11,300 x g and stored at minus 80ºC after washing the pellet in 50 mM potassium
phosphate, 1 mM EDTA, pH 7.2.
Frozen pellets were resuspended in BioNeb Buffer (10 mM Tris, 10 mM EDTA,
10 mM MgCl2, 20% glycerol, pH 8.0). Phenylmethylsulfonylfluoride (PMSF, 1mM),
lysozyme (25 mg/mL) and DNAse I (50 g/mL) were added, and the suspension was
homogenized and passed through a Bio-Neb (Bio-Rad) apparatus 5-7 times at 100 psi.
Centrifugation at 24,000 x g removed unlysed cells, and the supernatant was decanted
and analyzed for heme aa3 concentration on a Hewlett Packard 8453 UV/Visible diode
array spectrophotometer using the reduced minus oxidized spectrum, which has an
extinction coefficient of  = 24,000 M-cm- at 606-630 nm (van Gelder, 1966). The
supernatant was supplemented with 100 L of 100 mM PMSF and subjected to 153,000 x
g for 1.5 hours at 4ºC using a Ti50.2 rotor in a Beckman Optima LE-80K preparative
ultracentrifuge. The resulting membrane pellet was washed in 50 mM potassium
phosphate, 1 mM EDTA, pH 7.2, and the ultracentrifuge step was repeated after adding
PMSF to 1 mM. The membrane pellet was stored at minus 80ºC after decanting the
supernatant (Zhen et al., 1998).
Purification of R.sph. COX was accomplished via Ni2+-NTA chromatography
utilizing the poly-histidine tag on subunit I. The membrane pellet was resuspended in 10
mM Tris-KOH, 40 mM KCl, pH 8.0. Dodecyl maltoside (DM) was added to 2% and the
mixture was stirred for 15 minutes at 4ºC and then centrifuged at 37,000 x g for 20
minutes at 4ºC. The supernatant was transferred to a polycarbonate tube; imidazole was
added to 10 mM, and 0.8 mL of Ni2+-NTA resin (Qiagen) was added per mg of COX.
The mixture was rocked on a platform at 4ºC for 1 hour and then poured into a Bio-Rad
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glass econo-column (0.7 cm inner diameter, 30-50 cm length) and allowed to settle
without flow for 10-15 minutes. Gravity flow at a rate of 0.2-0.3 drops/second was used
to pack the column after which it was washed with 5-10 bed volumes of running buffer
(10 mM Tris-KOH, 40 mM KCl, 10 mM Imidazole, 0.1% DM, pH 8.0). Once the flow
through was clear, 2-3 bed volumes of elution buffer was layered onto the column (10
mM Tris-KOH, 40 mM KCl, 100 mM histidine, 0.1% DM, pH 8.0) and the flow rate was
slowed to 0.1-0.2 drops/second in order to keep the enzyme concentrated. The green
tinted fractions in the eluent were pooled and concentrated using 2 mL Millipore YM-100
Centricon devices at 4ºC. Multiple dilution and concentration steps were employed to
lower the histidine concentration below 1 mM using resuspension buffer (10 mM TrisKOH, 40 mM KCl, pH 8.0).

Biochemical Depletion of Subunit III from R.sph. COX
In order to remove subunit III, purified R.sph. COX incorporating a subunit I
histidine tag was incubated on a rotating platform at 4°C in 20 mM Tris, 150 mM KCl
and 12-15% Triton X-100 for 30 minutes. The ratio of Triton X-100 to COX was 100 mg
detergent to 1 mg protein. Imidazole was added to 10 mM and 0.8 mL of Ni2+-NTA resin
(Qiagen) was added for each milligram of oxidase. The slurry was incubated at 4°C on a
rocker platform for 15-30 minutes and then poured into an empty column and packed at a
fast flow rate. The column was washed with 10 bed volumes of Triton wash buffer (20
mM Tris, 150 mM KCl, 10 mM Imidazole, 0.05% Triton X-100, pH 7.5), and then 10
bed volumes of DM wash buffer (20 mM Tris, 150 mM KCl, 10 mM Imidazole, 0.05%
DM, pH 7.5). The enzyme was eluted with elution buffer (20 mM Tris, 150 mM KCl,
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100 mM Histidine, 0.05% DM, pH 7.5), and the entire procedure was repeated. After the
second elution, 2 mM EDTA was added to remove surface metal from the enzyme. To
reduce the histidine concentration below 1 mM, the sample was repeatedly washed and
concentrated in Millipore YM-100 Microcon filter devices using filtration wash buffer
(20 mM Tris, 50 mM KCl, 0.05% DM, pH 7.5). The approximate yield of I-IIBD was
35%.

Two Dimensional PAGE of Wildtype and Mutant R.sph COX
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) was conducted
using a modification of Schagger’s method for membrane protein complexes (Schagger
and von Jagow, 1991). R. sphaeroides COX stock enzyme was diluted to 0.7 g/L in
16% glycerol, and 7 g of sample was loaded per well onto a 4-15% gradient
polyacrylamide gel (Bio-Rad Ready Gel Tris-HCl, pH 8.8, Mini-PROTEAN).
Electrophoresis at 40 V for 30 minutes was followed by electrophoresis at 80 V for 4
hours at 4°C, using a discontinuous buffer system (Cathode Buffer = 50 mM Tricine, 15
mM BisTris, 0.002% Serva Blue, pH 7.0 at 4°C; Anode Buffer = 50 mM BisTris-HCl,
pH 7.0 at 4°C). The Serva Blue contained in the cathode buffer induced a charge shift in
the enzyme, so separation of the native enzyme forms was based primarily on size.
Following electrophoresis, an image of the gel was taken on a Fuji LAS-4000 imager in
precision mode.
SDS-PAGE was used to separate the native bands into their denatured
components along a second dimension. The selected bands, detected as areas of stain,
were excised from the native gel with a razor blade and incubated in 2% SDS at 37°C for
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30 minutes. The incubated bands were placed in a slot well within a 1 cm 6% stacking
layer of a 16% polyacrylamide gel (pH 8.8) containing 6 M urea and secured with 1%
agarose (Fuller et al., 1981). Electrophoresis was performed at 60 V for 25 minutes and
then 120 V for 2.5 hours. The gel was then stained with Coomassie G-250 according to
manufacturer’s directions (Bio-Rad) and subsequently silver stained according to the
method described below. Images of the Coomassie stained and silver stained gels were
captured on a Fuji LAS-4000 imager in the precision mode.

Silver Staining Polyacrylamide Protein Gels
Silver staining of PAGE protein gels was used to visualize protein bands with 10
ng/band sensitivity. In a glass container, the gels were soaked in 7% acetic acid for 7
minutes followed by two 20 minute washes in 50% methanol and two 10 minute washes
in Milli-Q water. The gels were soaked for 15 minutes in staining solution (0.8% silver
nitrate, 0.36% NaOH, 0.2 M NH4OH) and then washed twice for 5 minutes each with
Milli-Q water before swirling in developing solution (0.005% citric acid, 0.02%
formaldehyde) until the bands were of the desired intensity (about 3 minutes).
Development was stopped by three rinses in Milli-Q water. Gels were immediately
imaged on a Fuji LAS-4000 imager in the precision mode.

Estimating Subunit III Content of R.sph. 114 COX from Two Dimensional PAGE
Two dimensional PAGE was conducted on wildtype and mutant forms of COX as
described above. Silver stained second dimension SDS-PAGE gels were used to estimate
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the subunit III stoichiometry of the 114 truncation mutation. The density of the subunit
bands were quantified using Fujifilm MultiGuage V2.2 software.

Protein Immunoblotting of R.sph. COX Subunit III
In order to conduct immunoblot analysis of COX subunit III, a polyclonal
antibody was raised against the peptide corresponding to residues 64-77 of subunit III.
These residues are situated on the short loop between transmembrane helices 2 and 3 at
the bottom of the v-shaped cleft and are retained in the 114 truncation mutation. The
antibody was created as described previously (Geyer, 2007).
SDS-PAGE was conducted on wildtype and mutant COX using a 16% acrylamide
(37.5:1 acrylamide:bis) gel containing 6 M urea and 0.1% SDS (Fuller et al., 1981).
Seven g of COX were denatured in 3% SDS and Laemmli buffer (30 mM Tris-HCl,
15% glycerol, 0.005% bromophenol blue, pH 6.8) and then loaded into the gel. After
stacking in the 1 cm 6% stacking layer at 60 V for 20 minutes, the subunits could be
adequately separated by electrophoresis at 120 V for 2.5 hours. The gel and two sheets of
nitrocellulose were then soaked for 10-15 minutes in transfer buffer (10 mM CAPS, 10%
methanol, pH 11.0). A sandwich was prepared consisting of a sheet of filter paper (BioRad), 2 sheets of nitrocellulose, the gel, and another sheet of filter paper. The sandwich
was placed between two sponges and secured into a tank transfer apparatus (Bio-Rad)
filled with transfer buffer. A constant 200 mA current was applied for 90 minutes,
followed by 30 minutes at 500 mA. After transfer, the gel was stained with Coomassie G250 to evaluate transfer efficiency. The nitrocellulose sheets were briefly rinsed in MilliQ water before proceeding to immunoblotting.
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Non-specific binding was blocked by incubating the nitrocellulose membranes at
room temperature on an orbital platform for 1 hour with 3 changes of Tris-Buffer-Saline
(TBS-B: 50 mM Tris-HCl, 170 mM NaCl, 5% milk, pH 7.5). The cleft antibody was
diluted 1:250 in 25 mL of TBS-B for each nitrocellulose membrane. Primary antibody
incubation was conducted at room temperature for 1 hour on an orbital platform. The
blots were subsequently washed 3 times for 10 minutes each in TBS-B. The secondary
antibody was a Goat-Anti-Rabbit-IgG conjugated to Horse Radish Peroxidase used at a
1:3000 titer (Bio-Rad). Secondary antibody incubation for 1 hour at room temperature
was followed by washing the blots 3 times for 10 minutes each with TBS-B before
placing them in 0.1% TBS-B. The blots were developed by soaking for 3 minutes in
freshly prepared renaissance chemiluminescence reagent (100 mM Tris, 1.25 mM
luminol, 0.2 mM p-coumaric acid, 0.03% H2O2, pH 8.5). The blots were transferred to a
sheet protector and images were recorded on a Fuji LAS-4000 in increment mode.

MALDI-TOF Mass Spectrometry of Wildtype and Mutant R.sph. COX
MALDI-TOF mass spectrometry was used to assess the purity and subunit
composition of wildtype and mutant forms of COX. Samples were washed in 30 mM
Tris, pH 8.8 and concentrated to 2-3 g/L using Millipore YM-100 Microcon filter
devices. One microliter of sample was mixed with 1 L of the appropriate EAM matrix
and spotted onto a Bruker MTP-384 Ground Steel Target Plate. A 10 mg/mL SPA-EAM
matrix in 54% acetone/10% acetone/0.5% TFA was used to assess high molecular weight
peptides (>15 kD). For lower molecular weight peptides (<15 kD), 1 mg/mL CHCAEAM matrix in 5.4% acetonitrile/10% acetone/0.5% TFA was used. A Bruker Autoflex
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III MALDI-TOF/TOF mass spectrometer was used in the positive reflector mode to
analyze the samples.

Measuring the Activity and Catalytic Lifetime of R.sph. COX
To determine the maximum catalytic activity of solubilized R. sphaeroides COX,
enzyme was diluted to 2-5 M in 50 mM potassium phosphate, pH 7.4 containing 0.1%
DM and allowed to incubate on ice for at least 15 minutes prior to the assay. The rate of
oxygen consumption was measured in a water jacketed chamber at 25°C with a Clark
electrode (Yellow Springs Instrument Company Model 17372). The typical activity assay
buffer used was 50 mM potassium phosphate, 0.1% DM, pH 7.4, although in some cases
the assay buffer was supplemented with 1 mg/mL asolectin (L--phosphatidylcholine
from soybean, Type II-S, Sigma), which was sonicated to clarity prior to adding the DM.
Before enzyme addition, 50 M cytochrome c (type III), 18 mM ascorbate, and 0.6 mM
TMPD were incubated in assay buffer for 2-3 minutes to determine the auto-oxidation
rate of the reductants. Then, 2-10 picomoles of COX were added and the maximum rate
of oxygen consumption was measured. When measuring the maximal catalytic activity of
reconstituted COX in liposomes (COV), DM was omitted throughout. The auto-oxidation
was recorded as above with the addition of 6 M valinomycin and 6 M CCCP, to
dissipate the electrochemical gradient in the COVs. Then 2-10 picomoles of COVs were
added to measure the maximum uncoupled rate of oxygen reduction. To determine the
catalytic lifetime of forms of COX which undergo turnover induced inactivation, the
solubilized or reconstituted activity was measured over the course of 10-15 minutes in
order to record the entire inactivation curve.
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Measurement of the pH Dependence of R.sph. COX Activity and Catalytic Lifetime
To determine the pH dependence of oxygen reduction activity, activity assays
were conducted at pH values ranging from 6.0 to 10.0. Buffers suitable to the assay pH
were selected (pH 6.0-6.5, 25 mM MES; pH 7.0-8.5, 25 mM HEPES; pH 9.0-10.0, 25
mM CHES). Each buffer contained 0.1% DM and in some cases 1 mg/mL asolectin. The
ionic strength of the buffers was adjusted to I = 100 mM using an appropriate amount of
KCl as determined using an online buffer calculator
(http://www.liv.ac.uk/buffers/buffercalc.html). Solubilized enzyme was diluted to 2-5
M in 25 mM HEPES, 0.1% DM, I = 100 mM, pH 7.5, and was incubated on ice for at
least 15 minutes prior to the assays. Auto-oxidation rates using the appropriate buffer
were measured as described above for solubilized COX, and the amount of COX
subsequently added was adjusted for each pH value (2-30 picomoles) so as to maintain a
linear instrument response throughout the range of activity. Activity was measured for
10-15 minutes after adding COX to obtain the complete inactivation curve of those forms
of COX subject to turnover induced inactivation.

Calculating Turnover Induced Inactivation of Mutant R.sph. COX
The solubilized or reconstituted COX activity was measured over the course of
10-15 minutes in order to determine the catalytic lifetime of COX mutants which undergo
turnover induced inactivation. The increasing proportion of inactivated enzyme was
reflected by an exponential decay in the catalytic activity with respect to time. The
enzyme’s CC50 is defined as the number of catalytic turnovers undergone before the rate
reaches half maximal activity, and it was calculated as diagrammed in Figure 11 (also
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Figure 11
Calculation of CC50 value for R.sph. COX mutants undergoing turnover induced
inactivation. The auto-oxidation rate obtained in the absence of COX is extrapolated
(line 1), and a parallel line along the decay curve is drawn (line 2). This tangent intersects
the decay curve at the point of complete enzyme inactivation (point A). From point A, a
line is drawn vertically to intersection with line 1 (point B). The magnitude of line AB is
bisected (at point m), and a line perpendicular to line AB is drawn to the intersection with
the decay curve (point C). A vertical line is drawn from C to the intersection with line 1
(point D). The magnitude of line CD is used to calculate the number of catalytic
turnovers undergone before the enzyme population reaches half maximal activity. This
value, CC50, is the catalytic lifetime of the enzyme.
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see (Bratton et al., 1999; Mills et al., 2003; Mills and Hosler, 2005)). Briefly, the tangent
parallel to the extrapolated auto-oxidation rate was drawn along the exponential decay
curve. This tangent intersects the curve at the point of complete enzyme inactivation
(point A). A vertical line from point A to the extrapolated auto-oxidation rate (point B)
was bisected (at point m) and a perpendicular line was drawn from m to intersection with
the decay curve. This is the point of half maximal activity (point C). The magnitude of
the vertical line from half maximal activity to the extrapolated auto-oxidation rate (line
CD) is proportional to the number of moles of oxygen consumed, and it is used to
calculate the number of catalytic cycles the enzyme has undergone before reaching half
maximal activity, given that one catalytic turnover consumes one molecule of O2.

Reconstitution of R.sph. COX into Small Unilamellar Phospholipid Vesicles
R. sphaeroides COX was reconstituted into small unilamellar vesicles using the
cholate dialysis technique diagrammed in Figure 12 (Wilson and Prochaska, 1990).
Soybean asolectin (80 mg/mL, Sigma) was dispersed into 56 mM HEPES, pH 7.2, 7.2%
cholate (3x re-crystallized) using a Branson Sonifier 250 at a 50% duty cycle and 50%
power output for 7-10 cycles of 1 minute each. The lipids were kept on ice and the
sonicator tip was allowed to cool between cycles. The clarified phospholipid/cholate
mixture was centrifuged at 20,000 x g for 10 minutes to remove traces of titanium
fragments from the sonicator tip. COX was incubated on ice in Triton X-100 for 15-20
minutes to make the preparation monodisperse (3 mg detergent per mg COX). Then, 500
L of phospholipid/cholate was added to the COX incubation, followed by the addition
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Figure 12
Cholate dialysis technique for reconstituting COX into small unilamellar vesicles
(COV). R. sphaeroides COX was incubated with Triton X-100 (3 mg Triton/mg COX) on
ice for 15-30 minutes to achieve a monodisperse population of COX. Asolectin (80
mg/mL), cholate (7.2%) and HEPES (56 mM, pH 7.2) were sonicated to clarity, forming
mixed detergent/lipid micelles. The pre-incubated COX was mixed with the lipid mixture
and then an equal volume of 100 mM HEPES, pH 7.2 was added. Dialysis against 100
mM HEPES (pH 7.2) using a 10-14 kD molecular weight cutoff membrane removed the
cholate and drove the formation of COX vesicles (COV’s) which have an intravesicular
volume containing 100 mM HEPES, pH 7.2.
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of 500 L of 100 mM HEPES, pH 7.2. The solution was injected into a Slide-a-Lyzer
dialysis cassette (10,000 kD cut off) and dialyzed against 100 mM HEPES, pH 7.2 for 4
hours, resulting in cytochrome c oxidase vesicles (COV) with an intravesicular buffer of
100 mM HEPES, pH 7.2. External buffer was exchanged by a series of buffer changes: 1)
10 mM HEPES, 50 mM Sucrose, 50 mM KCl pH 7.2 (6-8 hours), 2) 1 mM HEPES, 50
mM Sucrose, 50 mM KCl pH 7.2 (12 hours), and if necessary, 3) 50 M HEPES, 50 mM
Sucrose, 50 mM KCl pH 7.2 (16 hours) (Cvetkov and Prochaska, 2007).

Respiratory Control Ratios of Reconstituted R.sph. COX
The respiratory control ratio (RCR) is a measure of the endogenous proton
permeability of the COVs (DiBiase and Prochaska, 1985; Wilson and Prochaska, 1990).
To measure the RCR of wildtype COVs, cytochrome c (50 M), ascorbate (18 mM) and
50 mM potassium phosphate (pH 7.4) were incubated with stirring for 2-3 minutes in the
water jacketed chamber of a Clark type oxygen electrode apparatus (Yellow Springs
Instruments). This rate of oxygen consumption in the absence of COVs, the autooxidation rate, was subtracted from all subsequent rates. Then 5-10 pmole of COVs were
added and the controlled rate was measured for 2 minutes. The addition of valinomycin
(6 M) allowed the valinomycin-stimulated rate to be measured for 2 minutes. Finally,
CCCP (6 M) was added and the fully uncoupled rate was measured. The RCR was
calculated as the ratio of the fully uncoupled rate (valinomycin and CCCP added) to the
rate in the controlled state wherein no ionophores are added. RCRval is the ratio of the
fully uncoupled rate to the valinomycin-stimulated rate (Wilson and Prochaska, 1990;
Cvetkov and Prochaska, 2007).
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In COX forms that undergo turnover induced inactivation, the RCR was measured
in three separate assays. The controlled rate was measured by incubating only
cytochrome c (50 M) and ascorbate (18 mM) in the reaction chamber during the autooxidation measurement. 5-10 pmole COVs were added and the controlled rate was
measured. The valinomycin-stimulated rate was measured by adding valinomycin (6 M)
in addition to cytochrome c and ascorbate during the auto-oxidation measurement. The
same amount of COVs as used for the controlled rate measurement was added to obtain
the valinomycin-stimulated rate. Finally, the fully uncoupled rate was obtained in a third
assay by adding both valinomycin and CCCP (6 M) to the cytochrome c and ascorbate
auto-oxidation measurement. The same amount of COVs was added as before, and the
fully uncoupled rate was measured. RCR and RCRval were calculated from the rates as
described above after subtracting the auto-oxidation rates.

Stopped Flow Measurement of R.sph. COV Proton Pumping Efficiency
An Applied Photophysics SV.20 Stopped-Flow Absorbance Analyzer was used to
measure the proton pumping efficiency of wildtype and mutant cytochrome c oxidase.
COX was reconstituted as described previously, and the external buffer was exchanged
via dialysis to low pumping buffer (50 M HEPES, 50 mM Sucrose, 50 mM KCl, pH
7.2) (Cvetkov and Prochaska, 2007). Stopped flow absorbance spectroscopy allowed
millisecond absorbance changes to be monitored upon mixing equal volumes of solutions
containing COVs or ferrocytochrome c. The electron transfer induced pH changes due to
proton pumping were monitored by inclusion of the membrane-impermeable, pHsensitive dye, phenol red. Specifically, the COVs were diluted with low pumping buffer
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to a heme aa3 concentration of 0.1 M, and phenol red was added to 100 M. A separate
solution of ferrocytochrome c (1.6 - 4 M) was prepared in low pumping buffer and 100
M phenol red. The solutions were titrated with 10-50 mM NaOH to a pH of 7.200 ±
0.005 using an Scientific Instruments IQ240 pH meter equipped with a stainless steel
probe. To monitor the extravesicular acidification due to proton pumping, 5 M
valinomycin was added to both solutions in order to dissipate the membrane potential.
The samples were loaded into two separate syringes and injected into the sample
handling unit of the stopped flow analyzer, and the absorbance at 558 nm through a 2 mm
path length cell was monitored upon sample mixing (an isosbestic point for
ferrocytochrome c oxidation). Averages of 10 reaction traces were taken per sample. The
magnitude of the decreases in dye absorbance due to acidification is proportional to the
number of protons pumped in the reaction. In order to calibrate the magnitude of the pH
changes, a separate set of samples were prepared which contained both 5 M CCCP and
5 M valinomycin. This dissipates both the charge and the proton gradients, so the
magnitude of the alkalinization changes observed is proportional to the number of
electrons consumed in the reaction (in order to reduce oxygen, one proton and one
electron is consumed). The proton pumping ratio (H+/e- ratio) indicates the number of
protons pumped for each input electron, with a theoretical value of 1.0. This value is
calculated as the ratio of the magnitude of the acidification traces (only valinomycin
present) to the magnitude of the alkalinization traces (both valinomycin and CCCP
present) (see Cvetkov and Prochaska, 2007).
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Discontinuous Sucrose Gradient Ultracentrifugation of R.sph. COX Vesicles
Discontinuous Sucrose Gradient Ultracentrifugation was used to separate
liposomes containing protein (pCOV) from vesicles devoid of COX. Solutions of varying
sucrose concentration were made in 10 mM Tris-HCl, pH 7.4, and correct sucrose
concentration was verified by their refractive indices. Two milliliters of cold 13% sucrose
solution was placed in the bottom of a Beckman centrifuge tube (13 x 51 mm), and 1 mL
of 12% sucrose, then 1 mL of 11% sucrose, and finally 1 mL of COV sample were
layered on top. The tubes were placed in a Beckman SW 50.1 swinging bucket rotor and
subjected to 300,000 x g for 22 hours at 4°C in a Beckman Optima LE-80K
Ultracentrifuge. Centrifugation resulted in the formation of two distinct bands: a
yellowish band near the bottom of the 13% layer (pCOV), and a white, cloudy band in
the 12% sucrose layer (Light COV) (see Figure 13). These bands were separately
collected with a blunt end needle (Cvetkov and Prochaska, 2007).

Estimation of the Number of R.sph. COX Molecules per Phospholipid Vesicle
Small unilamellar vesicles containing COX (pCOV) were separated from
liposomes devoid of enzyme via discontinuous sucrose density ultracentrifugation. The
pCOV fraction was analyzed for its heme and lipid content in order to estimate the
number of COX molecules per vesicle. The concentration of COX was calculated from
the reduced minus oxidized absorbance at 605 nm using an extinction coefficient of
24,000 M-cm- (van Gelder, 1966). To determine the lipid concentration, the pCOV
fraction was digested in 70% perchloric acid at 100°C for 1 hour. The inorganic
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Figure 13
Purification of COV’s using discontinuous sucrose gradient ultracentrifugation. Two
milliliters of ice-cold 13% sucrose was placed in the bottom of a Beckman centrifuge
tube. Upon this layer, 1 mL of 12% sucrose and then 1 mL of 11% sucrose were carefully
layered. All sucrose solutions contained 10 mM Tris-HCl, pH 7.2. Finally, 1 mL of COVs
was layered on top of the sucrose gradient. The sample was subjected to 300,000 x g for
22 hours at 4°C. Two bands resulted: a yellowish band in the 13% sucrose layer (pCOV),
and a white, cloudy band in the 12% layer (light COV). The bands were collected with a
blunt-tipped needle.
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phosphate concentration was then measured via a colorimetric assay (Organisciak and
Noell, 1976; Nguyen et al., 2002; Cvetkov and Prochaska, 2007).
Small unilamellar vesicles made via cholate dialysis have diameters ranging from
250 to 300 Å (Muller and Azzi, 1985). Given headgroup sizes for phospholipids in the
outer (74 Å) and inner (61 Å) monolayer (Huang and Mason, 1978), the number of lipids
per vesicle was calculated to be between 4250 (250 Å vesicle) and 6450 (300 Å vesicle).
The number of COX molecules per vesicle was calculated by dividing the aa3
concentration by the lipid concentration and then multiplying by the number of lipids per
vesicle.
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III. Results

Part One: Biophysical and Biochemical Characterization of Purified R.sph. COX
Vesicles

Measurement of the vectorial proton pumping activity of COX requires
reconstituting the enzyme into phospholipid vesicles using techniques which typically
result in preparations containing an excess number of liposomes devoid of enzyme.
Discontinuous sucrose gradient ultracentrifugation was used to separate these empty
liposomes from those containing R.sph. COX, and the purified COX vesicles (pCOV)
were characterized for their biophysical and biochemical properties.

Purification of R.sph. COV via Discontinuous Sucrose Gradient Ultracentrifugation
When reconstituting COX into phospholipid vesicles, an excess lipid to COX
stoichiometry is used to maximize reconstitution efficiency. This results in a
heterogeneous preparation consisting of both proteoliposomes and also many liposomes
devoid of enzyme. These liposomes lacking enzyme can cause technical problems such
as light scattering and increased net buffering capacity of the solution. In previous work,
liposomes lacking enzyme were removed from bovine COVs by discontinuous sucrose
density ultracentrifugation (Nguyen et al., 2002). In this study, the suitability of the
technique for R.sph. COVs was assessed and found to be applicable. Following
ultracentrifugation on a discontinuous sucrose gradient, two bands resulted from the
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R.sph. COV sample (see Figure 13). The yellowish band in the 13% sucrose layer
(pCOV) contained 80% of the COX recovered, while the white cloudy band in the 12%
sucrose layer (Light COV) contained some COX and lipid concentrations 6-8 fold higher
than the pCOV band. The total enzyme yield for R.sph. COVs was about 40%, compared
to a 60% yield obtained for bovine COVs. The R.sph. pCOV band was also more diffuse
than that seen for bovine. Overall, however, the data demonstrates that sucrose gradient
ultracentrifugation is a viable means of separating R.sph. COVs from empty liposomes
(see Discussion).

Functional and Biophysical Properties of R.sph. COV and pCOV
The usefulness of the purification technique requires minimal disruption of the
functional properties of COX and of the biophysical properties of the liposomes. These
properties were therefore assessed in the purified fraction of R.sph. COX liposomes
(pCOV) and compared to liposomes which had not undergone purification (COV).
Unpurified COVs displayed a steady-state activity of 708 ± 180 sec-1 (see Table I). The
pCOV fraction maintained steady-state activity at ~75% of the COV (535 ± 130 sec-1),
similar to the percent activity maintained for bovine pCOV (Nguyen et al., 2002).
Therefore, electron transfer rates were largely maintained in the pCOV preparations
relative to COVs.
Potential damage to the phospholipid vesicles caused by ultracentrifugation was
assessed by measuring the respiratory control ratio of pCOVs and COVs. The respiratory
control ratio is a measure of the endogenous proton permeability of COX vesicles
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Table I
Functional and Biophysical Properties of Unpurified (COV) and Purified (pCOV)
R.sph. COX Phospholipid Vesicles

R.sph. COV

R.sph. pCOV

TN (s-1) a

708 ± 180

535 ± 130

RCRb

8.6 ± 1.6

6.0 ± 1.3

RCRvalc

3.5 ± 0.7

2.4 ± 0.4

H+/e- (20 e-) d

0.9 ± 0.2

0.7 ± 0.2

H+/e- (40 e-)e

0.9 ± 0.1

0.5 ± 0.1

a

The maximum rate of electron transfer at pH 7.4 (e-/s*mol COX) was measured
polarographically by an oxygen electrode under saturating substrate conditions and in the
presence of uncoupling ionphores (50 M cytochrome c, 18 mM ascorbate, 6 M CCCP,
6 M valinomycin).
b
The ratio of the uncoupled activity (valinomycin and CCCP included) to the controlled
activity (in the absence of ionophores).
c
The ratio of the uncoupled activity to valinomycin-stimulated activity.
d
Proton pumping stoichiometry (H+/e-) indicates the number of protons pumped per
electron transferred to COX. To achieve 5 catalytic turnovers, 20 electrons/COX are
supplied (0.05 M COX, 1 M ferrocytochrome c).
e
40 electrons/COX results in 10 catalytic turnovers (0.05 M COX, 2 M
ferrocytochrome c).
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(Wilson and Prochaska, 1990). It is calculated as the ratio of the uncoupled rate of
electron transfer (in the presence of valinomycin and CCCP) to the rate of electron
transfer in the presence of an electrochemical proton gradient (no ionophores included).
A higher ratio can indicate vesicles which are more impermeable to protons, or less
“leaky” (Wilson and Prochaska, 1990). Unpurified COVs had RCR values of 8.6 ± 1.6
(see Table I). This value was maintained at ~70% in the pCOV fraction (6.0 ± 1.3). The
RCRval is the ratio of the uncoupled activity to the valinomycin-stimulated rate and
reflects the proton permeability of the membrane under the conditions used for proton
pumping (Wilson and Prochaska, 1990). Unpurified COVs had RCRval values of 3.5 ±
0.7, and pCOV maintained this value at ~70% (2.4 ± 0.4). As will be discussed further,
these results indicate that ultracentrifugation does not severely damage the ability of the
phospholipid vesicles to maintain an electrochemical gradient.
Finally, the proton pumping activity of pCOV was compared to unpurified COVs
by stopped-flow absorbance spectroscopy. The traces displayed in Figure 14 show that
the proton pumping activity of pCOV is maintained to a high degree relative to
unpurified COVs. The pH-induced absorbance changes at a cytochrome c isosbestic point
(556 nm) are monitored by the inclusion of phenol red in the assay buffer. The magnitude
of the decreases in absorbance (acidification) is proportional to the number of protons
pumped during the reaction, while the magnitude of the increases in dye absorbance
(alkalinization) is proportional to the number of electrons used (see Materials and
Methods). The proton pumping efficiency (H+/e-) is calculated by the ratio of the
absorbance decrease to that of the absorbance increase and has a theoretical value of one
(Krab and Wikstrom, 1978). The H+/e- ratios for R.sph. COVs and pCOVs are presented
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Figure 14
Proton pumping traces of R.sph. COV and pCOV. Proton pumping activity was
measured by stopped-flow absorbance spectroscopy on an Applied Photophysics SV.20
reaction analyzer. The reaction commenced upon mixing reconstituted COX with reduced
cytochrome c. Phenol red was included as a pH indicator to monitor pH-induced changes
in absorbance at 556 nm, an isosbestic point for cytochrome c reduction. Acidification
induced by the proton pumping activity of reconstituted COX in the presence of
valinomycin is shown in the lower traces. The alkalinization phase (upper traces) results
from the consumption of protons when reconstituted COX undergoes turnover in the
presence of CCCP and valinomycin. This trace is proportional to the number of electrons
+ transferred to COX. The H /e ratio is calculated from the extents of the lower and upper
traces. Displayed are representative traces for a 5 turnover experiment (0.05 M COX, 1
M ferrocytochrome c, 5 M CCCP and/or 5 M valinomycin, pH 7.2). A) unpurified
+ COX vesicles (COV) had H /e ratios of 0.9 ± 0.2 (5 turnovers). B) purified COX
+ vesicles (pCOV) had H /e ratios of 0.7 ± 0.1 (5 turnovers).
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in Table I. The unpurified COVs had H+/e- ratios of 0.9 ± 0.2 when the enzyme was
supplied with enough electrons for both 5 and 10 enzymatic turnovers (5 turnovers = 20
electrons/COX, 10 turnovers = 40 electrons/COX). When pCOVs were supplied with
enough electrons for 5 catalytic turnovers, the H+/e- ratio relative to COVs was
maintained at ~80% (0.7 ± 0.1). When pCOVs underwent 10 catalytic turnovers, they
maintained about 55% the efficiency of unpurified COVs (0.5 ± 0.1). This reduction in
proton pumping efficiency will be discussed, but the substantial pumping efficiency
maintained in low turnover experiments demonstrates the usefulness of
ultracentrifugation purification.
Two incentives for removing the liposomes devoid of enzyme are that their
presence increases the buffering capacity of the solution and that they increase light
scatter. Proton pumping assays are conducted in low buffer solution in order to monitor
pH changes caused by proton pumping. Given an equal number of turnovers, the extent
of the absorbance changes observed will depend on the buffering capacity of the solution.
In a less buffered solution, pH can change more easily and corresponding absorbance
changes will be greater. Therefore, it is notable that the absorbance change in the upper
trace of Figure 14 is greater for pCOV (B) than it is for the COVs (A), suggesting a
decrease in the buffering capacity resulting from the removal of the empty liposomes.
The degree of light scatter was analyzed by absorbance spectroscopy, and pCOV
scattered 50% less light at 550nm than did unpurified COVs. These results indicate the
usefulness of ultracentrifugal purification for decreasing the lipid-induced buffering
capacity and light scatter of solution.
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Estimation of the Number of COX Molecules per pCOV
In previous work, characterization of bovine pCOV revealed that there were on
average 2-3 COX molecules per liposome, a result consistent with the evidence that
bovine COX dimerizes in the membrane (Nguyen et al., 2002). The oligomeric state of
R.sph. in the membrane had not been previously examined, so the number R.sph COX
molecules per vesicles was estimated in the pCOV fraction. To do so, the COX and lipid
concentrations were determined by analysis of heme aa3 and inorganic phosphate
content, respectively. Liposomes made by the cholate dialysis technique have known
vesicular diameters (250-300 Å) and lipid packing constraints (Huang and Mason, 1978;
Muller and Azzi, 1985), which allows the number of COX molecules per vesicle to be
estimated. The results displayed in Table II indicate that R.sph. pCOV contained
approximately one COX molecule per phospholipid vesicle, in contrast to the 2-3 bovine
COX molecules estimated for bovine pCOV isolated by the same technique. This result
sheds insight into the oligomeric state of R.sph. in the lipid membrane, as will be
discussed.
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Table II
Estimation of the Number of COX Molecules per Phospholipid Vesicle in Purified
a
Liposomes

COX/COV 250Å
COX/COV 300Å

b

b

R.sph. pCOV

Bovine pCOV

0.72 ± 0.19

1.84 ± 0.36

1.09 ± 0.28

2.88 ± 0.56

a

Calculation was based on lipid and COX concentrations and known vesicular
curvatures and sizes (250-300 Å). COX concentration was determined by heme aa3
-1

-1

absorbance at 606 nm using an extinction coefficient of 24 mM cm . Lipid
concentration was determined by digesting pCOV in perchloric acid and then using a
colometric assay to determine phosphate concentration with nanomolar sensitivity. N = 6
b
These measurements are in agreement with published values (Nguyen et al., 2002).
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Part Two: Structural and Functional Characterization of R.sph. 114 COX

A pathogenic mitochondrial DNA mutation resulting in severe, episodic lactic
acidosis introduces a premature stop codon in COX subunit III at residue Q111 after the
third helix of subunit III (Tiranti et al., 2000). Protein sequence alignments indicate that
human Q111 aligns with I115 in the R. sphaeroides COX (see Figure 9A). A stop codon
was introduced at position 115 of subunit III in R.sph. COX, creating R.sph. 114 COX
to model the mitochondrial mutation. As shown in Figure 15, this mutation removes the
four c-terminal helices of subunit III while retaining the v-shaped lipid-binding cleft, the
subunit I-subunit III interface, and the residues conserved in the putative D-pathway
proton antenna of subunit III. The structural and functional properties of this mutant were
compared to wildtype COX and to two forms of COX in which subunit III has been
genetically or biochemically removed (I-IIGD and I-IIBD COX, respectively).
Characterization of this mutant shed insight into the functional importance of n-terminal
and c-terminal domains of subunit III as well as into the importance of its lipid-binding
cleft.

Expression and Purification of R.sph. 114 COX
R.sph. COX subunit III was mutated by replacing the codon for I115 with a stop
codon in order to truncate the subunit after 114 residues (114). The mutation was
modeled after a human mitochondrial disease mutation in which the four c-terminal
helices of the seven-helical subunit III are genetically removed (Tiranti et al., 2000). The
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Figure 15
The x-ray crystal structure of R.sph. COX showing the truncation of subunit III in
the 114 COX mutant. Subunit I (cyan) is shown with heme centers in yellow and the
mouth of the D-pathway indicated by D132 (red structure), surrounded by conserved
subunit III residues putatively acting as a proton antenna (pink structures). Subunit II is in
orange and subunit IV is in blue. Copper atoms are green spheres. The three n-terminal
helices of subunit III which are retained in the 114 mutant are shown in pink. In gray
are the helices of subunit III which are removed in the mutation (beginning with I115).
F101 is indicated in magenta at the top of subunit III helix 3. The 13 amino acid stretch
between F101 and I115 is colored in magenta. Within the v-shaped cleft of subunit III are
two phosphotidyl ethanolamine molecules designated PL1 (light green) and PL2 (dark
green). A) Side view in the plane of the membrane B) Top view shown from the
periplasmic space perpendicular to the membrane. Prepared using Accelrys DS Viewer
Pro (PDB 1M56 (Svensson-Ek et al., 2002)).
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mutated plasmid pRK415, designed for COX overexpression, was introduced into R.sph.
cells, and the protein was expressed and purified.
The bacterial growth rates and COX expression levels were compared between
R.sph. cells containing overexpression vectors for wildtype COX, 114 COX or I-IIGD
COX, in which subunit III has been genetically deleted. The strains of R.sph. cells
overexpressing 114 or I-IIGD COX grew at similar rates to cells which overexpressed
wildtype COX. After reaching an OD660 of 1.0, the cells were harvested and disrupted.
The cytoplasmic membranes were collected, washed and analyzed for heme content via
absorbance spectroscopy. The reduced minus oxidized spectrum of the purified
membranes had peaks at 550 nm, 560 nm, and 605 nm corresponding to heme c, heme b
and heme a content, respectively (Bratton et al., 2000). The ratio of the peak heights at
560 nm and 605 nm is proportional to the relative expression levels of b-type
cytochromes and COX. There are a number of cytochromes containing heme b which are
expressed in R. sphaeroides. In addition to the electron transport chain complex III
(cytochrome bc1) which contains cytochrome b, two of the alternate terminal oxidases
expressed R. sphaeroides contain heme b, namely cytochrome cbb3 and a quinol bd-type
oxidase (Mackenzie et al., 2001). Cytochrome cbb3 is expressed in high and low oxygen
concentrations, and quinol bd oxidase is expressed when O2 is limited or when electron
flow to COX is interrupted (Mouncey et al., 2000). Table III shows the heme b:COX
ratios for wildtype, 114 and I-IIGD cytoplasmic membranes. The elevated ratio for 114
and I-IIGD relative to wildtype indicated a lower proportion of COX in these membranes
as compared to cytochromes containing heme b, suggesting either impairment in COX
expression or higher expression of alternative oxidases containing heme b. A similar
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Table III
Relative Expression Levels of Wildtype, 114 and I-IIGD COX in R.sph. Purified
Membranes

a

A(560nm)/A(605nm)
R.sph. Wildtype

1.2 ± 0.2

R.sph. 114

2.4 ± 0.9
b

1.8

R.sph. I-IIGD

a

Purified cytoplasmic membranes from R.sph. cells overexpressing either wildtype,
114 or I-IIGD COX were analyzed for their heme content. The ratio of the reduced minus
oxidized absorbance at 560 nm to that at 605 nm indicates the relative expression levels
of heme b to heme a (COX). A lower ratio indicates higher relative COX expression.
b
A similar value has been reported in the literature (Bratton et al., 2000).
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result had been observed previously for R.sph. cells overexpressing I-IIGD COX (Bratton
et al., 2000).
Ni2+-NTA chromatography using a histidine tag engineered onto the c-terminus of
subunit I (Mitchell and Gennis, 1995) was used to purify COX from the cytoplasmic
membranes after they were solubilized with DM (Zhen et al., 1998). The 114
preparations consistently had reduced protein yields for nickel column purification
(~25% yield versus ~75% yield for wildtype). The loss of enzyme occurred during the
packing step of chromatography, suggesting impairment in the protein’s ability to bind
the nickel column. The packing flow through containing unbound 114 COX was
analyzed by absorbance spectroscopy and had a reduced minus oxidized -peak at 606
nm, indicating no significant disruption in the protein environment surrounding the heme
centers. A repeated chromatography attempt was made with the unbound 114 protein in
the packing flow, but it was almost completely unable to stick to the column (1% yield).
A single preparation of I-IIGD COX had a ~40% yield for nickel column purification. The
presence of a 114 truncation in COX subunit III therefore decreases both the expression
level of the protein and its ability to bind to a nickel column (see Discussion).

Optical Absorbance Analysis of R.sph 114 COX
The spectral absorbance properties of purified 114 COX were compared to
wildtype, I-IIGD and I-IIBD in order to assess the protein environment surrounding the
subunit I heme centers, and the results are summarized in Table IV. In the reduced
spectrum, the Soret and  peaks of 114 were respectively blue shifted by 2 and 1 nm
relative to wildtype, which absorbs at 445 nm and 605 nm when reduced. There was a 2
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Table IV
Optical Absorbance Parameters of Purified Wildtype, 114, I-IIGD and I-IIBD COX.

Reduced Spectrum

a

b

max

R.sph. Wildtype

445 nm

605 nm

5.4 ± 0.1

R.sph. 114

443 nm

604 nm

4.6 ± 0.2

R.sph. I-IIGD

443 nm

603 nm

4.5

R.sph. I-IIBD

445 nm

605 nm

5.3

e

Reduced minus Oxidized Spectrum

a

c

Soretmax

A(soret)/A

d


f

Soretmax

max

R.sph. Wildtype

446 nm

606 nm

R.sph. 114

446 nm

606 nm

R.sph. I-IIGD

446 nm

605 nm

R.sph. I-IIBD

446 nm

606 nm

2+

The dithionite-reduced spectra of Ni -NTA-purified COX
b
Maximal absorbance wavelength of the soret peak.
c
Maximal absorbance wavelength of the -peak.
d
Ratio of the maximal absorbance of the soret to -peak, indicating an increase in the
ratio of heme a to heme a3 content.
e
f

Similar values are published (Bratton et al., 2000).
2+
The dithionite-reduced minus ferricyanide-oxidized spectra of Ni -NTA-purified COX.
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nm blue shift for both the Soret and peak in the reduced spectrum of I-IIGD. The
reduced spectral peaks of I-IIBD were not shifted compared to wildtype. The amplitude of
the Soret to  peak for wildtype was 5.4 ± 0.1, and a similar value was observed for IIIBD (5.3). The ratio of the two peaks was decreased in the reduced 114 spectrum to 4.6
± 0.2, similar to the value observed for I-IIGD (4.5), which is in agreement with what has
been observed in other labs (Bratton et al., 2000).
The spectral changes described have been shown to result from the presence of
free subunit Ia in the preparation (Bratton et al., 2000). This is a non-reduceable, inactive
form of subunit I which does not contain heme a3. Heme a and heme a3 absorb at
different intensities in the -peak and Soret peaks such that the presence of subunit Ia,
which contains heme a but not heme a3, decreases the ratio of the Soret to -peak
absorbance (Vanneste, 1966; Bratton et al., 2000). Bratton et al. have removed the free
subunit Ia from I-IIGD preparations and found that fully purified I-IIGD has wildtype
spectral properties (Vanneste, 1966; Bratton et al., 2000). Therefore, the altered spectral
properties of the heterogeneous preparations of I-IIGD and 114 are not indicative of
misfolding in subunit I but rather to the presence of free subunit Ia, which is inactive and
does not disrupt activity.
Since the Fe3+ of heme a in free subunit Ia does not reduce, its spectral effects
should be minimized in a reduced minus oxidized (R-O) spectrum. Indeed, the R-O
spectrum of 114 exhibited a Soret peak at 446 nm and an peak at 606 nm, the same
values as were observed for wildtype and I-IIBD COX. The R-O spectral properties of IIIGD were also closer to those of wildtype, displaying only a 1 nm blue shift in the peak.
Figure 16 compares the shape of the R-O -peak for the different COX forms. Wildtype
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Figure 16
Reduced minus oxidized -peak of purified wildtype, 114, I-IIGD and I-IIBD COX.
Samples were diluted to about 1 M heme aa3 in 50 mM potassium phosphate, pH 6.5.
After the addition of ferricyanide, an oxidized spectrum was recorded on a Hewlett
Packard diode array spectrometer. Dithionite was added and a reduced spectrum was
recorded. The reduced minus oxidized spectra were normalized to 1 M heme aa3 for
comparison of the different COX forms. Wildtype, 114 and I-IIBD have a maximum at
606 nm, and the I-IIGD peak is blue shifted 1 nm. Both 114 and I-IIGD have a shoulder
on the blue side of the peak.
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(black) and I-IIBD (red) have similar peak shapes, but 114 (green) and I-IIGD (blue) both
have a shoulder on the blue side of the peak. This R-O spectral feature is also indicative
of the presence of free subunit Ia (Bratton et al., 2000). Therefore, R.sph. cells expressing
COX with either a genetic deletion or a 114 truncation of subunit III have increased
levels of free subunit Ia, which is purified in the preparations due to the presence of the
histidine tag on subunit I. Implications of this result will be presented in the Discussion,
although it is important to emphasize here that the presence of free subunit Ia does not
affect the functional properties of the enzyme because it is incapable of redox activity.

SDS-PAGE and Immunoblot Analysis of R.sph. 114 COX
The purity and subunit composition of 114 was analyzed by SDS-PAGE and
immunoblotting. These experiments were conducted for a variety of reasons. Firstly,
mutations of COX subunit III have in some cases resulted in a partial or nearly complete
loss of subunit III from the COX complex, so confirmation of the presence of SIII-114
was necessary (Tiranti et al., 2000; Varanasi et al., 2006; Geyer, 2007). In addition, a
truncation mutation in which the seventh -helix of subunit III was removed resulted in
what appeared to be proteolytic degradation of the subunit, perhaps as a result of
improper subunit III folding (Geyer, 2007). 114 COX needed to be assessed for a
similar process. Finally, the spectral properties of 114 suggested the presence of free
subunit Ia in the preparation. The approximate quantity of free subunit Ia could be
estimated by the relative intensities of the subunit I bands in an SDS-PAGE gel of 114
and wildtype. Therefore, SDS-PAGE and protein immunoblotting were used to address
these issues.
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A representative Coomassie-stained SDS-PAGE gel comparing 114 and
wildtype COX is shown in Figure 17A. Consistently, the 114 preparations had more
intense staining in bands corresponding to impurities, a result which was further analyzed
by two-dimensional PAGE as described below. The staining intensity of the subunit I
band in 114 preparations was typically about 20-30% more intense than the subunit I
band in wildtype COX, after normalizing these values by the intensities of their
respective subunit II doublet bands. This suggests that for every 3-5 assembled, active
COX molecules in the 114 preparations, there is about 1 molecule of free subunit Ia
which is not assembled with subunit II and is missing its active site. A similar enrichment
in free subunit Ia was observed for I-IIGD COX. Finally, in the 114 preparations there
were two bands which ran with an apparent molecular weight of ~10-15 kD (indicated by
arrows). These bands are likely candidates for the 114 truncation of subunit III (SIII114), a hypothesis which was further analyzed by both immunoblotting and MALDITOF mass spectrometry.
The putative SIII-114 doublet band observed in SDS-PAGE gels was assessed
by protein immunoblotting for its reactivity to a subunit III-specific polyclonal antibody.
The primary antibody was raised against a peptide corresponding to residues 64-77 of
subunit III, which are located in the short loop at the bottom of the subunit’s v-shaped
cleft. Figure 17B shows the protein immunoblot of wildtype and 114 COX. Due to the
different migration rates of full length subunit III and the putative truncation bands, a
sandwich of blotting membranes was used during the transfer. Shown are the blots
selected from the sandwich which were most enriched in each of the three bands
observed to have specific immunoreactivity. The bands at the top of the blots are due to
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Figure 17
SDS-PAGE and immunoblot analysis of wildtype and 114 COX. A) An SDS-PAGE
gel comparing wildtype and 114 COX. Seven g of COX were denatured with 3% SDS
in Laemmli buffer for 45 minutes at 37°C. Electrophoresis was conducted at 120 V for
2.5 hours on a 16% acrylamide gel containing 6 M urea and 0.1% SDS, pH 8.8. The gel
was stained with Bio-Rad Coomassie G-250 and an image was taken on a Fuji analyzer.
The 114 gels showed more impurities, had SI:SII band density ratios 1.2-1.3 times
greater than wildtype, and had a doublet around 10-15 kD. B) Protein immunoblot of
wildtype and 114 COX using a SIII-specfic antibody. Protein bands in SDS-PAGE gels
were transferred using a Bio-Rad tank transfer apparatus onto a sandwich of 2-3
nitrocellulose membranes (200 mA for 1.5 hrs, 500 mA for 0.5 hrs). The sandwich was
necessary due to differing transfer rates of full length and truncated subunit III. A
polyclonal antibody raised against residues 64-77 of subunit III was used to probe for
subunit III (Geyer, 2007). Wildtype had an immunoreactive band corresponding to full
length subunit III. 114 had an immunoreactive doublet which migrated within the
expected region for the truncation mutation.
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nonspecific binding, as was previously shown by competitive immunoblotting using the
purified peptide as a binding competitor (Geyer, 2007). A single band immunoreactive to
the subunit III antibody was observed in wildtype COX at the expected migration
distance of subunit III (22 kD). An immunoreactive band at this migration distance was
not observed in 114 COX, confirming the absence of full length subunit III in this
mutant. Notably, both bands in the putative 114 doublet were immunoreactive to the
subunit III antibody. These bands are shown on two different blots of the membrane
sandwich, as they had different transfer rates. These results confirm the presence of a
truncated form of subunit III in 114 COX and suggest the possibility of limited
proteolytic activity upon the truncated subunit.

MALDI-TOF Mass Spectral Analysis of R.sph. 114 COX
Immunoblot and SDS-PAGE analysis confirmed the presence of a truncated form
of subunit III in 114 COX, which migrated in the gel at a rate corresponding to a
molecular weight of ~10-15 kD. There was an additional immunoreactive band within
this same region, which could have resulted from post-translational, proteolytic
processing of subunit III-114. MALDI-TOF mass spectrometry was employed to
determine the exact molecular weights of these two forms of truncated subunit III in
order to better understand the extent and nature of the putative proteolytic activity. In
addition, the native processing of subunits II and IV in 114, wildtype and I-IIGD COX
was analyzed.
The mass spectra in Figure 18 show peaks within the mass range expected for the
subunit III truncation, comparing 114, I-IIGD and wildtype COX. Two peaks were
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Figure 18
MALDI-TOF mass spectral analysis of R.sph. COX SIII-114 content in R.sph.
wildtype, 114 and I-IIGD COX. Two g of sample were diluted 1:1 in a CHCA matrix,
spotted onto a Bruker stainless steel plate, and analyzed on a Bruker Autoflex III
MALDI-TOF/TOF mass spectrometer. 114 COX samples consistently exhibited peaks
at 11462 ± 8.9 m/z and 12919 ± 8.5 m/z, which were not observed in wildtype or I-IIGD.
The expected mass of SIII-114 is 12919 Da, and residues 2-101 of subunit III have a
calculated mass of 11461 Da.
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Table V
Summary of Subunit Peaks Observed in MALDI-TOF Mass Spectra of R.sph.
Wildtype, 114 and I-IIGD COX.
Subunit

Expected
Mass (Da)

Observed
WT (m/z)

Observed
114 (m/z)

Observed
I-IIGD (m/z)

SIVA’a

5272

5271 ± 4.1

N.O.b

5279 ± 9.1

SIV’(-AE)c

6039

6032 ± 3.4

6033 ± 4.4

6031 ± 5.3

SIII [2-101]d

11461

N.O.

11462 ± 8.9

N.O.

SIII [2-114]e

12915

N.O.

12919 ± 8.5

N.O.

SIIAf

29122

29415 ± 61

29402 ± 64

29433 ± 88

SIICg

30660

30628 ± 76

30612 ± 64

30608 ± 79

SII fullh (?)

32930

31966 ± 30

31985 ± 51

32006 ± 65

SIII’i

30041

30029 ± 71

N.O.

N.O.

a

Subunit IV which has been processed by removal of its 11 n-terminal amino acids.
N.O. = Not observed.
c
Subunit IV which has been process by removal of its 3 n-terminal amino acids.
d
The portion of subunit III corresponding to residues 2-101.
e
The portion of subunit III corresponding to residues 2-114.
f
Subunit II which has been processed to remove its 25 n-terminal and 15 c-terminal
amino acids.
g
Subunit II which has been processed to remove its 25 n-terminal amino acids.
h
Full length subunit II, notice the sizeable difference between observed and expected.
This peak could alternatively be an impurity
i
Subunit III with the n-terminal Met removed
b
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consistently observed in 114, one at 12919 ± 8.5 m/z and one at 11462 ± 8.9 m/z. These
peaks were absent from wildtype and I-IIGD COX spectra. The expected mass for a
subunit III truncation after residue 114 is 12915 Da, given that the n-terminal methionine
residue is cleaved from subunit III (Distler et al., 2004). The 12919 m/z peak, therefore,
was assigned to the truncation in subunit III resulting from the genetic introduction of a
stop codon at position 115 (SIII-114). The peak observed 1457 m/z units smaller than
SIII-114 (at 11462 m/z) is consistent with the expected molecular weight of subunit III
residues 2-101 (11461 m/z). This suggests that the 13 c-terminal amino acids of SIII114 can sometimes be cleaved from the truncated subunit, and the 11462 m/z peak was
assigned to SIII-[2-101] accordingly (see Table V). The cleavage would occur after F101,
which is located at the top of helix three at the phospholipid bilayer interface. The 13
amino acids putatively removed are the beginning of what would be in full length subunit
III a large periplasmic loop extending 30 amino acids to the next helix (four) in the R.sph.
COX structure (Svensson-Ek et al., 2002).
In R.sph. COX, subunit II undergoes native, post-translational proteolytic
processing, resulting in the removal of its 25 n-terminal amino acids and its 15 c-terminal
amino acids (Distler et al., 2004). The functional purpose of this processing is unknown,
but it results in a heterogeneous preparation of enzyme upon purification. In particular,
subunit II is present primarily in two forms. In subunit IIA, the processing has occurred at
both termini resulting in a mass of 29122 Da, but for subunit IIC, processing has only
occurred at the n-terminus to yield a mass of 30660 Da. Unprocessed subunit II can also
be present in the preparation, having a mass of 32930 Da. These processing differences
have not been observed to affect the activity of the protein (Hosler et al., 1992; Hiser et
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al., 2001; Distler et al., 2004). All three processing forms of subunit II were observed in
114, wildtype and I-IIGD preparations, as depicted in Figure 19 (see Table V).
Specifically, peaks near the expected mass of subunit IIA were observed in wildtype
(29415 ± 61 m/z), 114 (29402 ± 64 m/z) and I-IIGD (29433 ± 88 m/z), and subunit IIC
were also assigned for wildtype (30628 ± 76 m/z), 114 (30612 ± 64 m/z), and I-IIGD
(30608 ± 79 m/z). A peak about 900-1000 m/z less than the expected mass of full length
subunit II was observed in wildtype (31966 ± 30 m/z), 114 (31985 ± 51 m/z), and I-IIGD
(32006 ± 65 m/z), but the sizeable difference from the expected value should be noted. As
expected, a peak corresponding to the expected mass of subunit III (30041 Da) was
observed only in wildtype COX (30029 ± 71 m/z).
An examination of the relative peak areas in Figure 19 of the subunit II forms
revealed that in the 114 and I-IIGD preparations subunit IIA peak areas were ~3-4 fold
less than the area of the subunit IIC peaks. On the other hand, in wildtype COX the peak
areas corresponding to fully processed subunit IIA were ~5-7 fold greater than the peak
areas for partially processed subunit IIC. This same pattern was observed in SDS-PAGE
gels, as shown for 114 and wildtype COX in Figure 20. The relative band densities of
subunit IIA and IIC were determined from these gels. For 114, the less processed
subunit IIC band was ~3-5 times more intense than the fully processed subunit IIA band,
similar to the result seen for I-IIGD COX. However, in wildtype COX, the fully processed
subunit IIA band was ~7-9 fold more intense than the subunit IIC band, which was also
the case for I-IIBD COX. Therefore, when subunit III is absent or truncated after its third
helix, the native in vivo processing of subunit II appears to be altered. It should be
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Figure 19
MALDI-TOF mass spectral analysis of subunit II and III content in R.sph. wildtype,
114 and I-IIGD COX. Two g of sample were diluted 1:1 in a SPA matrix, spotted onto
a Bruker stainless steel plate, and analyzed on a Bruker Autoflex III MALDI-TOF/TOF
mass spectrometer. Wildtype samples contained peaks assigned to subunit III and to three
forms of subunit II (subunit II, IIA, IIC). 114 and I-IIGD samples did not contain a
subunit III peak but did contain three forms of subunit II. The peak areas for IIC were
consistently greater than those of IIA in 114 and I-IIGD COX preparations, contrary to
the pattern observed in wildtype COX
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Figure 20
SDS-PAGE analysis of subunit IIA and IIC in R.sph. wildtype and 114 COX. 1-10
g COX samples were denatured with 3% SDS in Laemmli buffer for 45 minutes at
37°C. Electrophoresis was conducted at 120 V for 3.0 hours on a 16% acrylamide gel
containing 6 M urea and 0.1% SDS, pH 8.8. The gel was stained with Bio-Rad
Coomassie G-250 and an image was taken on a Fuji analyzer. The subunit II doublet in
114 had more intense staining in the slower migrating form (IIC) compared to the faster
migrating form (IIA). In 114 COX, the IIC band was 3-5 more intense than the IIA
band, as estimated using Accelrys Multigauge software. In wildtype, IIA was 7-9 more
intense than IIC.
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Figure 21
MALDI-TOF mass spectral analysis of subunit IV content in R.sph. wildtype, 114
and I-IIGD COX. Two g of sample were diluted 1:1 in a CHCA matrix, spotted onto a
Bruker stainless steel plate, and analyzed on a Bruker Autoflex III MALDI-TOF/TOF
mass spectrometer. In wildtype and I-IIGD COX, two forms of natively-processed subunit
IV were observed consistently (IVA’ and IV’(-AE)). In 114 preparations, the IV’(-AE)
form was present, but the IVA’ form was not observed.

99

100

emphasized, however, that the differentially processed forms of subunit II do not have an
observed affect on the steady state activity of COX.
Subunit IV has also been observed in a variety of different forms in wildtype
COX (Distler et al., 2004). The expected mass range for subunit IV peaks is shown in
Figure 21. Two forms of subunit IV were observed in the spectra (see Table VI). Subunit
IVA’ has its n-terminus cleaved after Met11, has an expected mass of 5272 Da, and is the
form most abundant in wildtype COX (Distler et al., 2004). This form of the subunit
could also result from using the Met11 codon as the translation start site rather than Met1.
A subunit IVA’ peak was observed in wildtype (5271 ± 4.1) and I-IIGD (5279 ± 9.1), but
it was not observed in 114 COX. The subunit IV’(-AE) form has its first three nterminal residues cleaved and has a mass of 6039 Da. A peak at this mass was observed
in wildtype (6032 ± 3.4), 114 (6033 ± 4.4) and I-IIGD (6031 ± 5.3). These results
indicate that the truncation of subunit III after its third helix alters the native processing
of subunit IV as well as subunit II. Subunit IV has not been shown to have a functional
role in COX activity.

Two Dimensional PAGE Analysis of R.sph. 114 COX
Certain subunit III mutations result in a disruption of the subunit III interaction
with subunit I such that subunit III is partially depleted from the complex (Bratton et al.,
2000). In particular, a truncation of subunit III after its sixth helix resulted in depletion of
subunit III by up to 70% (Geyer, 2007). Since 114 COX could have different functional
properties than I-II COX, it was important to determine the stoichiometry of SIII-114 in
the COX complex. Two dimensional PAGE was employed to this end.
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Figure 22A shows a blue native PAGE gel of wildtype, 114 and I-IIGD COX.
The majority of wildtype COX migrates in two bands, which, as analyzed by a second
SDS-denaturing dimension (Figure 22B), correspond to 4 subunit COX (a) and a small
amount of COX containing only subunits I and II (b). Both 114 and I-IIGD COX migrate
in three bands on the native gel, with the I-IIGD bands running faster than those of 114.
The 114 native bands, denoted c, d and e, were denatured in SDS and run on a
second dimension in order to quantitate their purity and COX subunit content (Figure
22B). About 45% of the total 114 COX enzyme migrated in the native band d as
determined by its denser subunit II band in the 2D gel relative to the subunit II densities
of lanes c and e. The strikingly dark band corresponding to SIII-114 in the second
dimension of band d extends through 75% of the lane width. It was therefore assumed
that this portion of the band had COX with full incorporation of SIII-114. The 114
native band d also had a noticeable amount of impurities whose staining densities were a
third of the total staining density of the second dimension lane. Native band c, the slower
migrating band, contained an even greater amount of impurities; the 2D gel showed this
band consisted of 70% impurities and about 30% COX, which contained SIII-114.
Native band e contained the least amount of impurities (20% of the total lane density),
and some COX with SIII-114. The stoichiometry of SIII-114 incorporation for the
COX contained in native bands c and e was determined by comparing the density of their
subunit II bands in the 2D gel to density of their SIII-114 bands, using lane d as
calibration. Thus, bands c and e were found to incorporate SIII-114 with 65%
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Figure 22
Two-dimensional PAGE analysis of wildtype, 114 and I-IIGD COX. A) Seven g of
COX were diluted in 16% glycerol and electrophoresis was conducted at 80 V for 4 hours
at 4°C on a 4-15% gradient acrylamide gel, pH 8.8. A discontinuous buffer system was
used which employed Serva Blue in the cathode buffer to induce a charge shift in the
enzyme preparations (Schagger and von Jagow, 1991). Wildtype migrated primarily in
two bands (a, b), and both 114 (c-e) and I-IIGD (f-h) migrated in three bands. B) Bands
from the native gel were excised and incubated in 2% SDS for 30 min at 37°C. The bands
were fixed with 1% agarose to a 16% polyacrylamide gel containing 0.1% SDS and 6 M
urea (pH 8.8), and electrophoresis was conducted at 120 V for 2.5 hours. The gels were
silver stained and band intensity was analyzed. The composition of the native wildtype
bands contained 4 subunit COX (a) and a small amount of I-II COX (b). The 114 lanes
all contained COX with ~70% stoichiometry of SIII-114 and varying degrees of
impurities. The I-IIGD lanes all contained I-II COX and varying degrees of impurities.

103

104

stoichiometry. The overall percentage of COX containing subunit III-114 was estimated
by a weighted average, given the percentage of COX migrating in the particular band and
its estimated SIII-114 incorporation. The results indicate that 65-75% of COX contains
SIII-114. This calculation is summarized in Table VI. It should be noted that possible
saturation was not accounted for in the SIII-114 2D band used for calibration, making
these lower level estimates of SIII-114 incorporation.
Figure 22B shows the 2D lanes corresponding to the native gel bands for I-IIGD
COX. Similar to 114, these bands have decreasing amounts of impurity correlated to
increasing migration rates on the native gel. The total amount of impurity appears to be
less for I-IIGD than it is for 114. As expected, no subunit III band is present in I-IIGD.
These results indicate that the 114 preparations have a higher degree of impurity
as compared to wildtype and I-IIGD COX. The enrichment of impurities relative to
wildtype and I-IIGD was observed in SDS-PAGE gels for all three different purification
preparations of 114, despite following the same purification protocol used for wildtype
and I-IIGD. The molecular weights of these impurities were estimated by SDS-PAGE as
shown in Figure 23. The left panel shows a Coomassie stained SDS-PAGE gel of R.sph.
wildtype and 114 as well as bovine COX. The bovine COX subunits were used as
calibration, as their migration rates relative to their apparent molecular weights are
known (Kadenbach et al., 1983). The right panel is the silver stained second dimension
SDS gel of lane c from Figure 22B, the 114 band most enriched in impurities. The four
major impurities are labeled 1 through 4. The apparent molecular weights of these
impurities based on migration distances were calculated and the results are summarized
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Table VI
Summary of Two-Dimensional PAGE Analysis of 114 COX

Slow band
Impurties:COX

d
e

% of Total COX

f

114 stoichiometry

a

Middle band

b

Fast band

2.3

0.3

0.2

25%

45%

30%

65%

75%

65%

a

c

Slowest migrating band in the native PAGE gel (see Figure 22, band c).
Middle band on the native PAGE gel (Figure 22, band d).
c
Fastest migrating band in the native PAGE gel (Figure 22, band e).
d
A second SDS dimension was employed to determine the subunit components of the
three native gel bands observed for 114 COX. Silver staining density was determined
using Accelrys Multiguage software. The staining intensity due to impurities was divided
by the staining intensity of the sum of the COX subunits.
e
The percentage of total COX which migrated within the specified native gel band, as
determined from the second dimension SDS gel. The sum of the staining density due to
COX subunits within the specified 2D lane divided by the total staining density of COX
subunits in all 2D lanes.
f
The percentage of COX which contained subunit III-114, as determined from the
second dimension SDS gel. The second dimension of the middle native gel band had an
intense SIII-114 band covering 75% of the lane width. This portion was assumed to
have full incorporation of SIII-114, and was used to calibrate the SIII-114
stoichiometry of the other two bands.
b
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Figure 23
SDS-PAGE analysis of impurities contained in 114 COX preparations. An SDSPAGE Coomassie-stained gel with wildtype, 114 and bovine COX (A) is aligned with a
second dimension SDS silver-stained gel of the slowest migrating 114 native gel band
(B). This 2D band is the most enriched in impurities, which are enumerated 1-4 (see
Figure 22, band c). The bovine subunit migration distances were used to as calibration in
estimating the apparent molecular weight of impurity 1 (39 kD), 2 (33 kD), 3 (22 kD) and
4 (19 kD).
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Table VII
Summary of Masses of the Impurities Observed in 114 Preparations

a

b

Apparent MW

1

38.7 kD

-

2

33.0 kD

~34.8 m/z
or
d
32000 m/z

3

22.0 kD

22931 m/z

4

18.9 kD

19496 m/z

a

MS peak

c

Impurity

Four predominant impurities which are enriched in 114 preparations (see Figure 23).
The apparent molecular weight calculated by migration distances on SDS-PAGE using
bovine COX subunits as calibrating standards.
c
Peaks routinely observed in MALDI-TOF mass spectra which correspond to the
molecular weights estimated from SDS-PAGE.
d
This peak was also tentatively assigned to full length subunit II, although it is nearly
1000 m/z less than the expected molecular weight of subunit II.
b
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in Table VII. Also included in Table VII are comparable impurity peaks routinely
observed in the MALDI-TOF spectra of wildtype and 114 COX. A mass corresponding
to the ~38.7 kD impurity (1) was not observed in MALDI-TOF mass spectra. The ~ 33
kD impurity (2) could either be a protein of 34.8 m/z or an enrichment of full length
subunit II in the preparation (~32000 m/z). A mass potentially corresponding to the ~22
kD impurity (3) was routinely observed around 22930 m/z. And the ~19 kD impurity (4)
could be assigned to the 19490 m/z peak frequently observed. The identity of proteins
with these masses is not obvious. Their enrichment in the 114 preparations will be
discussed further.

Steady State Catalytic Activity of R.sph. 114 COX
When subunit III is removed from COX, the enzyme has a lower steady-state
activity at physiological pH (Gilderson et al., 2003). A closer examination reveals that the
pH dependence of steady-state activity is significantly altered in I-II COX. At low pH,
the activity of I-II COX is close to that of wildtype, but the activity plummets sharply
with increasing pH, displaying a pKa around 7.2 (Gilderson et al., 2003). For wildtype,
high steady-state activity levels are maintained, having a pKa around 8.5. The impaired
activity at physiological pH has been explained as a decreased ability of I-II COX to take
up protons through the D-pathway (Gilderson et al., 2003). The steady-state activity at
physiological pH and the pH dependence of activity were examined in 114 to determine
the functional effects of removing the four c-terminal helices of subunit III.
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The steady state catalytic activity of 114 at pH 7.4 was compared to wildype, IIIGD and I-IIBD COX, and the results are depicted in Figure 24 and summarized in Table
VIII. The assay was conducted under three different conditions: in 0.1% DM
(“detergent,” black bars), in 0.1% DM supplemented with 1 mg/mL asolectin (“lipid,”
light gray bars) and when COX was incorporated into phospholipid vesicles (“COV,”
medium gray bars). In detergent, wildtype COX displayed a steady state turnover of 1830
± 160 sec-1 at pH 7.4. The activity at physiological pH for 114 (860 ± 110 sec-1), I-IIGD
(845 ± 100 sec-1) and I-IIBD (1050 ± 205 sec-1) were statistically equivalent to each other
and about 50% that of wildtype. When the assay was conducted in lipid, the activity of
wildtype increased 15% to 2190 ± 185 sec-1 (statistically significant increase). Inclusion
of lipid in the assay did not statistically change the activity in 114 (890 ± 105 sec-1), IIIGD (900 ± 125 sec-1) or I-IIBD (1140 ± 220 sec-1). Reconstituting COX into phospholipid
vesicles resulted in a decrease of steady state turnover for wildtype to 1160 ± 165 sec-1,
and a similar decrease was also observed for 114 (630 ± 30 sec-1), I-IIGD (575 ± 35 sec-1)
and I-IIBD (760 ± 75 sec-1). These results indicate that the catalytic activity of 114 is
about half that of wildtype and is statistically equivalent to COX forms which do not
contain subunit III.
Figure 25 depicts the pH dependence of catalytic activity for wildtype, 114 and
I-IIBD COX. Wildtype (black) displays a decrease in activity with increasing pH. The data
can be fitted to a sigmoidal curve with a single pKa of 8.7 ± 0.1, a value in agreement
with published results (Gilderson et al., 2003). The pKa of I-IIBD COX steady-state
activity was decreased to 7.1 ± 0.2 (red), as expected. Similarly, the pKa of 114 COX
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Figure 24
Maximum steady state activity of R.sph. wildtype, 114, I-IIGD and I-IIBD COX. The
maximum rate of electron transfer at pH 7.4 was measured polarographically by an
oxygen electrode in saturating substrate conditions (50 M cytochrome c, 18 mM
ascorbate, 0.6 mM TMPD). The assay was conducted in 50 mM potassium phosphate, pH
7.4 which included 0.1% DM (black bars) or 0.1% DM and 1 mg/mL asolectin (light gray
bars). The enzyme was reconstituted into phospholipid vesicles and the activity was
determined in buffer without detergent and with 6 M valinomycin and 6 M CCCP
included (medium gray bars). For each assay condition, 114, I-IIGD and I-IIBD COX
activities were statistically equivalent to each other and about 50% of wildtype. The
presence of lipid did not alter the activity (as shown by multiple paired t tests).
Reconstitution into COVs uniformly reduced activity in all COX forms. N = 12.
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Table VIII
Summary of Functional Properties of Wildtype, 114, I-IIBD and I-IIGD COX.
Wildtype

114

I-IIGD

I-IIBD

Detergent

1830±160

860±110

845±100

1050±205

Lipid

2190±185

890±105

900±125

1140±220

COV

1160±165

630±30

575±35

760±75

8.7±0.1

7.4±0.1

-

7.1±0.2

11470±1240

9340±440

10670±1070

a

-1

Activity (s

pKa

)

b

TIA (#TN)

c

d

Detergent

~3×10

6e

Lipid

-

24270±3050

16090±2750

13160±220

COV

-

24110±2160

21000±2030

23160±1020

f

-

6.5±0.2

-

6.1±0.5

0.74±0.2

0.32±0.1

0.36±0.1

-

pKa
+

-h

H /e

g

a

Maximum steady state activity at pH 7.4
pKa of the sigmoidal curve fit (single pKa fit) of steady state activity data taken from
pH 6 to 10.
c
pKa of 114 steady state activity in presence of lipid = 7.3±0.1
d
Turnover induced inactivation CC50 values: the number of turnovers undergone before
steady state activity reaches half maximum
e
see (Varanasi et al., 2006)
f
pKa of the sigmoidal curve fit to TIA data taken from pH 6 to 10.
g
pKa of 114 TIA in presence of lipid = 6.5±0.1
h
Proton pumping stoichiometry: the number of protons pumped per electron transfer to
COX.
b
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Figure 25
pH dependence of steady state activity in R.sph. wildtype, 114, and I-IIBD COX.
The steady state activity was measured polarographically by an oxygen electrode in
saturating substrate conditions (50 M cytochrome c, 18 mM ascorbate, 0.6 mM TMPD).
Buffers suitable to the assay pH were selected (pH 6.0-6.5, 25 mM MES; pH 7.0-8.5, 25
mM HEPES; pH 9.0-10.0, 25 mM CHES). Each buffer contained 0.1% DM and the ionic
strength of the buffers was adjusted to I=100 mM using KCl. The results are plotted as
fraction of maximum activity with the fractional error indicated. A sigmoidal curve with a
single pKa provided the best fit for the data. Wildtype (black) had a pKa of 8.7 ± 0.1, and
114 (royal blue, 7.4 ± 0.1) and I-IIBD (red, 7.1 ± 0.2) both exhibited a decrease in pKa
by 1.5 units. For 114, the assay was also conducted with 1 mg/mL asolectin included in
the assay buffers (light blue, 7.3 ± 0.1). No shift in the pKa was observed relative to the
detergent-only assay. N = 3.
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decreased to 7.4 ± 0.1 (royal blue), within statistical equivalence of the pKa of I-IIBD
COX. Adding 1 mg/mL asolectin to the assay buffer did not significantly alter the pH
dependence of activity for 114 COX (light blue). Therefore, 114 COX shows a similar
pH dependence of steady-state activity to COX without subunit III. This profile is
significantly altered compared to wildtype COX, and the inclusion of lipid does not
ameliorate the deleterious effects on activity.

Turnover Induced Inactivation of R.sph. 114 COX
When subunit III is removed from COX, either through genetic or biochemical
means, the enzyme undergoes turnover induced inactivation, which is an irreversible
inactivation event occurring only during catalytic turnover (Bratton et al., 1999). The
catalytic lifetime of the enzyme can be quantified as a CC50 value, the number of catalytic
turnovers undergone before the activity reaches half maximum, assuming a first order
decay process (see Methods). Other investigators have determined the CC50 values of
wildtype (~3.0×106 turnovers) and found that the I-II COX catalytic lifetime dropped to
about 10,000 turnovers, only 0.2-0.5% of wildytpe (Bratton et al., 1999; Gilderson et al.,
2003; Mills et al., 2003; Mills and Hosler, 2005). Furthermore, turnover induced
inactivation displays a pH dependence such that at low pH, the catalytic lifetime is
increased. As pH increases, the catalytic lifetime drops off, displaying a pKa around 66.5 for I-II COX (Adelroth and Hosler, 2006). This suggests that turnover induced
inactivation is related to the slowed proton uptake observed in the absence of subunit III
(Gilderson et al., 2003; Mills et al., 2003; Mills and Hosler, 2005; Adelroth and Hosler,
2006). In addition to facilitating D-pathway proton uptake, subunit III has been proposed
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to play a role in structurally stabilizing subunit I to protect it from inactivation (Mills and
Hosler, 2005). The PL1 and PL2 lipids bound in the cleft region of subunit III (see
Figure 15) have suggested involvement in this stabilization (Varanasi et al., 2006).
Turnover induced inactivation in 114 was measured in the presence and absence of
exogenous lipid and compared to I-IIGD and I-IIBD COX in order to assess the role that
lipid and the three n-terminal helices of subunit III may play in protecting against
inactivation.
The previously published value for turnover induced inactivation of I-II COX was
reproduced for I-IIGD (9340 ± 440 turnovers) and I-IIBD (10670 ± 1070 turnovers) when
the assay was conducted in 0.1% DM at pH 7.4 (Figure 26, black bars, also see Table
VIII). The catalytic lifetime of 114 COX was statistically equivalent to I-IIBD and I-IIGD
in the detergent assay (11470 ± 1240 turnovers). When the assay buffer was
supplemented with 1 mg/mL asolectin, the catalytic lifetime of 114 increased 2.1 fold to
24270 ± 3050 turnovers. This result was statistically different (p < 0.001) than the more
modest increases observed for I-IIGD (1.7 fold increase) and I-IIBD (1.2 fold increase),
which had catalytic lifetimes in lipid micelles of 16090 ± 2750 turnovers and 13160 ±
220 turnovers, respectively (light gray bars). The catalytic lifetime of 114 was not
further increased relative to the lipid micelle assay when the enzyme was reconstituted
into phospholipid vesicles and measured in the presence of ionophores (24110 ± 2160
turnovers). However, reconstitution into lipid vesicles increased the catalytic lifetimes of
both I-IIBD (23160 ± 1020 turnovers) and I-IIGD (21000 ± 2030 turnovers) to statistical
equivalence with the catalytic lifetime of 114 achieved in lipid micelle (medium gray
bars). These results indicate that the presence of subunit III-114 provides a protective
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Figure 26
Catalytic lifetimes of R.sph. 114, I-IIGD and I-IIBD COX. Turnover induced
inactivation of COX can be quantitated by the CC50 value, which is the number of
catalytic turnovers undergone by an enzyme population before reaching half maximal
activity. The catalytic lifetimes were measured polarographically by an oxygen electrode
in saturating substrate conditions (50 M cytochrome c, 18 mM ascorbate, 0.6 mM
TMPD). The assay buffer was 50 mM potassium phosphate, pH 7.4 and included 0.1%
DM (black bars) or 0.1% DM and 1 mg/mL asolectin (light gray bars). The enzyme was
reconstituted into phospholipid vesicles and assays were conducted in buffer without
detergent and with the addition of 6 M valinomycin and 6 M CCCP (medium gray
bars).
In the detergent assay (black bars), 114, I-IIGD and I-IIBD lifetimes were statistically
equivalent to each other at about 10,000 turnovers. The presence of lipid (light gray bars)
increased the catalytic lifetime of 114 to 24270±3050, more than 2 fold. There were
more modest lipid-induced increases in the catalytic lifetimes of I-IIGD (1.7 fold) and IIIBD (1.2 fold), but these changes were statistically smaller than the increase observed for
114 (p < 0.001). Reconstitution into COVs (medium gray bars) did not significantly
alter the catalytic lifetime of 114 relative to its lipid-protected lifetime. The lifetimes of
reconstituted I-IIGD and I-IIBD COX were increased to levels statistically equivalent to the
lipid-protected 114 lifetime. These results indicate that the lipid micelle provides a
protection against inactivation for 114 which can only be achieved for I-IIGD and I-IIBD
COX in the lipid bilayer. N = 12.
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effect against turnover induced inactivation in lipid micelles that can only be achieved for
I-II COX when the enzyme is in the more constrained, lipid-saturated environment of a
lipid vesicle. The implications of this significant result will be expounded further.
The pH dependence of turnover induced inactivation for 114 and I-IIBD COX is
displayed in Figure 27 (see Table VIII). The data for I-IIBD COX (red) fit to a sigmoidal
curve with a pKa of 6.1 ± 0.5, in agreement with literature values (Adelroth and Hosler,
2006). The pH dependence of inactivation of 114 was somewhat shifted to the alkaline
(royal blue, 6.5 ± 0.2), although not to a statistically significant degree. Supplementing
the assay buffer with 1 mg/mL asolectin did not modify the pH dependence of 114
inactivation (light blue, 6.5 ± 0.1). These results suggest that the protection effect
provided by 114 COX in the presence of lipid is probably not due to improved Dpathway proton uptake but rather to structural stabilization of the enzyme (see
Discussion).

Proton Pumping Activity of R.sph. 114 COX
Removing subunit III from COX decreases its proton pumping efficiency to one
half that of wildtype COX (Mills et al., 2003). This effect could be due to the impaired
proton uptake in the D-pathway and/or due to a minor structural change in the vicinity of
E286 in subunit I, the point in the D-pathway at which the proton is transferred either to
the active site or to the pump site (Gilderson et al., 2003; Brzezinski and Johansson,
2010). The proton pumping activity of 114 COX was compared to wildtype and I-IIGD
COX in order to assess the importance of the three n-terminal helices for the proton
pumping activity of COX.
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Figure 27
pH dependence of the catalytic lifetimes in R.sph. 114, and I-IIBD COX. The
catalytic lifetime (CC50) was measured polarographically by an oxygen electrode in
saturating substrate conditions (50 M cytochrome c, 18 mM ascorbate, 0.6 mM TMPD).
Buffers suitable to the assay pH were selected (pH 6.0-6.5, 25 mM MES; pH 7.0-8.5, 25
mM HEPES; pH 9.0-10.0, 25 mM CHES). Each buffer contained 0.1% DM and an ionic
strength adjusted to I=100 mM using KCl. The results are plotted as fraction of maximum
catalytic lifetime with the fractional error indicated. A sigmoidal curve with a single pKa
provided the best fit for the data. The pKa values for 114 (royal blue, 6.5 ± 0.2) and IIIBD (red, 6.1 ± 0.5) were statistically equivalent. For 114, the assay was also conducted
with 1 mg/mL asolectin and 0.1% DM in the assay buffers (light blue, 6.5 ± 0.1). No shift
in the pKa was observed relative to the detergent-only assay. N = 3.
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Figure 28
Proton pumping activity of R.sph. wildtype, 114 and I-IIGD COVs. Proton pumping
activity was measured by stopped-flow absorbance spectroscopy on an Applied
Photophysics SV.20 Reaction Analyzer. Phenol red was used as a pH indicator to monitor
acidification-induced absorbance changes caused by the proton pumping activity of
reconstituted COX in the presence of valinomycin (lower traces). The alkalinization
phase (upper traces) results from the consumption of protons for O2 reduction observed
when reconstituted COX undergoes turnover in the presence of CCCP and valinomycin.
This absorbance change is proportional to the number of electrons transferred to COX.
+ The H /e ratio is calculated from the extents of the lower and upper traces. Displayed are
averaged traces for a 5 turnover experiment (0.05 M COX, 1 M ferrocytochrome c, 5
M CCCP, and/or 5 M valinomycin, pH 7.2). The COVs had RCR values of 6-10 and
RCRval values of 2-2.5.
+

-

+

-

Wildtype COVs (black) had an H /e ratio of 0.74 ± 0.2. The H /e ratios of 114 COVs
(blue, 0.32 ± 0.1) and I-IIGD COVs (green, 0.36 ± 0.1) were statistically equivalent and
about 50% less than wildtype.
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The proton pumping activities of wildtype, 114 and I-IIGD COVs were measured by
stopped flow absorbance spectroscopy, and the traces are shown in Figure 28. The upper
traces have been normalized, allowing a comparison of the pumping efficiencies of
wildtype (black), I-IIGD (green) and 114 (blue). The proton pumping efficiency of 114
(0.32 ± 0.1 H+/e-) is equivalent to I-IIGD (0.36 ± 0.2 H+/e-) and is about half the efficiency
of wildtype, which had an H+/e- of 0.74 ± 0.2 (see Table VIII). These results indicate that
the n-terminal region of subunit III is not sufficient to prevent the deleterious effects on
proton pumping that are seen in the absence of subunit III, a result which will be further
discussed.
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IV. Discussion
Biophysical and Biochemical Characterization of R.sph. pCOV Sheds Insight into
the Oligomeric Structure of R.sph. Cytochrome c Oxidase

Discontinuous sucrose gradient ultracentrifugation was used to separate
proteoliposomes containing R.sph. COX from liposomes devoid of enzyme. The purified
fraction containing COX (pCOV) was analyzed for its functional and biophysical
properties and compared to unpurified COVs. It was found that the purification technique
reduced the excess lipid concentration resulting in a decrease in the net buffering capacity
of the solution. Light scattering was also reduced, making pCOV better suited for low
buffer spectroscopic studies. The oxygen reduction and proton pumping activities of
pCOVs were maintained to a high degree relative to COVs, indicating that the technique
does not significantly damage the liposomes. Finally, the number of COX molecules per
vesicle was estimated by the lipid and protein concentration of the pCOV fraction and the
known size of the vesicles. It was found that there is only one R.sph. COX molecule per
liposome. A similar study conducted on bovine pCOV estimated the number of bovine
COX per vesicles was two or three. Taken together, these results indicate that maximally
functional R.sph. COX exists in the monomeric state when in the lipid bilayer, contrary to
the bovine enzyme which is dimeric.
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Discontinuous Sucrose Gradient Ultracentrifugation and Biophysical and Biochemical
Characterization of pCOV
Previous work on reconstituted bovine COX showed that discontinuous sucrose
gradient ultracentrifugation is a technique by which liposomes containing enzyme can be
purified away from liposomes devoid of enzyme (Nguyen et al., 2002). Unpurified
liposomal preparations (COV) typically contain about 6–7 liposomes devoid of enzyme
to every COX-containing liposome, so the need for such a purification method is critical
due to increased net buffering capacity from the phospholipid headgroups, deleterious
binding interactions between cytochrome c and the excess lipids (Choi and Dimitriais,
2004; Gorbenko et al., 2006), and due to light scattering which can complicate
spectroscopic measurements in the unpurified COV preparation. Since mutagenesis
studies in the bovine form of the enzyme are not easily performed and are inefficient
(Hosler et al., 2006), the structural and functional models for mutagenesis studies of COX
are bacterial oxidases, such as Rhodobacter sphaeroides and Paracoccus denitrificans
COX (Cao et al., 1992; Hosler et al., 1992; Hosler et al., 2006; Lee et al., 2009;
Brzezinski and Johansson, 2010). It was therefore important to ensure that the sucrose
ultracentrifugation technique would yield similar results for the R.sph. enzyme.
The results showed that R.sph. COX behaved somewhat differently in the gradient
than did bovine COX. R.sph. pCOV yields were somewhat lower (40% versus 60%) and
the bands were more diffuse than those seen for bovine COVs. This could be due to
increased protein–protein or protein–lipid interactions during the sedimentation process.
An attempt to disrupt ionic interactions revealed, however, that the sedimentation pattern
did not change in salt concentrations as high as 100 mM KCl. In any case, the bands were
tight enough and the yields were high enough for satisfactory purification of pCOVs.
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It was found that the purification procedure reduced the lipid concentration 6-8
fold in the pCOV fraction. The net buffering capacity of the solution was decreased as
evidenced by 30% greater extents of pH-induced absorbance changes, as monitored by
phenol red absorbance in proton pumping assays. Also, the light scatter of the pCOV
solutions was reduced by about half compared to unpurified COVs. The reduction in
buffer capacity and light scattering makes pCOVs more suited for low buffer
spectroscopic studies such as proton pumping assays.
Following ultracentrifugation, there was a decrease in maximum steady-state
turnover, in RCR values and in the H+/e- ratios of the pCOVs relative to unpurified
COVs. These decreases mirror the results seen in the bovine pCOVs (Nguyen et al.,
2002). A factor potentially contributing to the reduction in the functional activities could
be the high hydrostatic pressure (1500 atm) experienced by the COVs during
centrifugation. This pressure could cause physical damage to the enzyme, leakage of
intravesicular buffer, or cause the vesicles to break and reseal with complete exchange of
intravesicular buffer. Previous work presents evidence which suggests that vesicular
breakage is not a major cause for concern (Nguyen et al., 2002). Following
ultracentrifugation, the orientation of the cytochrome c binding face was assayed, and it
was found that proper orientation was equivalent in bovine COVs and pCOVs (85-90%
facing external). Furthermore, bovine pCOV were made with rhodamine labeled
phospholipids and found to migrate to the same position when recentrifuged on a fresh
gradient without significant loss of labeled phospholipid. Together, these tests suggest
that the vesicles are not breaking and resealing; no loss of lipid, no change in protein
density, and no alteration of the orientation of the COX molecules were observed.
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The effects of high hydrostatic pressure on detergent-solubilized bovine COX
have been examined elsewhere. At hydrostatic pressures above 2000 atm, the monomeric
form of bovine COX experienced dissociation of subunits VIa, VIb, III and VIIa and a
loss of electron transport activity (Stanicova et al., 2004; Stanicova et al., 2007). The
dimeric form of the enzyme was significantly more resistant to these high pressures and
did not undergo subunit dissociation. For bovine pCOV, SDS–PAGE analysis with
Coomassie staining of the lysed pCOV enzyme showed no such loss in subunit content
following discontinuous sucrose gradient ultracentrifugation (Nguyen and Prochaska,
unpublished results). Since the R.sph. enzyme lacks the nuclear subunits, the most likely
candidate for subunit dissociation under elevated hydrostatic pressures would be subunit
III, as the binding interaction between subunits I and II is more substantial (Thompson
and Ferguson-Miller, 1983; Qin et al., 2006). The fact that R.sph. COX undergoes
turnover induced inactivation in the absence of subunit III can be used as to test for
subunit III dissociation (Bratton et al., 1999; Gilderson et al., 2003; Mills et al., 2003;
Mills and Hosler, 2005). No evidence of turnover induced inactivation was observed in
the electron transfer activity assays of R.sph. pCOV, indicating that the enzyme is still
intact.
Elevated hydrostatic pressures have been shown to induce transient shape changes
in lipid vesicles which can cause intravesicular water leakage by an undefined
mechanism (Beney et al., 1997; Perrier-Cornet et al., 2005). It is possible that the
mechanism could involve transient pore formation, which could allow intravesicular
buffer to leak as well (Perrier-Cornet et al., 2005). In other words, the hydrostatic
pressures experienced by the pCOV during ultracentrifugation could potentially result in
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the loss of some intravesicular buffering capacity, although the use of zwitterionic
HEPES reduces this likelihood. To test this possibility, the intravesicular buffering
capacity was measured for bovine pCOVs and compared to unpurified COVs. The pCOV
fraction maintained about 70% of the buffering capacity of unpurified COVs (data not
shown). This minimal intravesicular buffer leakage could explain why proton pumping
experiments utilizing 10 enzymatic turnovers have decreased H+/e- pumping
stoichiometries relative to experiments using 5 catalytic turnovers (see Table I). The
decrease in the H+/e- ratio is not likely due to a decrease in the proton pumping capability
of the enzyme, but rather to the diminished intravesicular source of protons for pumping.
Taken together, these results indicate that our purification technique results in a pCOV
preparation suitable for low turnover studies; enzymatic activity, vesicle proton
impermeability and proton pumping capabilities are sufficiently retained.
The number of R.sph. COX molecules per lipid vesicle was found to be one,
contrary to the results for bovine COX which had 2-3 COX molecules per vesicle. The
manner in which this value was estimated assumes a uniform distribution of protein
molecules in the vesicles of the pCOV band. To test the validity of this assumption,
COVs were purified in sucrose concentrations as high as 17%. If the distribution of the
protein in the liposomes were not uniform, the liposomes containing more protein
molecules would have a greater density and therefore migrate farther through the
gradient, forming additional bands. A single band was still observed in the higher sucrose
concentrations, indicating that the R.sph. COX molecules are distributed uniformly in the
liposomes. Therefore, each pCOV typically contains only one COX molecule, which
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sheds insight into the oligomeric structure of R.sph. COX as will be further discussed
below.
Alternative procedures have been used to purify COX-containing liposomes from
those devoid of enzyme. These procedures include cytochrome c affinity chromatography
for the beef heart enzyme (Madden and Cullis, 1985) and nickel affinity chromatography
using the R.sph. enzyme with a poly-histidine tag located on the outward facing cterminus of subunit II (Hiser et al., 2001). Anion exchange chromatography of bovine
COVs resulted in a preparation of COX-containing liposomes with the proper orientation
of the cytochrome c binding face. However, the resulting preparations were very dilute,
of very low yield (less than 20% recovery), and were found unsuitable for proton
pumping experiments. R.sph. COX with a poly-histidine tag on subunit II was engineered
by Hiser et al. (Hiser et al., 2001). Nickel affinity chromatography of these COVs yielded
a purified preparation with complete retention of respiratory control and both electron
transfer and proton pumping activity (Hiser et al., 2001), results qualitatively similar to
those we observed with our technique, although the yield of the pCOV from the starting
COV was not discussed. They also estimated that 5–20 molecules of R.sph. COX were
incorporated per liposome based upon previously published electron microscopy
estimations of the number of bovine COX molecules in 300 Å diameter unpurified
liposomes (Tihova et al., 1993). Our results, based on direct measurement, indicate that
there is only one R.sph. COX molecule per liposome. In addressing this potential
contradiction it should be noted that our estimation was based on direct measurements of
the lipid and protein concentration. Hiser et al. estimated the number of COX molecules
based on electron microscopy of bovine liposomes and then assumed a similar number
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for R.sph. It is physically unlikely for 5–20 molecules of COX (dimensions of 44 by 76 Å
in the plane of the bilayer) to fit into a liposome only 300 Å in diameter, especially due to
the high radius of curvature of the bilayer. In addition, our direct measurements of vesicle
lipid and protein content have at most 20% error, not 5 to 20 fold error. Thus, the electron
microscopy result is most likely an overestimate of the number of COX molecules per
pCOV.
To summarize, discontinuous sucrose gradient ultracentrifugation was found to be
a useful method for separating R.sph. COX-containing vesicles from liposomes devoid of
enzyme. Decreased external buffering capacity of solution and reduced light scattering
were two positive effects of this purification procedure. The decreases in activities
following ultracentrifugation were minimal and could be explained by slight damage
caused by hydrostatic pressure to the enzyme and to the vesicles. The intravesicular
buffering capacity of the pCOV was maintained to a degree adequate for low turnover
proton pumping studies. It was found that the proteoliposomes contained one molecule of
R.sph. COX per vesicle.

The Oligomeric Structure of R.sph. COX in the Lipid Membrane
The oligomeric structure of bovine COX has been the subject of investigation for
some years. Early on, ultracentrifugal sedimentation velocity and gel filtration studies
indicated the enzyme was monomeric in DM detergent and had maximal electron transfer
and proton pumping activity as a monomer (Suarez et al., 1984; Thompson et al., 1985).
However, it was later shown that the bovine enzyme dimerizes when it is introduced into
the membrane environment, and it was proposed that dimerization was necessary for full
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proton pumping efficiency (Finel and Wikstrom, 1986). Chemical cross-linking
experiments were used to further validate that bovine COX exists in the dimeric state
when reconstituted into lipid vesicles (Estey and Prochaska, 1993). When the threedimensional x-ray crystal structure was obtained, bovine COX crystallized in the dimeric
state (Tsukihara et al., 1996). In the crystal structure, the monomer–monomer contacts
are largely via subunits VIa and VIb, which are lacking in the bacterial forms of the
enzyme (Lee et al., 2001). Musatov and Robinson confirmed that the presence of subunits
VIa and VIb were necessary for dimerization of the bovine enzyme and provided further
evidence that the bovine enzyme has a strong, intrinsic propensity to dimerize in the
phospholipid bilayer (Musatov and Robinson, 2002). It was also shown that when bovine
COX was converted to the monomeric form by exposure to Triton X-100 or alkaline pH,
the rate of the F to O step in the catalytic cycle was altered (Sadoski et al., 2001). Since
this reaction step is coupled to proton uptake and translocation, it was proposed that the
oligomeric structure of the enzyme plays some role in these functions. Taken together,
these results indicate that bovine COX dimerizes in the membrane and that the dimer
might be necessary for maximal proton pumping efficiency.
The oligomeric states of the bacterial COX forms have not been intensely studied,
so the oligomeric structure of R.sph. COX was unknown. Since R.sph. COX lacks
subunits VIa and VIb, it has been suggested to be monomeric, as it also crystallizes
essentially as a head to tail dimer, which is structurally impossible in the bilayer (Lee et
al., 2001; Svensson-Ek et al., 2002; Qin et al., 2006). Furthermore, it was shown that
cytochrome bo3 from E. coli was monomeric when in detergent micelle (Musatov et al.,
1999). Cytochrome bo3 is an ubiquinol oxidase belonging to the same heme-copper
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oxidase family as cytochrome c oxidase, catalyzing oxygen reduction coupled to proton
translocation. The four subunit E. coli ubiquinol oxidase has substantial structural
similarities to bacterial cytochrome aa3 oxidases (Chepuri et al., 1990; Abramson et al.,
2000). By analogy, it is therefore likely that R.sph. COX is also monomeric in detergent
micelle. However, given the evidence that the lipid membrane environment induces
bovine COX to dimerize, it is important to address whether a similar process could be
dimerizing R.sph. COX upon reconstitution into lipid vesicles. If R.sph. COX retains its
monomeric state in the lipid bilayer, this result could shed insight into whether or not
dimerization is critical to the proton pumping function of COX.
The results of this dissertation indicate that there is only one R.sph. COX
molecule per liposome. For the bovine enzyme, 2–3 COX molecules per liposome were
observed, consistent with the proposal that bovine COX experiences a driving force for
dimerization upon reconstitution into lipid vesicles (Musatov and Robinson, 2002;
Nguyen et al., 2002). No such driving force is apparent for R.sph. COX. The enzyme
appears to be in the monomeric state when reconstituted into lipid vesicles, suggesting
that the functional form of R.sph. COX is monomeric in vivo as well. This result further
highlights the role that the nuclear subunits play in facilitating dimerization, as their
absence in R.sph. COX is the predominant structural difference between the bacterial and
mitochondrial forms of the enzyme (Tsukihara et al., 1996; Iwata et al., 2002; SvenssonEk et al., 2002). Furthermore, the results indicate that the monomeric form of R.sph.
COX is capable of maximal electron transfer and proton pumping activity. This is a novel
result in that COX has not been definitively shown to be capable of maximal proton
pumping activity when in the monomeric state. Dimerization is therefore unlikely to be
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required for maximal proton pumping activity of mitochondrial COX, and the
dimerization behavior observed for bovine COX must play an alternate role such as
regulation or added stability, as has been previously proposed (Sadoski et al., 2001;
Stanicova et al., 2007; Fornuskova et al., 2010).

Structural and Functional Characterization of R.sph. 114 COX Sheds Insight into
the Role of Subunit III in the Proper Assembly and Function of COX

Cytochrome c oxidase subunit III is a member of the three subunit functional core
of the enzyme, although the explicit role of this subunit has not been fully elucidated. A
human mitochondrial disease has been shown to be due to a genetic truncation of subunit
III after only three of its seven helices. This mutation was modeled in R.sph. COX in
order to gain insight into the structural and functional significance of subunit III. The
114 mutation is ideally suited for studying any specific roles of the n-terminus, the vshaped cleft and the c-terminal bundle of the subunit (see Figure 15). When expressed in
R.sph. cells, the 114 COX mutant had lower levels of expression and seemed to impede
the rate of COX assembly. The enzyme incorporated the truncated subunit III with at
least 70% stoichiometry, and the subunit was subject to only minor proteolytic processing
at one specific cleavage site. Additionally, the native processing of subunits II and IV
was altered in the 114 and I-II COX forms. The proton pumping and oxygen electrode
activities were about half that of wildtype at physiological pH and were about equivalent
to I-II COX forms. Finally, 114 COX underwent turnover induced inactivation at a
similar rate as I-II COX. However, when the assay buffer was supplemented with
asolectin, the catalytic lifetime was statistically greater than that of I-II COX forms.
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Taken together, these results indicate that the c-terminal bundle of subunit III plays a role
in maximizing the assembly efficiency of COX and optimizing the native processing of
subunit II. Furthermore, the importance of the structural lipids within the v-shaped cleft is
highlighted as being important in providing protection against turnover-induced
inactivation.

The Role of Subunit III in the Assembly of R.sph. COX
Subunit III has been proposed to play a role in the proper assembly of COX.
Bratton et al. conducted a study in which the genes for subunit III and/or subunit II were
deleted from an overexpression vector which also contained the gene for subunit I with a
poly histidine tag (Bratton et al., 2000). In the absence of subunits II and III, a form of
subunit I was purified which contained heme a but not the heme a3-CuB active site
(subunit Ia). This suggested that subunit II is required for proper metal insertion of the
heme a3 active center. Indeed, when the genes for subunits I and II but not III were
present, a heterogeneous preparation resulted which had I-II COX with proper metal
center insertion and also a noticeable amount of free subunit Ia. This indicated that
subunit III was not required for the proper assembly of subunit I and II, but it did
participate in the process, as evidenced by the pooling of the subunit Ia assembly
intermediate in the absence of subunit III (Bratton et al., 2000). Free subunit Ia has been
shown to be an early assembly intermediate in COX assembly, both in prokaryotic and
mitochondrial forms of the enzyme (Bratton et al., 2000; Fontanesi et al., 2008;
Fernandez-Vizarra et al., 2009).
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The data presented here support the conclusion that subunit III is involved in
assembly and extend the argument by highlighting the necessity of the c-terminal domain
in this process. In both I-IIGD and 114 COX preparations, there was an enrichment of
free subunit Ia as compared to the wildtype preparations, and lower levels of COX were
noted in the membranes, suggesting assembly was hindered. A similar result was also
observed for a truncation mutation in subunit III which removed the seventh c-terminal
helix to form 238 COX (Geyer, 2007). It is not entirely clear what role the c-terminal
domain of subunit III could be playing in the proper assembly of COX. Since I-II COX
can form in the absence of subunit III, it is not a required component of the assembly
process, but its absence or truncation seems to present a bottleneck in the process such
that the assembly intermediate upstream accumulates. Therefore, it is likely to provide
stabilization which increases the rate of an assembly step (Bratton et al., 2000). Along
these lines, subunit III could be stabilizing an interaction between subunit I and surf1.
Surf1 is a COX assembly protein conserved from mammals to prokaryotes and is
involved in the insertion of heme a3 into subunit I (Smith et al., 2005; Stiburek and
Zeman, 2010). Heme a3 insertion seems to enhance the binding of subunit I to subunit II
(Stiburek and Zeman, 2010), so an impedance in the rate of heme a3 insertion would
result in a pooling of subunit I which would be devoid of heme a3 and unable to interact
with subunit II – in other words, free subunit Ia. Surf1 is a ~30 kD protein composed of
two transmembrane domains and a large globular domain extending into the periplasm or
inner membrane space (Stiburek and Zeman, 2010). The c-terminal domain of subunit III
could enhance a binding interaction between Surf1 and COX subunit I. If Surf1 bound to
helix 6 or 7 of subunit I – helices surrounding the subunit I heme a3 center – the c138

terminal domain of subunit III would be ideally situated to foster the Surf 1 – subunit I
interaction. Subunit III would not be required for the interaction, but would stabilize it
and enhance the rate of heme a3 insertion and subsequent binding of subunit II. In R.sph.,
putative COX assembly intermediates have also been isolated consisting of only subunits
I and III, so this type of interaction could be possible (Hiser and Hosler, 2001). There is
still much to be elucidated concerning the assembly process of COX, so there are many
other possible ways in which subunit III could be involved in the process. This example
highlights the type of role subunit III could putatively play.

The Role of Subunit III in the Native Processing of Subunit II
Early in the development of COX bacterial model systems, COX from P.dent. and
R.sph. were observed to undergo native processing in subunit II at the n- and c-termini
(Steinrucke et al., 1987; Cao et al., 1991). The reason for this processing is unknown,
although it could be to remove a targeting peptide (Cao et al., 1991). R.sph. COX which
has been purified by Ni2+-NTA chromatography contains three forms of subunit II – a
32930 Da form which is unprocessed, a 30660 Da form (IIC) which is only processed at
its n-terminus, and a 29122 Da form (IIA) which is fully processed at both termini
(Hosler et al., 1992; Zhen et al., 1998; Hiser et al., 2001; Distler et al., 2004). Hosler et
al. used DEAE-5PW chromatography to separate these three forms of COX and found
that they had equivalent rates of electron transfer (Hosler et al., 1992). Further analysis
by Hiser et al. confirmed equivalent steady state activity between a preparation with a
mixture of subunit II forms and a preparation of the purified fully-processed form (IIA).
Upon closer examination, however, evidence was revealed that the presence of the
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unprocessed form of subunit II might slightly elevate the KM of cytochrome c binding,
although the increase was close to the error in the measurements (Hiser et al., 2001). In
this dissertation, it was observed that I-IIGD and 114 COX had noticeably elevated
levels of the partially processed form of subunit II (form IIC) as compared to wildtype
preparations. This suggests that subunit III might participate in maintaining optimal rates
of proteolytic processing in subunit II, a step that could be required for optimal COX
activity in a limited substrate environment. This putative role for subunit III involves the
entire c-terminal domain, as 114 COX showed the same proteolytic processing patterns
in subunit II as I-IIGD COX. Steady-state levels of activity were not affected in I-IIGD and
114 COX as compared to I-IIBD COX. I-IIBD has the same ratios between the subunit II
forms as wildtype COX, due to the fact that for I-IIBD, subunit III is removed
biochemically from wildtype COX. Therefore, this demonstrates that the reduction in
steady-state activity of I-IIGD and 114 COX compared to wildtype COX was due to a
mechanism other than elevated levels of unprocessed subunit II.
At limiting levels of cytochrome c, the relative enrichment of the unprocessed
form of subunit II in the 114 and I-IIGD preparations might have a greater effect on
COX activity, providing a selective pressure for subunit II processing. However, it should
be noted that although both P. denitrificans and R. sphaeroides undergo subunit II
processing, the cleavage site at the n-terminus is not identical, suggesting that the
processing mechanism is not highly conserved (Hiser et al., 2001). Evidence for a similar
process in mitochondrial COX has not been observed, as subunit II from bovine COX
routinely runs as a single band on SDS-PAGE gels (Kadenbach et al., 1983; Ogunjimi et
al., 2000). Indeed, the protein coding sequence of bovine COX at the c-terminus
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terminates 20 amino acids shorter than R.sph., immediately after its last surface-exposed
helix, so the subunit appears to be translated devoid of the sequence that is usually
subsequently removed from the prokaryotic forms of COX (Tsukihara et al., 1996; Hiser
et al., 2001). This observation raises interesting evolutionary questions regarding the
different strategies of mammalian and prokaryotic COX assembly and native proteolytic
processing.

The Role of Subunit III in D-pathway Proton Uptake
In the absence of subunit III, steady-state activity, proton pumping efficiency and
the catalytic lifetime of COX decrease. It has been proposed that these effects are due to
decreased proton uptake through the D-pathway and due to a loss of structural support of
subunit I provided by subunit III (Gilderson et al., 2003; Mills and Hosler, 2005;
Adelroth and Hosler, 2006). In the 114 COX mutation, the four c-terminal helices of
subunit III have been removed, but the three n-terminal helices are retained, a region
which contains a putative proton antenna and the v-shaped cleft which binds lipids of
proposed functional importance. A functional analysis of this mutant is of value for
further elucidating the structural features of subunit III which allow it to confer its
protective effect to COX during catalytic turnover.
It has been proposed that subunit III helps maintain proton uptake through the Dpathway by acting as a proton antenna and/or by fine turning the pKa of subunit I residue
D132 to a value optimal for its role as the primary proton acceptor in the D-pathway
(Gilderson et al., 2003; Adelroth and Hosler, 2006). The subunit III residues thought to
be responsible for these proposed roles are located on its n-terminus. Specifically, the
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conserved histidines at positions 7 and 10 could act as a proton reservoir by virtue of the
fact that their pKa values are likely to be in the physiological range. Their presence could
serve to increase the local concentration of protons in order to maximize the rate of
proton uptake (Gilderson et al., 2003; Hosler, 2004). In addition, there are four
hydrophobic residues on the n-terminus of subunit III – Ile 11, Leu 12, Pro 13 and Pro 14.
These residues form part of a ring around the shallow well in which D132 is located. It
has been proposed that they could be acting to raise the pKa of D132 by partially
shielding it from the aqueous phase (Gilderson et al., 2003; Hosler, 2004). All of these
residues are retained in 114 COX but missing in I-II COX, so the 114 COX mutant
provides an opportunity to test these proposed roles for the n-terminus of subunit III.
Despite the presence of the n-terminal region of subunit III in the 114 mutant,
the rate of proton uptake through the D-pathway and the apparent pKa of D132 in 114
COX are similar to that of I-II COX. Firstly, the catalytic lifetimes were observed to be
equivalent in the I-II COX forms and 114 COX at physiological pH in DM (see Table
VIII). The catalytic lifetime as measured by the CC50 value has been shown to be a
qualitative measure of the rate of proton uptake through the D-pathway (Adelroth and
Hosler, 2006). The equivalent CC50 values of 114 and I-II COX indicates that the rate of
proton uptake through the D-pathway is similar in the two enzyme forms. There was an
elevated catalytic lifetime seen for 114 in lipid micelle compared to I-II COX, but the
fact that this was not observed in detergent implies that this lipid-mediated effect results
from a mechanism other than the action of the putative proton antenna region, as will be
discussed below. Secondly, the apparent pKa of the D-pathway is equivalent in 114 and
I-II COX, as monitored by steady-state electron transfer activity (Figure 25, Table VIII).
142

When D-pathway proton uptake is impaired, the rate limiting step in the reaction cycle is
proton uptake through the D-pathway during the F  O transition (Adelroth and Hosler,
2006). The pKa of steady-state activity under impaired uptake conditions is therefore
closely related to the apparent pKa of a critical D-pathway residue, putatively D132
(Gilderson et al., 2003; Mills and Hosler, 2005; Adelroth and Hosler, 2006). In the case
of wildtype, proton uptake through the D-pathway is not rate limiting, so the pH profile
of wildtype steady-state activity also reflects a large contribution from E286 (Adelroth
and Hosler, 2006). The equivalent pH profiles of I-II COX and 114 suggests that the
subunit III n-terminal residues are not altering the apparent pKa of the D-pathway as had
been previously proposed.
The results do not entirely dismiss the proton antenna and/or hydrophobic tuning
roles for subunit III, however. As already articulated, the lipid-mediated link between the
c-terminal bundle and the n-terminal bundle seems to be of functional significance. It is
possible that the c-terminal bundle serves to properly position the n-terminus of subunit
III so as to maximize its function as a proton antenna or as a shield from aqueous
solution. In other words, it could be that the reason no evidence was seen for n-terminal
proton collection or elevation in the pKa of D132 was because the n-terminus cannot
properly align for such functions without the c-terminal bundle.
The yield and purity of Ni2+-NTA purified 114 COX provides some evidence for
improper folding of subunit III-114. Protein yields for Ni2+-NTA purification were only
about 25% for 114 COX, compared to 75% yields typically obtained for wildtype COX.
The 114 COX protein that did not bind to the nickel column had normal spectral
properties indicating that subunit I was properly folded, however it never bound to the
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column despite repetitive recycling attempts. It could be that the truncated subunit III was
misfolded and facilitated aggregation that masked the histidine tag and prevented binding
and subsequent purification. It should be noted that if this is the case, then the majority of
the misfolded subunit III would not be purified, and perhaps the portion that was purified
had a properly folded subunit III-114.
It was also the case that the 114 preparations had greater enrichment in the
impurities often noticed in R.sph. COX preparations. The molecular weights of these
impurities were measured (see Table VII), but no obvious protein candidates could be
identified from known assembly factors or proteases which might be specifically
interacting with subunit III if it were misfolded. These impurities could be present due to
non-specific interactions with partially misfolded subunit III-114.
Although subunit III-114 might be somewhat misfolded, there are a few reasons
why this structural disruption is probably not severe. Firstly, the specific protection
provided by the lipids against turnover induced inactivation for 114 COX would require
binding to a three-dimensional protein structure that is not significantly perturbed.
Secondly, subunit III-114 binds well to subunit I. It was estimated by two dimensional
PAGE that at least 70% of COX had subunit III-114 incorporated (see Figure 22B,
Table VI). This was a much higher stoichiometry of subunit III incorporation than was
observed for another truncation in subunit III which removed only the last c-terminal
helix, 238 COX. The 238 mutant was suspected of extensive folding problems as it
seemed to be undergoing significant proteolytic degradation in vivo (Geyer, 2007). The
high level of subunit III-114 binding to subunit I, therefore, suggests that this
interaction is not significantly perturbed by improper folding. Related to this point is the
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fact that 114 did not seem to be undergoing extensive proteolytic degradation of the
truncated subunit III. Only one proteolytic product of SIII-114 was observed (see
Figures 17 and 18, Table V), and this product resulted from the removal of the 13 nterminal amino acids of SIII-114 which would form part of a periplasmic loop in
wildtype COX (Svensson-Ek et al., 2002). Disorder in this small stretch of SIII-114
would be expected, so its proteolytic removal is not indicative of systemic misfolding of
SIII-114.
Although severe misfolding of subunit III is not likely to be the case, it is possible
that minor structural alterations of the n-terminus of subunit III could prevent it from
performing its proposed roles in proton collection and in shielding of D132 from the
aqueous environment thereby raising its pKa. This hypothesis could be tested by a series
of mutational experiments in the n-terminal region of subunit III. Firstly, the conserved
histidines His7 and His10 could be mutated to non-protonatable residues. If these
residues are critical to maintaining rapid D-pathway proton uptake, mutating them should
decrease the catalytic lifetime of the protein. Secondly, the conserved hydrophobic patch
– Ile11 and Leu12 – could be mutated to more polar residues to examine their
contribution to rapid proton uptake. If a shift in the pKa of steady-state turnover is
observed, it is likely that the residues are important for elevating the pKa of D132.
Finally, the conserved proline residues at positions 13 and 14 could be mutated to glycine
residues. The two adjacent prolines introduce a sharp turn in the structure and may orient
the n-terminus in an optimal position for proton collection and hydrophobic tuning of
D132’s pKa. These proline mutations would shed insight into the conformational
sensitivity of the n-terminal region. If deleterious effects were noted for the histidine
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and/or hydrophobic mutants, the putative roles of proton collection and pKa fine tuning
would be more firmly established. Then, if deleterious effects were also noted for the
proline mutations, it could help to explain why the proton antenna and hydrophobic tuner
functions were not observed in 114 COX and could highlight the importance of the cterminal domain in aligning the n-terminus of subunit III.

The Role of Subunit III and Its Cleft Lipids in Stabilizing the D-pathway and Active Site
Subunit III has been proposed to stabilize the proper structure of the ordered
water molecules that compose the D-pathway, thereby facilitating maximum proton
uptake through the D-pathway and preventing turnover induced inactivation (Hosler,
2004). A comparison of the x-ray crystal structures for wildtype and I-II COX revealed a
difference in the water arrangement of the D-pathway when subunit III was absent (Qin
et al., 2006). Proton transfer through the D-pathway is accomplished by the Grotthuss
mechanism, which requires a reorientation of the water molecules after each proton
transfer event (Nagle and Tristram-Nagle, 1983; Hosler, 2004). An optimal flexibility in
the proton pathway would allow the water molecules to reorient but not to diffuse to
different locations. Subunit III, in combination with its putative structural lipids has been
proposed to play such a role in providing the optimal structural support for the Dpathway (Hosler, 2004; Varanasi et al., 2006).
The results of this dissertation are consistent with the hypothesis that subunit III
and its cleft lipids aid in stabilizing the D-pathway to prevent turnover induced
inactivation. The catalytic lifetime of 114 COX was statistically equivalent to both
forms of I-II COX when the assay was conducted in DM detergent (see Table VIII).
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However, upon supplementing the assay buffer with 1 mg/mL asolectin, the catalytic
lifetime of 114 increased 2.1 fold, a value statistically greater than the more modest
increases observed for the two different I-II COX forms. The catalytic lifetime of 114
was not further increased relative to the lipid micelle assay when the enzyme was
reconstituted into phospholipid vesicles and assayed in the presence of ionophores.
However, reconstitution into lipid vesicles increased the catalytic lifetimes of both forms
of I-II COX to statistical equivalence with the catalytic lifetime of 114 achieved in lipid
micelle. The presence of subunit III-114 and excess lipid, therefore, seems to provide a
protective effect against turnover induced inactivation that can only be achieved for I-II
COX when the enzyme is in the more constrained environment of a lipid vesicle.
The elevated protection against turnover induced inactivation provided by SIII114 and lipid suggests a specific binding effect of the lipid to subunit III-114. The
114 truncation of subunit III retains all but one of the conserved amino acids which bind
the lipids (see Figure 6). Specifically, all the residues associated with PL1 are present
(amino acids R137, L145, L196 and L203 of subunit I; amino acids W58, W59, M55,
F86 and F93 of subunit III), and all of the residues in van der Waals contact with the fatty
acid tails of PL2 are also present (amino acids W59, M55 and F86). The only subunit III
lipid-associated residue which is missing in 114 COX is R226, which coordinates the
head group of PL2 by an ionic and h-bond interaction between its guanidinium nitrogens
and the negatively charged phosphate head group (Svensson-Ek et al., 2002; Varanasi et
al., 2006). R226 is located on helix 6 of subunit III and therefore fosters a lipid-mediated
connection between the c-terminal and n-terminal domains of subunit III. The interaction
with R226 is the strongest single protein interaction for PL2 (Varanasi et al., 2006), so its
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absence might cause PL2 to be partially depleted from the enzyme. In the R.sph. crystal
structure, the bound cleft lipids are phosphatidyl ethanolamines with oleic acid tails
(18:1) (Svensson-Ek et al., 2002; Varanasi et al., 2006), a lipid which is present in
asolectin (Varanasi et al., 2006). Therefore, in the assay in which asolectin is present in
the buffer, the high lipid concentrations could be increasing the likelihood that a lipid will
bind in the potentially vacated PL2 site.
It is therefore proposed that the elevated catalytic lifetime seen in the presence of
excess lipid results from a lipid binding in the PL2 position and conferring added
structural support to help maintain the proper orientation of the D-pathway waters.
Several of the conserved residues in subunit III interact with both lipids. For instance, Trp
59 on helix 2 intercalates between the fatty acid tails of PL1 and PL2, and F86 on helix 3
makes contact with both lipids as well. The presence of PL2 would therefore confer
greater stability to the entire protein-lipid-protein structure which bridges the v-shaped
cleft of subunit III. PL1 binds on the opposite face of subunit I helices 3 and 4, which
contain most of the conserved residues coordinating the water molecules of the Dpathway (N139, S197, S200, S201, N207). On these same subunit I helices are residues
which interact with portions of the fatty acid tail of PL1 (L196, L203). Also, the subunit I
residue which coordinates the PL1 headgroup (R137) is only two amino acids removed
from the conserved D-pathway residue N139 (Svensson-Ek et al., 2002; Hosler, 2004;
Varanasi et al., 2006). As such, there is a strong potential for a structural link between the
lipids in the v-shaped cleft and the coordination of the water molecules in the D-pathway.
When the two different I-II COX forms were reconstituted into phospholipid
vesicles, they had protection against turnover induced inactivation at levels similar to
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what 114 COX achieved in lipid micelle. In an attempt to decipher whether the
increased lifetime was due to a biophysical property of the phospholipid bilayer or due to
a lipid binding interaction with I-II COX, the asolectin concentration was increased 10
fold in the solubilized assay. The catalytic lifetime of I-IIGD COX was not increased when
asolectin concentrations were as high as 10 mg/mL in solution, suggesting that the
molecular mechanism for the protection effect observed in 114 COX in lipid micelle is
impaired or absent in forms of COX that have subunit III removed (I-II COX). Since
114 COX has the three n-terminal helices of subunit III containing most of the
conserved lipid-associated amino acids, this observation strengthens the proposal that the
cleft lipids are bound in conserved locations in order to provide structural support which
protects COX from inactivation. The increased lifetime observed upon reconstitution of III COX is likely caused by a biophysical property of the phospholipid bilayer, rather than
by a lipid binding in a specific location within the three-dimensional structure of the
protein, as is proposed for 114 COX. Phospholipid bilayers have been shown to
laterally compress and decrease the conformational dynamics of transmembrane proteins
(Dan and Safran, 1998; Kusnetzow et al., 2006). As such, the bilayer could serve to
reduce deleterious structural oscillations in I-II COX by a lateral compression
mechanism, thereby reducing the likelihood of turnover induced inactivation to levels
similar to those achieved by 114 COX through the proposed binding in the v-shaped
cleft of a phospholipid molecule from the lipid micelle.
Some phospholipids have been shown to increase the rate of proton uptake
through the D-pathway by serving as proton donors via ionizable phospholipid
headgroups (Adelroth and Hosler, 2006). The pH profiles of steady-state activity and
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turnover induced inactivation are not altered for 114 COX when they are conducted in
the presence or absence of lipid. This suggests that the partial lipid protection against
inactivation is not due to the introduction of an additional proton donor to the D-pathway.
Rather, the protection seems to be structural in nature.
Given this proposed role, it is of particular interest that subunit III labeling with
DCCD perturbs the tails of the lipids within the v-shaped cleft (Shinzawa-Itoh et al.,
2007). Prochaska et al. showed that subunit III can be specifically labeled at position E90
with DCCD, a modification which decreases proton pumping efficiency as well as
steady-state activity (Prochaska et al., 1981). E90 is flanked by F86 and F93, two of the
amino acids which are in van der Waals contact with the fatty acid tails of PL1
(Svensson-Ek et al., 2002; Varanasi et al., 2006). The x-ray crystal structure of bovine
COX labeled at E90 with DCCD shows that the tails of the cleft lipids are perturbed by
the bulky cyclohexyl groups (Shinzawa-Itoh et al., 2007). The positions of the lipids in
bovine and R.sph. COX are conserved, so it is of relevance that one of the tails of PL1
which is perturbed by DCCD has a conserved structural connection extending 16 Å to
H284, which is a ligand of CuB – the active site copper which is depleted from enzyme
that has undergone turnover induced inactivation (Svensson-Ek et al., 2002; Tsukihara et
al., 2003; Varanasi et al., 2006). To add further weight, our lab has recently shown that
turnover induced inactivation occurs in bovine and R.sph. COX when they are labeled
with DCCD (unpublished results). Perhaps the deleterious effects of DCCD labeling on
COX pumping, steady-state activity and catalytic lifetime are in part due to structural
perturbation of the subunit III cleft lipid tails.
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The structural support putatively offered by the cleft lipids of subunit III is not
sufficient to maintain adequate rates of proton uptake for maximal function in the
absence of the c-terminal bundle. Upon truncation of the four c-terminal helices, activity
levels and proton pumping are diminished to I-II COX levels, even in the presence of
lipid. Additionally, the more than two fold increase in the catalytic lifetime of 114 COX
afforded by excess lipid still increases the lifetime to only about 1% of the lifetime of
wildtype COX, highlighting the importance of the c-terminal bundle. Mutations in full
length subunit III which disrupt the binding interactions of the lipids have been shown to
result in turnover induced inactivation as well (Varanasi et al., 2006). This suggests that
both full length subunit III and the cleft lipids are necessary for maximal protection from
turnover induced inactivation.
The importance of the c-terminal bundle for maintenance of native proton
pumping stoichiometries may also be partially mediated by the subunit III cleft lipids. In
this work, it was found that 114 COX pumped with the same stoichiometry as I-IIGD
COX, which was about half the efficiency of wildtype (see Figure 28, Table VIII). As
stated previously, the only conserved lipid-binding residue which is truncated in 114 is
R226 on helix 6 of subunit III. A point mutation has been made in subunit III which
converts R226 to an alanine, thereby abolishing the interaction it forms with the head
group of PL2 (Varanasi et al., 2006). Remarkably, the R226A mutant pumps with only
about 50% the efficiency of wildtype COX, similar to the efficiency seen when the bulk
of the c-terminal domain is removed entirely (this work; Varanasi et al., 2006). These
results point to the importance of the lipid-mediated interaction between the n- and cterminal bundles of subunit III for maintaining maximal proton pumping efficiency.
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In short, structural and functional studies on R.sph. 114 COX have provided
further evidence for the importance of the subunit III cleft lipids and for the criticalness
of the lipid-mediated interactions within subunit III. R.sph. 114 COX was observed to
have an increased catalytic lifetime when in lipid micelle, an effect which seems to result
from the specific binding of lipid. It was proposed that a lipid binds in the PL2 position
and serves to increase the protein-lipid interactions within the cleft. An examination of
the crystal structure reveals that this could have a fairly direct stabilizing effect on the
coordination of D-pathway water molecules and on the stability of the subunit I active
site via a CuB ligand. The limitedness of the stabilizing effect, however, points to the
importance of the c-terminal bundle and to the importance of intra-subunit interactions
between the n- and c-terminal bundles.

R.sph. 114 COX and Human Mitochondrial Disease
The R.sph. 114 COX mutation was modeled after a mutation in human
mitochondrial cytochrome c oxidase subunit III which results in a disease state typified
by severe lactic acidosis episodes and neuromuscular impairments (Tiranti et al., 2000).
When the corresponding mutation was made in the simpler R.sph. form of the enzyme,
the protein was found to have electron transfer and proton pumping activities that were
reduced to about half that of wildtype COX. The 114 COX protein was also subject to
turnover induced inactivation, suggesting that proton uptake through the D-pathway was
impaired. Furthermore, evidence of early assembly intermediate pooling suggested that
the rate of COX assembly was not optimal, and that there were lower levels of COX
protein in the membranes as compared to alternative terminal oxidases. These results can
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be gleaned for insight into the molecular mechanisms of the diseased state and into some
of the differences between mitochondrial and bacterial COX forms.
The pathological condition that resulted from the truncation in subunit III COX
was reported by Tiranti et al. (Tiranti et al., 2000). A stable cell line homoplasmic for the
mutation was created using the fibroblasts from a patient. Western blot analysis of Blue
Native PAGE gels of the mitochondrial fraction of digitonin-treated cells indicated that
fully assembled COX was absent and that COX assembly intermediates were
accumulated. The investigators did not find evidence of a subunit III peptide resulting
from the confirmed presence of the mutated mRNA transcript for subunit III, although
they were limited by a lack of a specific antibody for subunit III. From pulse-chase
experiments with [35S] methionine, they concluded that truncated subunit III was not
being translated. This however, is likely to be a premature and faulty conclusion; an
examination of the polyacrylamide gel of the translation products showed multiple bands
in the region where truncated subunit III runs in our SDS-PAGE gels of purified R.sph.
114 COX. The band is likely to be faint, given that 3 of the 10 methionines are removed
when subunit III is truncated and that the band for full length subunit III was already faint
in the control cell lines as compared to other COX subunits (Tiranti et al., 2000). It is
likely that the faint band corresponding to truncated subunit III is occluded by the
multiple translation products of similar molecular weight. To add to this argument, the
BN-PAGE gels of the mutant mitochondrial cells displayed a shift in the band position of
one of the assembly intermediates. The authors attributed this to a “qualitative
abnormality of COX assembly,” but given that truncated subunit III-114 incorporated in
the bacterial COX with high stoichiometry, the shift observed in the BN-PAGE of the
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mitochondrial COX assembly intermediates is likely to be due to incorporation of the
truncated form of subunit III.
The assembly of mitochondrial COX is more complicated than it is for bacterial
COX, as there are 10 nuclear-encoded subunits incorporated into the complex (Tsukihara
et al., 1996; Fontanesi et al., 2008; Fornuskova et al., 2010; Stiburek and Zeman, 2010).
The initial assembly intermediate is subunit Ia, similar to the case for the R.sph. system
(Bratton et al., 2000; Fontanesi et al., 2008). Next, the nuclear subunits IV and Va bind to
subunit I to form intermediate 2 (Fernandez-Vizarra et al., 2009). Subunit II binds to
intermediate 2, followed by subunit III. The binding of subunit III initiates a cascade of
nuclear subunit binding (Fontanesi et al., 2006; Fernandez-Vizarra et al., 2009). Tiranti et
al. postulated that downstream assembly of the nuclear encoded subunits was impaired
due to the absence of subunit III (Tiranti et al., 2000). As already noted, it is debatable
that truncated subunit III was missing from the mitochondrial COX complex, as the
authors did acknowledge in their discussion. The results described in this dissertation
highlight the necessity of a more thorough investigation of the presence of truncated
subunit III in the mitochondrial COX mutant cell lines. Furthermore, they provide
evidence that the truncation of subunit III can also affect what is thought to be upstream
assembly of COX. Whether or not this is also the case in the mitochondrial enzyme
remains to be tested, as assembly is likely to be more stringent and regulated for
mitochondrial COX (Hiser and Hosler, 2001; Fontanesi et al., 2006; Fontanesi et al.,
2008; Fornuskova et al., 2010).
Functional assays of the human mitochondrial COX mutant with truncated
subunit III were limited due to the fact that the protein was not purified. The rate of
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oxygen reduction in the mutant cell lines was reduced to about 15% of the control cell
lines when the assay was conducted in whole mitochondria (Tiranti et al., 2000). These
assays were normalized to the activity of citrate synthase, which is a marker enzyme for
the relative number of mitochondria. Since they were not normalized to the concentration
of COX, it is difficult to interpret the meaning of this result. The authors assumed the
decreased activity was due to presumed lower levels of COX protein rather than to a
decrease in the activity of mutated COX. The functional studies of the R.sph. 114 COX
mutant provide a better glimpse into the deleterious functional effects of the subunit III
mutation. It is likely that the mitochondrial subunit III truncation resulted in a similar loss
of electron transfer and proton pumping activity. Furthermore, our lab has recently shown
that bovine COX also undergoes turnover induced inactivation in the absence of subunit
III (A. Kaliappan, unpublished results). Since the R.sph. 114 COX mutant demonstrated
that the full length of subunit III is required for prevention of inactivation, it is possible
that turnover-induced inactivation of COX is occurring in the diseased mitochondria.
In summary, modeling the human mitochondrial disease by the R.sph. 114 COX
mutation has served to provide a more full view of what could be occurring in the
mutated mitochondrial COX. This work points to the necessity of a more robust assay for
the presence of truncated subunit III in the mutated mitochondrial COX complex. It also
raises the possibility of upstream impairment in COX assembly. Finally, it provides
evidence that the mutated mitochondrial COX is likely to be hindered in its electron
transfer and proton pumping capacities and to be subject to turnover induced inactivation.
Continued investigation of the mitochondrial and bacterial COX mutation has the
potential to shed further insight into the structural features of subunit III which enable it
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to play roles in COX assembly and maximal function and into the differences between
the mitochondrial and bacterial systems.
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V. Conclusions

Discontinuous sucrose gradient ultracentrifugation was found to be a suitable
technique for removing liposomes lacking protein from those containing R.sph. COX.
The reduced lipid concentrations resulted in lower net buffering capacity and decreased
light scattering, making the technique useful for low buffer spectroscopic studies. It was
found that there is only one R.sph. COX molecule per liposome. The enzyme therefore
appears to be in the monomeric state when reconstituted into lipid vesicles, suggesting
that the functional form of R.sph. COX is monomeric in vivo as well. The results show
that monomeric R.sph. COX is capable of maximal turnover and proton pumping activity.
This is a novel result in that COX has not been definitively shown to be capable of
maximal proton pumping activity when in the monomeric state.
Structural and functional characterization of a c-terminal subunit III truncation
mutation have provided further evidence that subunit III and its cleft lipids aid in
stabilizing the D-pathway to prevent turnover induced inactivation. This mutant removes
the four c-terminal helices of subunit III, leaving the three n-terminal helices which form
a v-shaped cleft containing a conserved binding region for two lipids. The mutant with
truncated subunit III provided greater protective effects against turnover-induced
inactivation when assayed in lipid micelle as compared to COX with subunit III removed
either by biochemical or genetic means. The exogenous lipid used in the assay is
proposed to bind in the potentially vacated lipid site contained in truncated subunit III.
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An examination of the crystal structure reveals that the bound lipid could have a fairly
direct stabilizing effect on the coordination of D-pathway water molecules and on the
stability of the subunit I active site. The stabilizing effect is limited in that the mutant
does not support wildtype activities, which points to the importance of the c-terminal
bundle and to the importance of intra-subunit interactions between the n- and c-terminal
bundles. The c-terminal bundle of subunit III was also found to play roles in maximizing
the assembly of COX and in optimizing the native processing of subunit II. Since the
truncation mutation is modeled from a human mitochondrial disease mutation, these
findings can be used to further understand the molecular mechanisms of that disease state
and to shed insight into the differences between mitochondrial and bacterial COX forms.
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Appendix
Probing the Dynamic Conformation of R.sph. COX Subunit III with Thiol-Reactive
Fluorophores

The role of subunit III in the structure and function of cytochrome c oxidase is a
matter of continued investigation. In this dissertation, a role for subunit III in stabilizing
the D-pathway and subunit I active site was investigated. It is possible that this
stabilization role could be affected through redox-linked conformational changes. These
conformational changes could also serve to regulate the catalytic activity of the enzyme.
Site-directed antibodies bound to subunit III of bovine COX have been shown to increase
the rate of electron transfer, perhaps by locking the enzyme into a more active
conformation (Lincoln et al., 2003). In addition, specific peptides within the threedimensional structure of COX subunit III have been identified which have altered solvent
accessibility in the various catalytic intermediate states, indicating that structural
conformational changes in subunit III could be occurring during the catalytic cycle of
COX (Busenlehner et al., 2006). These putative conformational changes have not been
completely described, and the possibility of a link between the conformation of subunit
III and activity at the subunit I active site is still being investigated. The experiments
described in this appendix are aimed at testing the hypothesis that redox-linked
conformational changes occur in COX subunit III. These putative conformational
changes could play a regulatory or stabilization role for COX.
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Site-specific fluorescence spectroscopy is a method by which protein
conformational dynamics can be studied. Thiol-reactive fluorophores can be conjugated
to the cysteine residues in proteins (Haughland, 2002). The local environment of the
protein surrounding the probe will influence the fluorescent properties of the probe
(Haughland, 2002; Lakowicz, 2006). For example, changes in the hydrophobicity or
flexibility of the environment will alter the emission wavelength/intensity or the
anisotropy of the probe’s emission (Hudson and Weber, 1973; Haughland, 2002).
Therefore, if a conformational change in the protein alters the location of the fluorophore
such that it is in an environment with altered hydrophobicity or flexibility, the
conformational change will influence the measureable fluorescence properties of the
probe (Hibbs et al., 2005; Bell et al., 2006). The long term goal of these studies is to
direct fluorescent probes to specific locations in the three dimensional structure of COX
subunit III by preparing single cysteine mutants. Conformational changes in these
specific locations can then be assessed through a variety of fluorescence experiments.
This appendix described the progress made toward creating and characterizing single
cysteine mutants and toward developing protocols for assaying conformational dynamics.

Methods
Mutagenesis of R.sph. COX Subunit III to Create Single Cysteine Mutants
A pRK415-CA1CS3 plasmid was received from Robert Gennis at the University
of Illinois, Champaign-Urbana. This plasmid is a broad host range overexpression vector
used for expressing COX in R.sph. The plasmid contained a subunit I gene in which the
two native cysteines (C64, C88) were mutated to alanines and which had a polyhistidine
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tag engineered onto the c-terminus. In addition, the subunit III gene in the plasmid had its
three native cysteines mutated to serines (C143, C146, C223). Also contained in the
plasmid were a subunit II gene and two accessory proteins for COX assembly. The
CA1CS3 COX protein expressed from this plasmid has no cysteine residues available for
bioconjugation.
The subunit III gene from the pRK415-CA1CS3 plasmid was engineered into the
pMB301 vector and used as the template DNA for introducing single cysteines into
subunit III by replacing non-conserved amino acids. Two single cysteine mutants were
created using the protocols described (see Methods). The mutants were sequenced by
Davis Sequencing to verify correct mutagenesis. The A4C mutant was created to analyze
the conformational dynamics at the n-terminus of subunit III (mutagenesis primer
sequence: 5’-GGG AAC CAT GGC CCA CTG CAA-3’). The S187C mutant was created
to study the conformation dynamics of the periplasmic loop which extends from helix 5
to helix 6 in subunit III (mutagenesis primer sequence: 5’-CAG GCC TAC GAA TAC
TGC CAC GCG GCT TTC-3’). The conformation of this loop is suspected of playing a
regulatory role for COX activity; a site-directed antibody bound on this loop in bovine
COX increased the catalytic activity of the enzyme (Lincoln et al., 2003). These mutants
were expressed and purified and their functional properties were assessed according to
protocols described in the Methods section.

Bioconjugation of R.sph. Wildtype COX with Thiol-Reactive Fluorophores
R.sph. COX contains three native cysteines in subunit III which can be conjugated
to thiol-reactive flourophores. For labeling with 5-((((2-iodoacetyl)amino)ethyl)amino)

161

naphthalene-1-sulfonic acid (IAEDANS), a stock solution of 1-2 mM IAEDANS was
prepared in 20 mM HEPES, pH 8.0, and its concentration was verified spectroscopically
using an extinction coefficient of 5,700 M-1cm-1 at 336 nm (Haughland, 2002). COX
samples were diluted to 1-5 M in 20 mM HEPES, pH 8.0. IAEDANS was added at
COX:IAEDANS stoichiometry of 1:10, and the reaction was incubated in the dark at
room temperature for 1 hour. A 100 molar excess of DTT was used to quench unreacted
IAEDANS, which was then removed by successive washes in Millipore YM-100
Microcon filter devices. In the second wash step, 20 mM ferricyanide was added to
oxidize the enzyme. Wash steps were repeated approximately four times until the flow
through buffer was free of DTT, ferricyanide and IAEDANS as analyzed by UV and
fluorescence spectroscopy.
For labeling with MIANS (2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid),
1-2 mM stock solutions were made in methanol and the concentration was verified
spectroscopically using an extinction coefficient of 27,000 M-1cm-1 at 322 nm
(Haughland, 2002). COX samples were diluted to 1-5 M in 20 mM HEPES, 0.1% DM,
pH 7.5. MIANS was added at COX:MIANS stoichiometry of 1:5. Total methanol
concentrations did not exceed 0.5%. The reaction was incubated in the dark at room
temperature for 1 hour. A 100 molar excess of DTT was used to quench unreacted
MIANS, which was then removed by successive washes as described above.

Labeling Stoichiometry and Subunit Localization of R.sph. COX-AEDANS
The subunit localization of the AEDANS and MIANS probes in conjugated COX
was determined via SDS-PAGE. Labeled COX was denatured in 3% SDS, Laemmli
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sample buffer (Bio-Rad) and run on a 16% polyacrylamide (37.5:1 acrylamide:bis) gel
containing 6 M urea and 0.1% SDS (Fuller et al., 1981). The fluorescence signal of the
gel was captured using a Fuji LAS-4000 Imager with a UV box for excitation, a 515 nm
cutoff filter and an exposure time of 5-15 seconds. The gels were stained with Coomassie
G-250 and an image of the protein bands was recorded on a Fuji LAS-4000 imager.
To determine the stoichiometry of probe labeling, the extinction coefficients of
oxidized R.sph. COX at 336 nm (43,000 M-1cm-1) and 322 nm (37,000 M-1cm-1) were
determined using the known extinction coefficient for the reduced minus oxidized peak at
606 nm (24,000 mM-1cm-1, see (van Gelder, 1966)). The extinction coefficient of
IAEDANS at 336 nm is 5,700 M-1cm-1, and MIANS has an extinction coefficient of
27,000 M-1cm-1 at 322 nm (Haughland, 2002). COX concentration was determined from
the reduced minus oxidized spectrum (van Gelder, 1966), and the absorbance of the
oxidized COX spectrum at 336 nm or 322 nm was used to determine the concentration of
AEDANS or MIANS after correcting for the absorbance contribution from oxidized
COX at this wavelength. The labeling stoichiometry was calculated by dividing the probe
concentration by the COX concentration. To verify the spectroscopic result, MALDITOF mass spectrometry was conducted on COX-AEDANS and the mass peaks of the
subunits were compared to wildtype.

Trapping R.sph. COX in the PM State
The PM state was prepared by exposing oxidized COX to a mixture of carbon
monoxide (CO) and air at a pH of 8.0 (Junemann et al., 2000; Rich et al., 2002).
Conjugated, oxidized COX (1 M COX in 20 mM HEPES, 0.1% DM, pH 8.0) was
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sealed in a quartz cuvette and connected to a vacuum/gas line inserted through the septum
cap. Oxidized COX was exposed to 3 cycles of vacuum (10 seconds) and CO (5
seconds). CO was of ultra high purity (Weiler Gases and Welding Supplies). After CO
exposure, the septum was briefly punctured with a needle to allow exposure to air. The
kinetics of PM formation were followed via absorbance spectroscopy on Hewlett Packard
8453 UV/Visible diode array spectrophotometer. The PM minus O spectrum has
characteristic absorbance features at 441 nm and 607 nm (peaks) and 417 nm (trough).
The amount of PM formation was calculated using an extinction coefficient of 10,400 M1

cm-1 at 607-630 nm in the PM minus O spectrum (Rich et al., 2002). The PM state was

formed with 90-95% yield and within 2-3 minutes ( = 1.3 min), as shown in Figure A-1.

Fluorescence Characterization of R.sph. COX-AEDANS in the O and PM States
The fluorescence properties of COX-AEDANS in the O and PM states were
measured on a Varian Cary Eclipse fluorescence spectrometer. The emission spectrum of
oxidized 1 M COX-AEDANS in 20 mM HEPES, 0.1% DM, pH 8.0 was obtained using
a PMT setting of 850 V and excitation and emission slit widths of 5 nm each (excitation
 = 336 nm). An average of five spectra was taken per sample. The anisotropy of O state
COX-AEDANS was measured using a Varian manual polarizer accessory. An average of
five anisotropy readings were taken using an excitation wavelength of 336 nm, an
emission wavelength of 471 nm, and the same PMT and slit width settings as for the
emission spectral measurements. Anisotropy values were corrected for the G factor of the
instrument which was determined using Aldrich Ludox TM-50 colloidal silica suspension
as a light scattering agent.
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Figure A-1
Formation of the PM state of R.sph. COX. The PM state was prepared by exposing
oxidized COX to a mixture of carbon monoxide (CO) and air at a pH of 8.0 (Junemann et
al., 2000; Rich et al., 2002). Conjugated, oxidized COX (1 mM COX in 20 mM HEPES,
0.1% DM, pH 8.0) was sealed in a quartz cuvette and connected to a vacuum/gas line
inserted through the septum cap. Oxidized COX was exposed to 3 cycles of vacuum (10
seconds) and CO (5 seconds). CO was of ultra high purity (Weiler Gases and Welding
Supplies). After CO exposure, the septum was briefly punctured with a needle to allow
exposure to air. The kinetics of PM formation were followed via absorbance spectroscopy
on a Hewlett Packard 8453 UV/Visible diode array spectrophotometer. A) PM minus O
spectra with respect to time. The arrows indicate direction of absorbance changes. The PM
minus O spectrum has characteristic absorbance features at 441 nm, 607 nm and 417 nm.
B) Kinetics of PM formation (PM minus O absorbance at 607 – 630 nm). The PM state was
formed with 90-95% yield. A time constant was derived from a single exponential fit of
the data ( = 1.3 min).
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After exposing the sample to CO and air, as described above, the changes in
emission intensity at 471 nm were monitored with respect to time using the Varian
kinetics software provided with the instrument and the same instrumental parameters
used for the emission spectrum. After complete formation of the PM intermediate (15
minutes), five emission spectra were recorded and averaged. The anisotropy readings
were then recorded for the PM state as described above.

Results and Discussion
The long term goal of this project is to study the conformational dynamics of
COX subunit III by site-directed fluorescence spectroscopy. Single cysteine mutants of
subunit III will be used to study conformational dynamics within specific regions of the
subunit. After labeling the mutants with thiol-reactive fluorophores, the fluorescence
properties of the probes will be characterized during assays in which COX is undergoing
putative conformational changes. Toward this end, two single cysteine mutants were
created and their functional properties were assessed and found to be similar to wildtype
COX. In addition, wildtype COX was used to develop protocols for labeling the enzyme
with flourophores and for developing conformational dynamics assays. It was found that
the native cysteines in subunit III could be specifically and efficiently labeled with
MIANS or IAEDANS fluorophores. Developing assays for conformational dynamics
proved difficult due to inner filter effects caused by COX and substrates and due to
instrumental limitations. The approach which best minimized the inner filter effect was to
trap the labeled enzyme in the O and PM intermediate states and to comparatively
characterize the fluorescent properties of these states. The fluorescence properties of
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wildtype COX-AEDANS were found to be equivalent in the O and PM states; the
maximal emission wavelength and anisotropy were statistically equal. The shapes of the
emission spectra were also similar. The only statistically significant difference between
the two states was that the PM state had a lower maximal intensity than the O state.
However, due to the large bandwidth that was required for the fluorescence experiments,
this difference cannot be distinguished from an inner filter effect. Since the native
cysteines in subunit III are located on helices 4 and 6 of COX subunit III, results indicate
that these regions of the subunit do not move when the enzyme proceeds from the O state
to the PM state. A positive control and heightened instrumental sensitivity are necessary
in order to draw definitive conclusions and to pursue these studies further.

Functional Properties of R.sph. COX Subunit III Cysteine Mutants
The functional properties of three cysteine mutants were tested in order to assess
their suitability for use in site-directed fluorescence studies of COX. A cysteine-free
mutant was created by mutating the cysteines in subunit I to alanines and the cysteines in
subunit III to serines (CA1CS3). The plasmid for this mutant was given to us by Robert
Gennis and was used to create two single cysteine mutants in subunit III, namely
CA1CS3-A4C and CA1CS3-S187C. The cells expressing these mutants grew similar to
wildtype and the purified proteins had spectral properties identical to wildtype (not
shown), indicating that the mutations did not alter the protein environment surrounding
the heme centers. SDS-PAGE analysis revealed that all the subunits of the mutants were
present in approximately stoichiometric amounts. The electron transfer activities of all
mutants were statistically equivalent to wildtype (Table A-I). Furthermore, the proton
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Table A-I
R.sph. Wildtype and Cysteine Mutant COX Maximal Catalytic Activities

-1 a

Activity (s )
Wildtype
CA1CS3

b

1370 ± 130
1390 ± 140

CA1CS3-A4C

1320 ± 150

CA1CS3-S187C

1260 ± 120

a

Maximum catalytic activity measured via oxygen electrode (50 mM potassium
phosphate, pH 7.4; 0.1% DM; 50 M cytochrome c, 18 mM ascorbate, 0.6 mM TMPD).
b
Cysteine-free mutant. The cysteines in subunit I and III were replaced with alanines and
serines, respectively.
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Figure A-2
Proton Pumping Traces for R.sph. Wildtype and Cysteine-Free COX. Proton
pumping activity was measured by stopped-flow absorbance spectroscopy on an Applied
Photophysics SV.20 Reaction Analyzer. The reaction commenced upon mixing
reconstituted COX with reduced cytochrome c. Phenol red was included as a pH indicator
to monitor pH-induced changes in absorbance at 556 nm, an isosbestic point for
cytochrome c reduction. Acidification induced by the proton pumping activity of
reconstituted COX in the presence of valinomycin is shown in the lower traces. The
alkalinization phase (upper traces) results from the consumption of protons when
reconstituted COX undergoes turnover in the presence of CCCP and valinomycin. This
+ trace is proportional to the number of electrons transferred to COX. The H /e ratio is
calculated from the extents of the lower and upper traces. Displayed are representative
traces for a 5 turnover experiment (0.05 M COX, 1 M ferrocytochrome c, 5 M CCCP
+ and/or 5 M valinomycin, pH 7.2). A) Wildtype COX vesicles had H /e ratios of 0.9 ±
+ 0.2 (5 turnovers). B) Cysteine-free (CA1CS3) COX vesicles had H /e ratios of 0.9 ± 0.1
(5 turnovers).
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pumping H+/e- ratio of CA1CS3 (0.9 ± 0.1) was equivalent to wildtype (0.9 ± 0.2) as
shown in Figure A-2. These preliminary results indicate that these mutants are likely to
be suitable for site-directed fluorescence studies, having functional properties similar to
wildtype. These mutants are of value for directing thiol-reactive probes to the n-terminus
of subunit III (CA1CS3-A4C), and for studying the conformation of the subunit III
periplasmic loop which may be linked to the redox activity of the enzyme (CA1CS3S187C).

Labeling Wildtype COX Subunit III with Thiol-Reactive Fluorophores
Wildtype R.sph. COX was used to develop fluorophore labeling protocols by
virtue of the fact that subunit III contains three native cysteines and the native cysteines
in the other subunits are substantially less reactive, being involved in disulfide bonds or
metal ligation. COX contains internal chromophores, so the fluorophores used for sitedirected labeling must have spectroscopic properties that do not overlap with those of
COX (Yonetani, 1961; Vanneste, 1966; Lambeth et al., 1973). Other factors to consider
when selecting fluorophores are as follows: 1) smaller probes are less likely to be
excluded from the reaction site due to stearic interference and will be more confined to a
discrete, localized area, 2) probes with faster and more specific thiol-reactivity will have
reduced cross-reactivity with amine groups, and 3) the hydrophobicity of a probe
determines whether it will react with buried or solvent-accessible residues. Due to their
conformity to the above criterion and their use in other protein conformation studies, two
fluorescent probes were identified as candidates for these experiments. IAEDANS is a
hydrophilic probe which undergoes spectral shifts and changes in emission intensity in
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response to alterations in aqueous solvation (Hudson and Weber, 1973; Haughland,
2002). It also has a relatively long fluorescence lifetime making it suitable for anisotropy
experiments (Haughland, 2002). MIANS is a hydrophobic probe with emission
properties highly sensitive to changes in ionic strength and hydrophobicity (Abbott et al.,
2000; Haughland, 2002).
Both IAEDANS and MIANS were found to react efficiently and specifically with
the native cysteines contained in COX subunit III. When labeled COX-AEDANS and
COX-MIANS were denatured and run out on an SDS-PAGE gel, the fluorescence signal
was localized to the subunit III band (Figure A-3). Absorbance spectroscopy revealed
that COX-MIANS contained 2-3 MIANS molecules per COX molecule and that COXAEDANS contained two AEDANS molecules per COX (Table A-II). The subunit III
peak in the MALDI-TOF mass spectrum of COX-AEDANS was shifted by a mass
equivalent to two AEDANS molecules (615 Da). Given that the subunit contains three
native cysteine residues, these results indicate specific and efficient labeling of COX
subunit III.
Two of the subunit III cysteines (C143 and C146) are located on helix 4 about
half way through the bilayer. The other cysteine (C223) is located on helix 6, about a
quarter of the way into the bilayer on the cytoplasmic side. The environment surrounding
C223 is more hydrophobic than helix 4, and so it is possible that the hydrophilic
IAEDANS probe labels the two cysteines on helix 4, and that the more hydrophobic
MIANS probe labels both helix 4 and 6.
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Figure A-3
Bioconjugation of R.sph.wildtype COX with IAEDANS and MIANS fluorophores.
A) Wildtype COX labeled with IAEADANS. COX samples were diluted to 1-5 M in
20 mM HEPES, pH 8.0. IAEDANS was added at COX:IAEDANS stoichiometry of 1:10,
and the reaction was incubated in the dark at room temperature for 1 hour. A 100 molar
excess of DTT was used to quench unreacted IAEDANS, which was then removed by
successive washes in Millipore YM-100 Microcon filter devices. Seven g of COXAEDANS were denatured with 3% SDS in Laemmli buffer for 45 minutes at 37°C.
Electrophoresis was conducted at 120 V for 2.5 hours on a 16% acrylamide gel
containing 6 M urea and 0.1% SDS, pH 8.8. An image of the fluorescence emission was
recorded on a Fuji LAS-4000 imager (left panel). The gel was then stained with
Coomassie G-250 and an image was recorded (right panel). B) Wildtype COX labeled
with MIANS. Labeling protocol was the same as for IAEDANS, except the buffer was 20
mM HEPES, pH 7.5, 0.1% DM, and a COX:MIANS stoichiometry of 1:5 was used.
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Table A-II
Stoichiometry of Flourophore Labeling in R.sph. Wildtype COX
PROBE:COX
UV-Visa

PROBE:SIII
Mass Specb

COX-AEDANS

2.1 ± 0.3

2

COX-MIANS

2.5 ± 0.4

-

a

Number of probe molecules per COX determined by UV-Vis spectroscopy using
extinction coefficients for oxidized COX and for the probe at 336 nm (IAEDANS) or 322
nm (MIANS), as described in the text.
b
MALDI-TOF mass spectrometry was conducted on COX-AEDANS and the subunit
peaks were compared to those of wildtype. The subunit III peak was shifted by the mass
of two AEDANS molecules.
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Characterizing the Fluorescent Properties of COX-AEDANS in the O and PM States
The fluorescence properties of COX-AEDANS were compared in the O and the
PM states in order to assess any putative conformational changes taking place during the
transition between these catalytic states during the redox cycle of COX. The emission of
AEDANS is highly sensitive to the degree of aqueous solvation; spectral shifts and
intensity changes are observed corresponding to the hydrophobicity of the probe’s
environment (Hudson and Weber, 1973). The maximal emission wavelength of COXAEDANS in the O state (471 ± 2 nm) did not change when the enzyme was converted to
the PM state (Table A-III). The shapes of the emission spectra in the O and the PM states
were also similar (Figure A-4A). First derivative plots of the emission spectra did not
elucidate any differences (Figure A-4B), indicating that there were no spectral shifts in
AEDANS fluorescence when COX was in the O versus the PM state. This indicates that
the hydrophobicity of the environment surrounding the probes was not different in the O
and PM states.
Fluorescence anisotropy is a measure of the degree of rotational freedom allowed
to a fluorophore (Haughland, 2002; Lakowicz, 2006). When a probe is conjugated to a
protein, the anisotropy of the probe is influenced by the flexibility of that region of the
protein. The anisotropy of COX-AEDANS in the O and PM states was assessed in order
to probe for changes in protein flexibility. The anisotropy of AEDANS did not change
when COX was in the O state (0.21 ± 0.01) versus the PM state (Table A-III), which
indicates that the protein environment surrounding the probe had about the same degree
of flexibility in the two states.
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Table A-III
Emission and Anisotropy Properties of COX-AEDANS in the O and PM States.
a

b

O State

PM State

MAX

c

471 ± 2

471 ± 1

d

286 ± 6

262 ± 16

0.21 ± 0.01

0.21 ± 0.02

IMAX
e


a

The O state was formed by exposing COX-AEDANS to potassium ferricyanide and then
washing in 20 mM HEPES, pH 8.0 to remove excess reagent.
b
The PM state was formed by exposing oxidized COX-AEDANS to carbon monoxide
and air at pH 8.0.
c
The wavelength of maximal emission intensity.
d
Fluorescence emission intensity at the maximal emission wavelength.
e
The anisotropy of the sample at MAX
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Figure A-4
Fluorescence Properties of COX-AEDANS in the O and PM State. A) Emission
spectra of the O (black) and PM (red) states. Oxidized COX-AEDANS was diluted to 1
M in 20 mM HEPES, 0.1% DM, pH 8.0. The emission spectrum was recorded using an
excitation wavelength of 336 nm, a PMT setting of 850 V and slit widths of 5 nm for both
excitation and emission. The sample was then exposed to CO and air and allowed to sit
for 15 minutes to form the PM state. The emission spectrum were then recorded for the PM
state. B) A first derivative plot of the emission spectra of the O (black) and PM (red) states
of COX-AEDANS. C) Emission intensity at 471 nm during the transition from the O to
the PM state. This is an example trace of the emission intensity following exposure of
oxidized COX-AEDANS to CO and air. The decrease in fluorescence observed was
biphasic. The first phase was not always observed and had a time constant of  = 0.6 min.
The second phase had a time constant of  = 526 min. Total decreases in fluorescence
intensity ranged from 2-16%, which could be correlated to an inner filter effect, i.e.
changes in absorbance of the sample at the excitation and emission wavelengths resulted
in a decrease in emission intensity.
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There was a statistically significant decrease in AEDANS emission intensity when COX
was in the PM versus the O state (Table A-III, Figure A-4A). The kinetics of the
fluorescence emission decrease were monitored during the O to the PM state following
exposure to CO and air (Figure A-4C). The decrease was biphasic, although the initial
fast phase was not reproducible. Neither of the time constants ( = 0.6 min,  = 526
min) matched the kinetics of the O  PM transition as measured by absorbance
spectroscopy, which was a monophasic process (of  = 1.3 min). Since there were no
corresponding spectral shifts, this decrease in emission cannot be attributed to a change in
the hydrophobicity surrounding the probe. It could be due to either the introduction of a
quenching species or due to an inner filter effect. An inner filter effect is a change in the
sample absorbance at the excitation and/or emission wavelength (Yappert and Ingle,
1989; Puchalski et al., 1991; Kubista et al., 1994). If the absorbance at 336 and/or 471 nm
of COX-AEDANS is increased in the PM versus the O state, this will filter the excitation
and emission light and decrease the fluorescence emission. This would not be reflective
of a change in fluorescence properties of the probe. The changes in emission intensity
expected from the inner filter effect were calculated from the absorbance changes at 336
and 471 nm of the COX-AEDANS sample in the O and the PM states, taking into account
that the bandwidth used for fluorescence measurements was five times larger than the
bandwidth used for measuring the absorbance at these wavelengths (Yappert and Ingle,
1989; Puchalski et al., 1991; Kubista et al., 1994). The expected changes due to the inner
filter effect were such that the emission changes observed between the O and the PM
states could be attributed to the inner filter effect.
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Taken together, these results indicate that there are no differences in the
hydrophobicity or flexibility of COX subunit III in the regions surrounding the probes on
helix four and possibly six. It may be that there are conformational changes occurring
that the experimental technique cannot measure. For instance, the helices could be
moving vertical to the plane of the membrane, which would not necessarily result in
altered hydrophobicity or flexibility. To test for this kind of motion, a single cysteine
should be introduced at the top or bottom of the transmembrane helix. If a vertical motion
is occurring in the helix, the probe may move in or out of the membrane, which would
alter its fluorescence properties. The CA1CS3-S187C mutant introduces a single cysteine
into subunit III on the periplasmic side of helix five at the bilayer interface. Conducting
these experiments on that mutant could be of benefit.
The sensitivity of these experiments is limited by the broad bandwidth that is
required to receive an adequate signal. The 10 nm bandwidth used makes the technique
less sensitive to spectral shifts and it augments the inner filter effect. One way of
circumventing this problem would be to use a probe with a higher extinction coefficient
at the excitation wavelength. This proves to be difficult given that COX has internal
chromophores and that the probes must have spectroscopic properties which do not
overlap with COX absorbance. Another option for reducing the bandwidth is to use a
more sensitive instrument. The feasibility of conducting these experiments on an ISS PC1
photon counting spectrophotometer is being assessed.
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Conclusions
Definitive evidence for conformational movement in COX subunit III was not
observed when the native cysteines of subunit III were labeled with AEDANS and the
fluorescence properties of the O and PM state were compared. The probes are most likely
localized within the bilayer on helix four and possibly six. Vertical motion within the
plane of the bilayer would not be easily assessed by probe in these locations, so
conformational changes in this vicinity cannot be ruled out. The techniques developed
should be useful for examining potential motion in other areas of subunit III which are
more likely to undergo conformational change. Toward that end, the single cysteine
mutants A4C and S187C were constructed and their functional properties were found to
be similar to wildtype, making them suitable candidates for these studies. The minor
absorbance changes in COX at the excitation and emission wavelengths of the probe are
magnified by the broad bandwidth required for these experiments. In order to detect
potentially small fluorescence changes, an instrument with higher sensitivity is required.
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LIST OF ABBREVIATIONS

A560

Absorbance measured at 560 nm

A605

Absorbance measured at 605 nm

aa3

Hemes a and a3 of cytochrome c oxidase

ATP

Adenosine 5’-triphosphate

BN-PAGE

Blue native polyacrylamide gel electrophoresis

bp

Basepair

CAPS

N-cyclohexyl-3-aminopropanesulfonic acid

CCCP

Carbonyl cyanide m-chlorophenylhydrazone

CHCA

α-cyano-4-hydroxysuccinnamic acid

CHES

N-cyclohexyl-2-aminoethanesulfonic acid

CO

Carbon monoxide

COV

Phospholipid vesicles containing cytochrome c oxidase

COX

Cytochrome c oxidase

Da

Dalton

DCCD

N, N’-dicyclohexylcarbodiimide

DM

Dodecyl-β-D-maltoside

DNA

Deoxyribonucleic acid

DNAse

Deoxyribonuclease

dNTP

Deoxy nucleotide triphosphate

EAM

Energy absorbing matrix
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EDTA

Ethlenediaminetetraacetic acid

F State

An oxyferryl intermediate of cytochrome c oxidase

FAD+

Flavin adenine dinucleotide

FADH2

Reduced flavin adenine dinucleotide

H+/e-

Ratio of protons translocated to electrons transferred

H-bond

Hydrogen bond

HEPES

N-(2-hydroxyethyl) piperazine-N’-2-ethanesulfonic acid

IAEDANS

5-((((2-iodoacetyl)amino)ethyl)amino) naphthalene-1-sulfonic acid

I-II COX

Cytochrome c oxidase in which subunit III is removed either
biochemically or genetically

I-IIBD COX

Cytochrome c oxidase in which subunit III is biochemically
depleted

I-IIGD COX

Cytochrome c oxidase in which subunit III is genetically deleted

kb

Kilobase

kD

Kilodalton

LB

Luria-Bertani

m/z

Mass to charge ratio

mA

Milliamps

MALDI-TOF

matrix assisted laser desorption time of flight

MIANS

2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid

NAD+

Nicotinamide adenine dinucleotide

NADH

Reduced nicotinamide adenine dinucleotide

O State

The oxidized state of cytochrome c oxidase

OD660

Optical density measured at 660 nm

P.dent.

Paracoccus denitrificans
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pCOV

Cytochrome c oxidase vesicles purified by discontinuous sucrose
gradient ultracentrifugation

PDB

Protein databank

pH

-log [H+]

PL1

The phospholipid bound in the v-shaped cleft of subunit III at
position 1

PL2

The phospholipid bound in the v-shaped cleft of subunit III at
position 2

PM State

An oxyferryl intermediate of cytochrome c oxidase

PMSF

Phenylmethylsulfonylfluoride

R State

The reduced state of cytochrome c oxidase

R.sph.

Rhodobacter sphaeroides

RCR

Respiratory control ratio

RCRval

Respiratory control ratio relative to the valinomycin rate

R-O

Reduced minus oxidized

SDS

Sodium dodecyl sulfate

SDS-PAGE

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

SI

Subunit I

SII

Subunit II

SIII

Subunit III

SIII-114

Subunit III genetically truncated after residue 114

SIV

Subunit IV

SPA

Sinapinic acid

TBS-B

Tris buffered saline containing 5% powdered milk

TFA

Trifluoroacetic acid
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TMPD

N, N, N’, N’, -tetramethyl-p-phenylenediamine

TN

Turnover number (number of electrons transferred per second per
mole of cytochrome c oxidase

Tris

Tris (hydroxymethyl) aminoethane

Val

Valinomycin

WT

Wild-type Rhodobacter sphaeroides cytochrome c oxidase

114 COX

Cytochrome c oxidase in which subunit III is genetically truncated
after residue 114
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